Teacher-to-parent communication and vision care–seeking behaviour among primary school students

Hong Kong Med J 2022 Apr;28(2):152–60  |  Epub 25 Mar 2022
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE (HEALTHCARE IN MAINLAND CHINA)
Teacher-to-parent communication and vision care–seeking behaviour among primary school students
K Du, PhD Candidate1; J Huang, PhD Candidate2; H Guan, PhD1; J Zhao, PhD1; Y Zhang, PhD Candidate1; Y Shi, PhD1
1 Center for Experimental Economics in Education, Shaanxi Normal University, Xi’an, China
2 College of Economics and Management, China Agricultural University, Beijing, China
 
Corresponding author: Dr H Guan (guanhongyu2016@163.com)
 
 Full paper in PDF
 
Abstract
Introduction: To determine the associations between teacher-to-parent communication and vision care–seeking behaviour among students.
 
Methods: This cross-sectional study included 19 934 students from 252 primary schools in two prefectures in western China. Information regarding the sampled students was collected through questionnaires and vision examinations. Eligible students with uncorrected refractive error were allocated to four groups according to whether and how parents were informed about vision problems in their children: uninformed, informed by only teachers or only students, or informed by both. The relationship between teacher-to-parent communication and vision care–seeking behaviour was analysed by multiple logistic regression.
 
Results: Among valid responses (n=2922) analysed, 42.3% (n=1235) of parents were not informed about vision problems in their children. Teacher-to-parent communication enabled 35.9% (n=1050) of parents to learn about vision problems in their children. When only teachers informed parents, the odds of students having refraction examinations (odds ratio [OR]=1.499; P=0.002) and spectacles ownership (OR=1.755; P=0.002) were significantly higher than for students in the uninformed group. When both students and teachers informed parents, the odds of students having refraction examinations (OR=5.565; P<0.001) and spectacles ownership (OR=7.935; P<0.001) were highest.
 
Conclusions: Knowledge of vision problems is an essential step in vision care for students. Teacherto- parent communication concerning vision problems is positively associated with the rate of vision care–seeking behaviour. Teacher-to-parent communication provides an important route for parents to learn about vision problems in their children.
 
 
New knowledge added by this study
  • Knowledge of vision problems is an essential step in vision care for students. More than 40% of parents were not informed by students or teachers about vision problems in their children.
  • Teacher-to-parent communication is significantly associated with students having refraction examination and spectacles ownership.
  • Teacher-to-parent communication provides an important method for parents to learn about vision problems in their children; it also reinforces the effects of students informing their parents.
Implications for clinical practice or policy
  • Policymakers should carefully consider the role of teachers in vision care for students; teacher-to-parent communication is a cost-effective way to enhance vision care–seeking behaviour among students.
  • Teachers should participate in vision care for students, at least in the form of communication with parents.
 
 
Introduction
Uncorrected refractive error is the leading cause of visual impairment among children worldwide; it affects nearly 13 million children under the age of 16 years, half of whom live in China.1 Uncorrected refractive error can lead to various broader issues if not treated in a timely manner.2 Uncorrected refractive error in school-aged children reportedly has negative effects on academic performance,3 physical and mental health, and quality of life.4 Fortunately, over 80% of refractive error can be easily and safely corrected by accurately prescribed spectacles.5 However, the correction rate in rural areas in China is very low.6 A study in 2014 revealed that in rural China, as few as one in six children needing spectacles actually wears them.7
 
The lack of vision problem awareness at the family level is an important contributing factor in the low rate of refractive correction in rural areas.8 There are two main ways for parents to learn about vision problems in their children: from the children themselves and from their teachers. Information conveyed by a teacher is more likely to receive parental attention and cause parents to take action.9 Teacher-to-parent communication (TPC) allows parents and teachers to exchange information, strengthen feelings of mutual obligation and trust, and coordinate efforts to help students thrive in terms of mental health, school engagement, and school performance.10 11
 
However, the relationship between TPC and vision care–seeking behaviour among students is not well-investigated, particularly in more realistic settings. Researchers have indicated that teachers have an important role in vision care for students. Chinese rural teachers can perform vision screening accurately for students with only moderate training.12 Teachers can help to improve the uptake of spectacles and the use of spectacles among students who participate in free spectacles distribution programmes.13 Considering the potentially important role of teachers in vision care for students, further analyses are needed regarding the interactions between TPC and vision care–seeking behaviour among students.
 
In this study, our overall goal was to identify the associations between TPC and vision care–seeking behaviour among students. Specifically, when teachers informed students’ parents that their children could not see the blackboard clearly, we assessed whether the information sharing interacted with vision care–seeking behaviour among students, including refraction examinations and spectacles ownership. To meet this goal, we had three specific objectives. First, we documented the rates of vision care–seeking behaviour in four groups, according to whether and how the parents were informed about vision problems in their children. Second, we explored the relationship between TPC and refraction examination history. Third, we investigated the association between spectacles ownership and TPC.
 
Methods
Setting
The data analysed in this study were collected in two adjacent provinces (Gansu and Shaanxi) of western China in September 2012. In each of the provinces, one prefecture that is of the province was chosen for this study: Tianshui prefecture in Gansu and Yulin prefecture in Shaanxi. For sample selection, we obtained a list of all rural primary schools in each prefecture. We randomly selected 252 townships, then randomly selected one school per township for inclusion in the study. Within each school, one class was randomly chosen in each of the fourth and fifth grades. This cross-sectional study was approved by Stanford University (No. ISRCTN03252665, registration site: http://isrctn.org).
 
Data collection
The data collected in this study included three parts: a standardised maths test, questionnaires, and a vision screening. The standardised maths test was timed (25 min) and proctored by two study enumerators at each school. Mathematics testing was conducted to reduce the effect of home learning on performance; this facilitated greater focus on classroom learning.7 We standardised the baseline maths score, such that the mean score was 0 and the standard deviation was 1.
 
Questionnaires were used to collect data from students, including grade, gender, boarding status, the main caregivers, parental education, and siblings. A parental questionnaire asked whether any family members wore spectacles and whether the parents thought spectacles were useful. Family wealth was calculated by summing the values, as reported in the China Rural Household Survey Yearbook,14 of the items on the list of 13 durable consumer goods owned by the family. A parental questionnaire asked about ownership of 13 selected items as an index of family wealth. The distance from the school to the county seat was approximated using Google Maps (Google LLC, Mountain View [CA], United States).
 
Vision care–seeking behaviour was measured via self-reporting on the questionnaires administered to students; it included refraction examination history (defined as undergoing a refraction examination in a professional institution before the day of questionnaire administration) and spectacle ownership (defined as the possession of spectacles before the day of questionnaire administration). To reduce the measurement error, we also asked these two questions to each student’s parents. Individuals with inconsistent answers were excluded from the study.
 
Teacher-to-parent communication was measured by asking parents whether they had been informed by teachers that their children could not see the blackboard clearly. Students were also asked whether they had informed their parents about their vision problems. Based on the responses to these two questions, we allocated all students with vision problems into four groups: neither teachers nor students informed parents (uninformed group), only students informed parents, only teachers informed parents, and both teachers and students informed parents (Fig).
 

Figure. Flowchart of participants in the study
 
Visual acuity assessment and refraction
After completion of the maths test and questionnaires, a two-part eye examination was administered to students by a team of qualified optometrists who followed a prescribed protocol to ensure standardisation and quality.
 
First, visual acuity screenings were administered using Early Treatment Diabetic Retinopathy Study eye charts, which are regarded as the worldwide standard for accurate visual acuity measurement.15 Visual acuity values, measured by the Early Treatment Diabetic Retinopathy Study eye charts, were transformed into logarithm of the minimum angle of resolution (logMAR) units; logMAR is one of the most commonly used continuous scales in the field of ophthalmology/optometry.3 15 Students who failed the visual acuity screening test (using a visual acuity cut-off of ≤6/12 in either eye) were enrolled in a second vision test.
 
The second vision test was conducted by a team of one optometrist, one nurse, and one staff assistant. Children with uncorrected visual acuity ≤6/12 in either eye underwent cycloplegia with up to 3 drops each of cyclopentolate 1% and proparacaine hydrochloride 0.5%. To ensure that vision problems among the students could be treated using spectacles, the students were examined via automated refraction (Topcon KR 8900; Topcon, Tokyo, Japan) and subjective refinement by a local optometrist who had previously been trained by experienced optometrists from Zhongshan Ophthalmic Center.
 
Vision problems in the students could be corrected using spectacles if they met the following criteria: first, an uncorrected (ie, without spectacles) visual acuity of ≤6/12 in either eye and refractive error within the limits associated with significantly greater improvement in visual acuity upon correction (myopia ≤-0.75 dioptres, hyperopia >=2.00 dioptres, or astigmatism [non-spherical refractive error] >=1.00 dioptres)7; second, visual acuity improvement to >6/12 in both eyes was possible with spectacles.
 
Statistical methods
Descriptive statistical analyses were performed to summarise the demographics of the students and to compare the proportions of students who had undergone refraction examination and owned spectacles among four groups by using the Chi squared test and one-way analysis of variance. Refraction examination and spectacle ownership were both regarded as dummy variables that equalled one if the corresponding behaviour had occurred before the study.
 
Multiple logistic regression was conducted to ascertain the relationship between TPC and vision care–seeking behaviour, including refraction examination history and spectacle ownership. In all regression analyses, the same covariates were controlled. Variables included standardised maths score, grade (grade 5=1), sex (male=1), boarding status (boarding at school=1), logMAR (continuous scale of visual acuity), whether parents are the main caregivers (yes=1), parental education for both mother and father (completed >=12 years of education=1), siblings (at least one sibling=1), whether any family members wear spectacles (yes=1), whether parents think spectacles are useful (yes=1), family wealth, and distance from school to the county seat. A P value of <0.05 was regarded as a statistically significant difference. All analyses were performed using Stata 14.1 (Stata Corp, College Station [TX], United States).
 
Results
Among 19 934 students in 252 schools, 4839 (24.3%) students failed the vision screening. In total, 3177 (65.7%) students in 250 schools were eligible for spectacles to improve visual acuity (two schools were excluded because no students at either school met the inclusion criteria). After the exclusion of students with missing information, the remaining 2922 students were divided into four subgroups. In our study, 42.3% (n=1235) of parents were not informed by either their children or their children’s teachers. Teacher-to-parent communication enabled 35.9% (n=1050) of parents to learn about vision problems in their children. In total, 20.2% (n=590) parents were informed only by teachers and 15.7% (n=460) were informed by both teachers and students, respectively (Fig).
 
The mean (± standard deviation) age of all students with vision problems was 10.51 ± 1.10 years (range, 8-15). Among all respondents, 1418 (48.5%) were boys and 1504 (51.5%) were girls. Most students’ main caregivers were their parents (86.4%). Other participants’ characteristics are shown in Table 1, including the comparison of characteristics among the four groups.
 

Table 1. Characteristics of children with correctable refractive error, stratified according to subgroup* (n=2922 included in subgroup analyses)
 
The rate of vision care–seeking behaviour among all students was very low. The number of students who received vision care services decreased gradually at each step. In all, 57.7% (n=1687) of parents were informed about vision problems in their children; only 32.7% (n=954) of all parents took their children for refraction examinations. Finally, only 19.2% (n=560) of students owned spectacles before the study (Table 2). The rates of vision care–seeking behaviour significantly differed among the four groups. When comparing the rates of refraction examination history and spectacle ownership among three types of informed groups with the uninformed group, we found significant differences (P<0.001) in all comparisons (Table 2). In the uninformed group, comparatively few parents took their children to receive a refraction examination and/or obtained spectacles for their children. In the group where parents were informed only by students, more children had undergone refraction examinations and/or owned spectacles than in the group where parents were informed only by teachers. When both teachers and students informed parents, the rates of refraction examinations and spectacles ownership were highest among the four groups.
 

Table 2. Vision care-seeking behaviours among subgroups of children with correctable refractive error (n=2922)
 
In the multiple logistic regression analyses of potential predictors of refraction examination, we found that information sharing (including TPC) was significantly associated with refraction examination history (Table 3). Compared with the uninformed group, the odds of students having a refraction examination was higher in each of the other three groups. When only teachers informed parents, the odds ratio (OR) was 1.499, which was lower than in the group where only students informed parents (OR=2.839). When both students and teachers informed parents, the odds of students having a refraction examination was highest (OR=5.565). Additionally, the following characteristics were significantly positively associated with refraction examination history: receiving a better maths score (P=0.031), being male (P=0.015), having a worse visual ability (P<0.001), having at least one other family member who wears spectacles (P<0.001), being in the top wealth tercile (P<0.018), and having parents who think that spectacles are useful (P<0.001) [Table 3].
 

Table 3. Multiple logistic regression analyses of potential predictors of refraction examination (n=2922)
 
Multiple logistic regression analyses were used to estimate the relationship between TPC and spectacles ownership (Table 4). Teacher-to-parent communication was significantly positively associated with spectacles ownership, regardless of whether students informed parents about their vision problems. The odds of students having spectacles ownership in the group where parents were informed by both teachers and students (OR=7.935) was almost 1.8 times that in the group where parents were informed only by students (OR=4.413). The odds of students having spectacles ownership in the group where parents were informed by students only was twice that in the group where parents were informed only by teachers (OR=1.755). Furthermore, the following characteristics were significantly positively associated with spectacles ownership: having worse visual acuity (P<0.001), having parents as the main caregivers (P<0.017), having at least one other family member who wears spectacles (P<0.001), and having parents who think spectacles are useful (P<0.001). Notably, students with at least one sibling (P=0.003) were more unlikely to purchase spectacles (Table 4).
 

Table 4. Multiple logistic regression analyses of potential predictors of spectacles ownership (n=2922)
 
Discussion
Factors affecting vision care–seeking behaviour
In this study, we found that the rate of vision care–seeking behaviour was very low in our sample area, similar to previous results.16 17 There are two possible reasons for the low vision care–seeking behaviour rate. First, parents may not know that their children cannot see the blackboard clearly; thus, they will not actively seek vision care services. Second, the number of students receiving vision care services has been decreasing throughout the process of three stages: parental knowledge that their children have vision problems, parental action to ensure their children undergo refraction examinations, and parental acquisition of spectacles for their children. Furthermore, despite sufficient information, many parents do not seek vision care services because of misinformation or misunderstanding.18 19
 
Knowledge of vision problems is the initial aspect of the vision care–seeking process for students. The rates of refraction examination history (18.1%) and spectacles ownership (6.6%) were the lowest in the uninformed group, which comprised more than 40% of parents in this study. When parents were informed by students and/or teachers, the rate of vision care–seeking behaviour was much higher. Teacher-to-parent communication provides an important method for parents to learn about vision problems in their children. In this study, 20.2% of parents learned about their children’s vision problems only from teachers.
 
Effects of teacher-to-parent communication on vision care–seeking behaviour
Although a considerable proportion of students did not receive vision care in the care-seeking process, TPC can reduce this to some extent. When both teachers and students informed parents, the rate of spectacles ownership was the highest. In the group that parents were informed by both teachers and students, 46% of students finally received spectacles, which is 7-times more students than in the group in which parents were not informed. Furthermore, the odds of students having refraction examination and spectacles ownership were higher in the group where parents were informed only by students than in the group where parents were informed only by teachers. These additional opportunities may increase the likelihood that parents act to correct those vision problems.
 
There are two possible explanations for the positive association between TPC and vision care–seeking behaviours among students in this study. Teacher-to-parent communication provides an important channel for parents to learn about the vision problems in their children, which is a starting point and key aspect of vision care for students. Second, TPC reinforces the effects of students informing their parents. Compared with the group where parents were informed only by students, the rates of refraction examinations and spectacles ownership were nearly twofold greater in the group where parents were informed by both students and teachers. This was presumably because parents learned about vision problems in their children from two sources; the information from the students was reinforced by the information from the teacher.20
 
Implications of promoting teacher-to-parent communication
Small efforts by teachers may have great benefits in terms of vision care for students. Compared with intervention programmes to increase the correction rate,7 21 the results of present study indicate that TPC is both easy and cost-effective. Teachers should inform parents that their children cannot see the blackboard clearly. Studies of free spectacles distribution programmes have also shown that teachers can improve spectacles usage rates among students who have received spectacles.13 22 Moreover, wearing spectacles can improve academic performance,7 21 implying that TPC may both increase the correction rate and have a positive role in academic performance. Therefore, policymakers should carefully consider the role of teachers in protecting vision among students. Indeed, the Chinese Government has noted that multilateral cooperation (involving teachers, schools, parents, and society in general) should be encouraged to protect vision among students, in an effort to improve health status among young people by 2020.23
 
Unfortunately, the TPC ratio is very low. A recent study in China noted that approximately half of the parents and teachers communicate, in any form, during the course of an entire school year.24 In our study, the proportion of parents who were informed by teachers was only approximately 36%, including parents informed only by teachers (20%) and parents informed by both teachers and students (16%). This is presumably because teachers do not know a particular student’s vision status because it is not a vital consideration for most education work. Vision screening is the best method to detect vision problems.25 The education bureau and the health bureau should conduct routine vision screenings and encourage teachers to engage in vision protection (eg, communicate with parents about vision problems in students).5 25 If those stakeholders began to take action, more parents will learn about vision problems in their children and seek vision care services.
 
Effects of students’ informing on vision care–seeking behaviour
In the present study, the effects of students informing parents were greater than the effects of teachers informing parents when only one party informs the parents of vision problems. This finding implies that parents were more likely to act when they received information from students. However, students are often unaware of vision problems. Thus, teachers have an important effect; a previous survey reported that teachers were most likely to perceive visual impairment in children (70.6%), followed by the children’s parents (18.9%) and by the children themselves (7.9%).26 Therefore, careful attention is needed concerning the role of teachers in identifying vision problems, encouraging communication between students and their parents about such problems.
 
Limitations
There were three important limitations in this study. First, the study could not investigate any causal link between TPC and vision care–seeking behaviour because of the cross-sectional design. However, the findings provide a foundation for follow-up analyses of causality. Second, this study only focused on whether teachers informed parents about vision problems in their children; it did not collect information concerning how parents were informed. Teacher-to-parent communication may happen in many ways, particularly in the internet era (eg, teachers communicate with parents via instant messenger). Additional research is needed to determine the types of TPC that are most effective in vision care for students. Third, the participants in this study were recruited from two provinces in rural north-western China, which limits the external validity of the findings. Despite this limitation, in the context of widespread uncorrected vision impairment among students,27 our study still has important implications for improving the uptake rate of vision care services.
 
Conclusions
Teacher-to-parent communication can significantly enhance the rates of refractive examinations and spectacles uptake through direct and indirect ways. Not only teacher informing provides a new channel for parents to learn about their students’ vision problems, but also reinforce the information told by students. Teacher-to-parent communication is an easy and cost-effective way to improve the rate of vision care–seeking behaviour. Policymakers should encourage teachers to be more involved in students’ vision protection, such as motivating teachers to communicate timely with parents about the students’ vision status.
 
Author contributions
Concept or design: K Du, J Huang.
Acquisition of data: H Guan, Y Shi.
Analysis or interpretation of data: All authors.
Drafting of the manuscript: K Du.
Critical revision of the manuscript for important intellectual content: All authors.
 
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have no conflicts of interest to disclose.
 
Funding/support
This research was supported by the 111 Project (Ref: B16031). H Guan has received funding from the National Natural Science Foundation of China (Ref: 71803107). The funders had no role in the design of the study, the acquisition or interpretation of results, or the decision to submit the manuscript for publication.
 
Ethics approval
This study was approved by Stanford University (No. ISRCTN03252665). Permission was received from local boards of education in each region and the principals of all schools. The presented data are anonymised, and the risk of identification is low. The principles of the Declaration of Helsinki were followed throughout.
 
References
1. Jonas JB, Xu L, Wei WB, et al. Myopia in China: a population-based cross-sectional, histological, and experimental study. The Lancet 2016;388:S20. Crossref
2. Smith TS, Frick KD, Holden BA, Fricke TR, Naidoo KS. Potential lost productivity resulting from the global burden of uncorrected refractive error. Bull World Health Organ 2009;87:431-7. Crossref
3. Yi H, Zhang L, Ma X, et al. Poor vision among China’s rural primary school students: Prevalence, correlates and consequences. China Econ Rev 2015;33:247-62. Crossref
4. Chadha RK, Subramanian A. The effect of visual impairment on quality of life of children aged 3-16 years. Br J Ophthalmol 2011;95:642-5. Crossref
5. World Health Organization. Sight test and glasses could dramatically improve the lives of 150 million people with poor vision. 2006; Available from: http://www.who.int/mediacentre/news/releases/2006/pr55/en/. Accessed 9 Jan 2018.
6. He M, Xu J, Yin Q, Ellwein LB. Need and challenges of refractive correction in urban Chinese school children. Optom Vis Sci 2005;82:229-34. Crossref
7. Ma X, Zhou Z, Yi H, et al. Effect of providing free glasses on children’s educational outcomes in China: cluster randomized controlled trial. BMJ 2014;349:g5740. Crossref
8. Resnikoff S, Pasolini D, Mariotti SP, Pokharel GP. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ 2008;86:63-70. Crossref
9. Adams KS, Christenson SL. Trust and the family–school relationship examination of parent–teacher differences in elementary and secondary grades. J Sch Psychol 2000;38:477-97. Crossref
10. Franklin CG, Kim JS, Ryan TN, Kelly MS, Montgomery KL. Teacher involvement in school mental health interventions: A systematic review. Child Youth Serv Rev 2012;34:973-82. Crossref
11. Kraft M, Dougherty SM. The effect of teacher-family communication on student engagement: evidence from a randomized field experiment. J Res Educ Eff 2013;6:199-222. Crossref
12. Sharma A, Li L, Song Y, et al. Strategies to improve the accuracy of vision measurement by teachers in rural Chinese secondary schoolchildren: Xichang pediatric refractive error study (X-PRES) report no. 6. Arch Ophthalmol 2008;126:1434-40. Crossref
13. Yi H, Zhang H, Ma X, et al. Impact of free glasses and a teacher incentive on children’s use of eyeglasses: a cluster-randomized controlled trial. Am J Ophthalmol 2015;160:889-96.e1. Crossref
14. China National Bureau of Statistics. China Statistical Yearbook. Beijing, China: China State Statistical Press; 2013.
15. Camparini M, Cassinari P, Ferrigno L, Macaluso C. ETDRS-Fast: implementing psychophysical adaptive methods to standardized visual acuity measurement with ETDRS charts. Invest Ophthalmol Vis Sci 2001;42:1226-31.
16. Qian DJ, Zhong H, Nie Q, Li J, Yuan Y, Pan CW. Spectacles need and ownership among multiethnic students in rural China. Public Health 2018;157:86-93. Crossref
17. Zhao J, Guan H, Du K, et al. Visual impairment and spectacles ownership among upper secondary school students in northwestern China. Hong Kong Med J 2020;26:35-43. Crossref
18. Dudovitz RN, Izadpanah N, Chung PJ, Slusser W. Parent, teacher, and student perspectives on how corrective lenses improve child wellbeing and school function. Matern Child Health J 2016;20:974-83. Crossref
19. Senthilkumar D, Balasubramaniam SM, Kumaran SE, Ramani KK. Parents’ awareness and perception of children’s eye diseases in Chennai, India. Optom Vis Sci 2013;90:1462-6. Crossref
20. Verhulst FC, Dekker MC, van der Ende J. Parent, teacher and self-reports as predictors of signs of disturbance in adolescents: whose information carries the most weight? Acta Psychiatr Scand 1997;96:75-81. Crossref
21. Ma Y, Congdon N, Shi Y, et al. Effect of a local vision care center on eyeglasses use and school performance in rural China: a cluster randomized clinical trial. JAMA Ophthalmol 2018;136:731-7. Crossref
22. Wang X, Ma Y, Hu M, et al. Teachers’ influence on purchase and wear of children’s glasses in rural China: The PRICE study. Clin Exp Ophthalmol 2019;47:179-86. Crossref
23. Ministry of Education, PRC Government. Ministry of education on implement plan for comprehensive prevention and control of myopia among children and adolescents. Available from: http://www.moe.gov.cn/srcsite/A17/moe_943/s3285/201808/t20180830_346672.html. Accessed 9 Jan 2020.
24. Li G, Lin M, Liu C, Johnson A, Li Y, Loyalka P. The prevalence of parent-teacher interaction in developing countries and its effect on student outcomes. Teach Teach Educ 2019;86:102878. Crossref
25. Glewwe P, Park A, Meng Z. A better vision for development: eyeglasses and academic performance in rural primary schools in China. J Dev Econ 2016;122:170-82. Crossref
26. Alves MR, Temporini ER, Kara-José N. Ophthalmological evaluation of schoolchildren of the public educational system of the city of São Paulo, Brazil: medical and social aspects [in Portuguese]. Arq Bras Oftalmol 2000;63:359-63. Crossref
27. Ma Y, Zhang X, He F, et al. Visual impairment in rural and migrant Chinese school-going children: prevalence, severity, correction and associations. Br J Ophthal 2022;106:275-80. Crossref

Antibiogram data from private hospitals in Hong Kong: 6-year retrospective study

Hong Kong Med J 2022 Apr;28(2):140–51  |  Epub 8 Apr 2022
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Antibiogram data from private hospitals in Hong Kong: 6-year retrospective study
Leo Lui, MB, BS, FHKAM (Pathology); LC Wong, MSc; H Chen, MB, BS, FHKAM (Community Medicine); Raymond WH Yung, MB, BS, FHKAM (Pathology); for The Working Group of Collaboration between CHP and Private Hospitals on Safe Use of Antibiotics and Infection Control
1 Infection Control Branch, Centre for Health Protection, Hong Kong SAR Government, Hong Kong
2 Department of Pathology (Clinical Microbiology), Hong Kong Sanatorium & Hospital, Hong Kong
 
Corresponding author: Dr Leo Lui (leo_lui@dh.gov.hk)
 
 Full paper in PDF
 
Abstract
Introduction: The surveillance of antibiotic resistance is critical for the establishment of effective control strategies. The antibiotic resistance situations in private hospitals in Hong Kong have not been systematically described. The objective of the study was to analyse antibiogram data from private hospitals and describe the temporal trends of non-susceptibility percentages in this setting.
 
Methods: This retrospective descriptive study used antibiogram data from all private hospitals in Hong Kong that had been collected annually for 6 years (2014-2019). Data on six targeted bacteria and their corresponding multidrug-resistant organisms were included.
 
Results: The non-susceptibility percentages of isolates remained stable or decreased during the study period: methicillin-resistant Staphylococcus aureus had a stable prevalence of approximately 20%; extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species had stable prevalences of 20% to 30% and 10% to 20%, respectively; multidrug-resistant Acinetobacter species had prevalences of approximately 2% to 8%, which decreased over time; multidrug-resistant Pseudomonas aeruginosa had prevalences of 0.0% to 0.3%; Streptococcus pneumoniae penicillin and macrolide non-susceptibility percentages were 2% to 9% and 71% to 79%, respectively. These values generally were comparable with findings from public hospitals and Residential Care Homes for the Elderly in Hong Kong. However, the prevalences of carbapenem-resistant Enterobacteriaceae, which are increasing in Hong Kong and other nations, were also increasing in our dataset despite their currently low values (<1% for Escherichia coli and <2% for Klebsiella species).
 
Conclusion: The antibiotic resistance landscape among private hospitals in Hong Kong is satisfactory overall; there remains a need for surveillance, antibiotic stewardship, and other infection control measures.
 
 
New knowledge added by this study
  • This report of antibiotic resistance prevalence includes 6 years of data from all private hospitals in Hong Kong.
  • The prevalences of methicillin-resistant Staphylococcus aureus and extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species were moderate but stable (approximately 20%).
  • The prevalences of multidrug-resistant Acinetobacter species (approximately 2%-8%) and multidrug-resistant Pseudomonas aeruginosa (0%-0.3%) were low.
Implications for clinical practice or policy
  • Antibiogram data can be used to monitor antibiotic resistance trends, which may help to guide empirical treatment and assess the effectiveness of infection control measures.
  • The lower prevalences of multidrug-resistant organisms (MDROs) in private hospitals (compared with public hospitals) may be related to the presence of additional staff members and the use of a strict MDRO carrier isolation policy.
 
 
Introduction
Surveillance is a critical aspect of antibiotic resistance control. Susceptibility data periodically collected from patients can be used to construct antibiograms for monitoring of resistance trends and guidance of empirical treatment.1
 
The Working Group of Collaboration between the Centre for Health Protection (CHP) and Private Hospitals on Safe Use of Antibiotics and Infection Control (the “Working Group”) was established to exchange information regarding infection prevention and to promote safe antibiotic use. Members included the Infection Control Branch of the CHP and the Hong Kong Private Hospitals Association. Each year, the Infection Control Branch collected from and shared the susceptibility data with private hospitals. The resulting antibiograms were uploaded to the CHP website.2
 
Hong Kong runs a dual-track healthcare system, in which the private sector complements the public system with a range of general and specialist services. In accordance with the market-set price principle, private hospitals and out-patient clinics establish their charges based on the costs of services provided. Although private sector expenses can be severalfold higher than the expenses of their public counterparts, services provided by the private sector are often considered more flexible and personalised; thus, they are more appealing to individuals with the ability and interest in payment for such services. In 2018, private hospitals provided approximately 5000 beds for >370 000 in-patients, which constituted approximately 17% of all in-patients in Hong Kong.3 4
 
The objective of this study was to analyse the antibiogram data collected from private hospitals in Hong Kong by describing the temporal trends of non-susceptibility percentages in this setting. The results may provide insights regarding the current level of antibiotic resistance in private hospitals, in comparison with other settings; they may guide the establishment of future surveillance methods.
 
Methods
Private hospitals included
The surveillance data submitted by all 12 private hospitals during the period from 2014 to 2019 were included in this study. Please refer to the Acknowledgement for the membership of the Working Group and their affiliated hospitals/institutions.
 
Targeted bacteria
Considering the antibiotic resistance situations in Hong Kong and other countries, as well as the health effects of various bacterial species, members of the Working Group agreed upon six targeted bacteria for the annual submission of antibiotic susceptibility testing (AST) results, including: Staphylococcus aureus, Escherichia coli, Klebsiella spp, Pseudomonas aeruginosa, Acinetobacter spp, and Streptococcus pneumoniae (since 2015).
 
Multidrug-resistant organisms
Resistant strains of the targeted bacteria can cause increased morbidity and mortality because of limited treatment options. International health authorities have set clear priorities in their efforts to control multidrug-resistant organisms (MDROs).5 6 The definitions for MDROs used in this study were as follows: methicillin-resistant S aureus (MRSA) demonstrated resistance to methicillin, oxacillin, cefoxitin, or cloxacillin; extended-spectrum beta-lactamase-producing (ESBL+) E coli or Klebsiella spp were defined as E coli or Klebsiella spp isolates with positive ESBL test results; carbapenem-resistant Enterobacteriaceae (CRE) were defined as E coli or Klebsiella spp with resistance to a carbapenem (ertapenem, imipenem, or meropenem); multidrug-resistant P aeruginosa (MRPA) demonstrated simultaneous resistance to 11 drugs under four classes of antibiotics (beta-lactams, carbapenems, aminoglycosides, and fluoroquinolones); multidrug-resistant Acinetobacter spp (MDRA) demonstrated simultaneous resistance to 12 drugs under five classes of antibiotics (cephalosporins, fluoroquinolones, aminoglycosides, beta-lactams [± beta-lactamase inhibitor], and carbapenems). Tests to identify MRPA and MDRA were performed in accordance with Hospital Authority guidelines, although piperacillin assessment was omitted. Multidrug-resistant strains of S pneumoniae have not been defined.
 
Data collection
The following data (concerning the previous calendar year) were annually collected from the Infection Control Teams of individual private hospitals: identification number and date for admission or attendance; location of specimen collection (in- or out-patient); specimen type (eg, sputum or mid-stream urine) and specimen date (collection, request, or laboratory registration); identification number of isolates within the same specimen; and AST results of each targeted bacterium. Only isolates from clinical specimens (rather than screening specimens) were submitted.
 
Antibiotic susceptibility testing results
The AST results were divided into three categories: “susceptible”, “intermediate”, and “resistant”. “Intermediate” and “resistant” were collectively regarded as “non-susceptible” (NS). Interpretations by private hospital microbiology laboratories were based on Clinical Laboratory Standards Institute definitions.
 
Data analysis
Repeated isolates were de-duplicated for each calendar year using the first isolate in each admission, location, specimen group, and targeted bacterium. Importantly, some isolates may not have been tested for susceptibility to all antibiotics listed. The NS percentages for each antibiotic were calculated based on the proportion of isolates tested for that antibiotic. The Cochran–Armitage trend test was used for temporal trends. P values <0.05 were considered statistically significant. All analyses were performed using Stata 14.2 (Stata Corp, College Station [TX], US).
 
Ethical approval and reporting standards
Patient consent was not obtained because aggregated patient data were used without identifying information.2 Ethics approval was obtained. This manuscript adheres to the STROBE statement checklist of cross-sectional studies for items to be included.
 
Results
The total number of isolates per year, NS percentages, and MDRO percentages for isolates from both in- and out-patients were calculated for S aureus (Table 1), E coli (Table 2), Klebsiella spp (Table 3), P aeruginosa (Table 4), Acinetobacter spp (Table 5), and S pneumoniae (Table 6). Key in-patient results are highlighted below.
 

Table 1. Non-susceptibility in Staphylococcus aureus isolates from in- and out-patients, 2014-2019
 

Table 2. Non-susceptibility in Escherichia coli isolates from in- and out-patients, 2014-2019
 

Table 3. Non-susceptibility in Klebsiella isolates from in- and out-patients, 2014-2019
 

Table 4. Non-susceptibility in Pseudomonas aeruginosa isolates from in- and out-patients, 2014-2019
 

Table 5. Non-susceptibility in Acinetobacter isolates from in- and out-patients, 2014-2019
 

Table 6. Non-susceptibility in Streptococcus pneumoniae isolates from in- and out-patients, 2014-2019
 
Staphylococcus aureus
There were approximately 4100 to 5800 S aureus isolates per year (Table 1); respiratory specimens comprised 50% and wound/pus swab specimens comprised approximately 35% (online Supplementary Table). The NS percentage for clindamycin ranged from 24% to 31%. The NS percentages for co-trimoxazole and fusidic acid were low (1%-2% and 3%-5%, respectively). Staphylococcus aureus showed full susceptibility to both vancomycin and linezolid (ie, NS percentages of 0%). The overall prevalence of MRSA was 19% to 22%. For analysis of blood specimens, 29 to 73 isolates were obtained from in-patients each year; of these, 10% to 18% were MRSA.
 
Escherichia coli
There were approximately 7900 to 9700 E coli isolates per year (Table 2); nearly 70% were from urine and approximately 10% were from wound/pus swabs. The NS percentages for amoxicillin-clavulanate and cefuroxime (parenteral) were moderately high (25%-33% and 36%-38%, respectively). The NS percentages for fluoroquinolones were also moderately high (eg, 31%-37% for levofloxacin). The NS percentages for nitrofurantoin and carbapenems were low (4%-8% and 0%-1%, respectively). In terms of MDROs, ESBL+ E coli demonstrated moderate prevalence (25%-28%), while carbapenem-resistant E coli was uncommon (0.1%-0.7%) among all isolates.
 
Klebsiella spp
There were approximately 2400 to 3400 Klebsiella isolates per year (Table 3); >30% were from urine and >30% were from respiratory specimens. The NS percentages were somewhat high: 16% to 24% for amoxicillin-clavulanate, 25% to 30% for cefuroxime (parenteral), 12% to 18% for levofloxacin, and 18% to 26% for ciprofloxacin. The NS percentage for carbapenems ranged from 0% to 2%, with an increasing trend during the study period. In terms of MDROs, ESBL+ Klebsiella demonstrated low prevalence (13%-17%), while carbapenem-resistant Klebsiella was uncommon (0.2%-1.3%) among all isolates.
 
Pseudomonas aeruginosa
There were approximately 1300 to 1800 P aeruginosa isolates per year (Table 4); approximately 60% were from respiratory specimens and 15% were from wound/pus swabs. The NS percentage for the antipseudomonal beta-lactams piperacillin-tazobactam was generally low (6%-11%), whereas it was very high for ticarcillin-clavulanate (63%-74%). The NS percentages for aminoglycosides were also generally low (3%-11% for gentamicin and 1%-5% for amikacin). The NS percentage for ciprofloxacin remained consistent throughout the study period (14%-15%). The prevalence of MRPA was very low (0.0%-0.3%).
 
Acinetobacter spp
There were approximately 400 to 500 Acinetobacter isolates per year (Table 5); they were mostly from respiratory specimens, wound/pus swabs, and urine (70%, 12%, and 10%, respectively). The NS percentages for sulbactam-containing antibiotics were 7% to 17% (ampicillin-sulbactam) and 8% to 15% (cefoperazone-sulbactam). The NS percentages for fluoroquinolones (eg, ciprofloxacin) ranged from 13% to 25%. The NS percentages for carbapenems were somewhat high values (8%-20% for imipenem and 8%-19% for meropenem). The overall prevalence of MDRA ranged from 2.2% to 7.8%.
 
Streptococcus pneumoniae
There were approximately 300 to 600 S pneumoniae isolates per year (Table 6); approximately 90% were from respiratory specimens. The NS percentages for beta-lactams were low (2%-9% for penicillin, 2%-10% for cefotaxime, and 1%-7% for ceftriaxone). The NS percentages for fluoroquinolones (eg, levofloxacin) were low (0%-3%); the NS percentages for macrolides (eg, erythromycin) were very high (71%-79%). Streptococcus pneumoniae showed full susceptibility to vancomycin (ie, NS percentage of 0%).
 
Discussion
To our knowledge, this is the first analysis of susceptibility data among private hospitals in Hong Kong. Such information provides important guidance for clinical management and infection control measures in the private sector. Here, we consider our findings within local and international contexts.
 
Staphylococcus aureus
Staphylococcus aureus infections are usually treated by amoxicillin-clavulanate, cloxacillin, or cefazolin unless contra-indicated (eg, in cases of drug allergy) or MRSA is suspected. For mild and superficial infections, oral agents such as clindamycin and co-trimoxazole can be considered, particularly when such treatment is supported by AST results. Routine combination treatment with aminoglycosides for serious infections is no longer recommended because this carries a risk of nephrotoxicity.7
 
Methicillin-resistant S aureus bacteraemia is a serious condition with substantial mortality (>30%).8 Methicillin-resistant S aureus is prevalent in Hong Kong; in 2020, it comprised 43.1% of S aureus isolates among all clinical specimens in public hospitals, as well as 46.6% of isolates from blood cultures.9 Residential Care Home for the Elderly (RCHE) resident carriage rates reportedly range from 30.1% to 37.9%.10 11 In Australia, MRSA is present in 17% to 22% of blood and other specimens.12 In the UK, MRSA was present in 6.0% of invasive isolates in 201913; this low rate could be related to the extensive surveillance and infection control efforts that resulted in a remarkable 86% decrease in bloodstream infections (from 7700 to 1114 per year) from 2003 to 2012.14 Moreover, the prevalence of MRSA among S aureus isolates from human specimens decreased from 14% in 2013 to 7% in 2017.15 The prevalence of methicillin resistance should be considered when selecting empirical therapy for patients with S aureus infections.
 
Vancomycin is a key component of therapy for serious MRSA infections. Consistent with the low prevalence of vancomycin resistance worldwide,16 vancomycin-resistant S aureus was absent from our dataset. Staphylococcus aureus rarely demonstrates resistance to linezolid17; as expected, S aureus isolates in this study showed full susceptibility to linezolid. However, although the NS percentages for co-trimoxazole and fusidic acid were low, these agents should serve as adjuncts only instead of monotherapy in serious infections.
 
Escherichia coli and Klebsiella spp
Non-extended-spectrum beta-lactamaseproducing isolates
Susceptible strains of E coli and Klebsiella spp are usually treatable by amoxicillin-clavulanate or cefuroxime.18 However, ESBL-producing strains should be suspected in cases of serious infection because of Enterobacteriaceae prevalence in Hong Kong, where ESBL-producing E coli is regarded as a critical MDRO.18
 
Extended-spectrum beta-lactamase-producing isolates
Community spread is an important source of ESBL-related infections; food animals are presumed to serve as a major reservoir.19 For instance, the isolation rate from pig offal is 52.4%.20 Among public hospitals, the percentage of resistance to third-generation cephalosporins (“3GC”) as a surrogate marker for ESBL production among E coli is approximately 26%9; this value is similar to our findings. Furthermore, 17.0% to 18.6% of E coli isolates from community urinary specimens demonstrate ESBL-producing activity.9 Among RCHE residents, 55.9% were reported to be carriers of ESBL-producing bacteria.9 In the UK, 12% of E coli isolates from blood specimens showed ESBL-producing activity15; Singaporean public hospitals identified ESBL-producing activity in 25.2% of E coli isolates and 28.2% of Klebsiella isolates in 2017.21 From 2014 to 2019, the percentages of ESBL-producing isolates among Klebsiella isolates at public hospitals in Hong Kong were 19% to 22%.9
 
Surveillance data regarding ESBL prevalence can be affected by changes in laboratory practice over time. Specifically, the Clinical and Laboratory Standards Institute revised the cephalosporin breakpoints in 2014, thus eliminating the need to perform ESBL testing for clinical management—testing remains necessary for some infection control purposes and epidemiological investigations.22 However, not all laboratories have adopted the revised approach and the change remains controversial.23 The clinical specimen data in this study indicate that all participating private hospitals have continued to perform ESBL testing for Enterobacteriaceae isolates.
 
For serious infections caused by ESBL-producing organisms, carbapenems are the most effective treatments.18
 
Carbapenem resistance
Our findings indicate that carbapenem resistance remains uncommon but is increasing. Among the known carbapenem resistance mechanisms, carbapenemase production is the most important from an infection control perspective, considering its propensity to spread to other organisms.24 Carbapenem-resistant Enterobacteriaceae is often resistant to multiple classes of antibiotics, which hinders treatment.25 The prevalence of this high-priority MDRO is increasing worldwide,5 6 presumably in relation to heightened awareness, modified screening practices, and increased transmission.26
 
Public hospitals in Hong Kong reported increasing NS to carbapenem among E coli isolates from 0.2% in 2016 to 0.4% in 2020 (NS percentage of 1.1%-1.8% for Klebsiella).9 Carbapenem-resistant E coli has become a major target of infection control efforts in public hospitals.27 In contrast, CRE was not found among RCHE residents in a 2018 study.10
 
The limited treatment choices for CRE infection include beta-lactam agents such as ceftazidime-avibactam (inactive against metallo-beta-lactamases), aztreonam (active against metallo-beta-lactamases alone), and cefiderocol (active against all major classes of beta-lactamases); the choices also include non-beta-lactam agents such as intravenous colistin or tigecycline (if no alternative is available). A single dose of oral fosfomycin may be used for uncomplicated cystitis. Generally, these agents are either less readily available in Hong Kong (beta-lactams)28 or may cause severe adverse effects (eg, nephrotoxicity for colistin and increased all-cause mortality for tigecycline).29
 
Pseudomonas aeruginosa
Piperacillin ± tazobactam and ticarcillin-clavulanate are commonly recommended for the treatment of P aeruginosa infections. Our data indicated susceptibility to piperacillin-tazobactam and a lack of susceptibility to ticarcillin-clavulanate. Thus, the use of ticarcillin-clavulanate should be supported by AST results. For serious infections, combination treatment (eg, beta-lactam and aminoglycoside) may be required to achieve synergistic effects.18
 
The prevalence of MRPA in our study was consistently low (0.0%-0.3%), consistent with data from public hospitals (0.02%-0.06% for 2014-2018).27 Data from other sources indicate higher prevalences of MRPA (eg, 12%-14% among blood isolates, according to the European Centre for Disease Prevention and Control).30 However, the definition of MRPA can vary among sources.31 For instance, the European Centre for Disease Prevention and Control uses combined resistance to three or more antibiotic groups. The strict definition of simultaneous resistance to four antibiotic classes used in Hong Kong may at least partially contribute to the overall low prevalence.
 
Acinetobacter spp
Acinetobacter can survive for prolonged periods in dry environments, which facilitates nosocomial transmission.32 Sulbactam-containing beta lactams are highly effective against Acinetobacter.18
 
Similar to MRPA, definitions of MDRA vary. In the UK, multi-resistant Acinetobacter spp or multi-resistant Acinetobacter baumannii (MRAB) demonstrate co-resistance to aminoglycosides and 3GC; the term MRAB-C refers to MRAB with carbapenem resistance.33 Using an MDRA definition identical to ours, public hospitals reported a decreasing MDRA prevalence (from 24% to 9% in 2014 to 201827); another study indicated that 0.6% of 1028 RCHE residents were carriers of MDRA.10 In analyses of carbapenem-resistant Acinetobacter alone, the prevalence in public hospitals ranged from 44% in 2014 to 53% in 201911; 9.1% of RCHE residents were carriers.11
 
Antibiotic-resistant Acinetobacter is classified as a ‘critical threat’ by the World Health Organization and an ‘urgent threat’ by the US Centers for Disease Control and Prevention. Thus, although its prevalence is decreasing, MDRA should be closely monitored for any rebound.
 
Streptococcus pneumoniae
The primary treatments for invasive pneumococcal infection are beta-lactams (penicillin G or 3GC) for susceptible strains and vancomycin for penicillin-resistant strains (plus 3GC for meningitis).
 
In Europe, the prevalence of penicillin resistance among S pneumoniae isolates is approximately 12% to 14% (2015-2019, invasive isolates)30; the prevalence of macrolide resistance is approximately 14% to 16%. In Australia, these values are 3% to 6% and >20% to 25%, respectively.12 Our findings indicated a low NS percentage for penicillin but a very high NS percentage for macrolides; these findings are compatible with the recommendation that macrolides should not be used as monotherapy during empirical treatment of infections in Hong Kong.18 Fluoroquinolone resistance was previously reported to be high34 (>13.3% for levofloxacin), although recent data from laboratory surveillance by the CHP in the community setting indicate lower resistance (0.0%-4.4% in 2014-2019).9 Our data are similar to the community values, as expected for an organism that most commonly causes community-acquired pneumonia.18
 
Since the introduction of pneumococcal vaccination, the disease burden caused by penicillin- and erythromycin-resistant strains has decreased in the US.5 In Hong Kong, approximately 180 invasive pneumococcal infections are reported each year.35 Similar to other countries, Hong Kong has gradually made pneumococcal vaccination available to children, older adults, and high-risk individuals for >10 years.35 As vaccine coverage increases, it would be prudent to assess the changes in disease burden caused by resistant strains of pneumococcus.
 
Implications
Compared with public hospitals, private hospitals tend to have lower MDRO prevalences, particularly for MRSA and MDRA, while following an overall similar prevalence pattern (ie, increasing CRE, stable ESBL, decreasing MDRA, and negligible MRPA). Nonetheless, further MDRO monitoring (particularly for CRE and MDRA) is warranted.
 
There may be multiple reasons for the lower overall NS percentages, which could not be assessed using the data collected in this study (eg, case composition, antibiotic consumption, and diagnostic practices). However, the physical environment and isolation policy within private hospitals may contribute to a generally lower NS percentage. A key private hospital prescribes single-room isolation for all MDRO carriers with strict contact precautions.36 A more spacious environment with fewer beds per cubicle could theoretically lead to a lower cross-contamination rate through indirect contact (eg, by shared toilets), which is a main route for MDRO spread. With respect to staffing, the infection-control-nurse-to-bed ratio may be more likely to meet (personal communication) the level recommended by the CHP (1:150 for acute hospitals).37 Sufficient single-patient rooms and staffing (eg, nursing) are regarded as crucial components of efforts to reduce healthcare-associated colonisations and infections.38 39
 
Notably, the NS percentage was generally lower among out-patient isolates than among in-patient isolates, consistent with the reported literature.40
 
Strengths
First, the AST data were stratified by both location (in- and out-patient) and specimen groups. The stratification of antibiogram data can facilitate antibiotic stewardship programmes by exposing important differences in susceptibility.41 Second, the collected data spanned a 6-year period with a large number of isolates, enabling the application of a consistent methodology that can enhance trend analysis accuracy. Third, MDRO prevalences were collected; such data are not required by the World Health Organization42 but are frequently regarded as key information in international surveillance reports.5 12 15 30
 
Limitations
Cautious interpretation of the findings is necessary. First, a subset of the antibiotic-bacterium combinations were tested in a smaller proportion of isolates (<70%), which could have led to biased assessment. Second, because member hospital laboratories had different levels and types of accreditation, inter-laboratory practice variations could have influenced the AST results. Third, the specimen group classification was arbitrary. Fourth, differences in case composition among hospitals may lead to misleading conclusions if direct head-to-head comparison is performed. Finally, CRE was defined by susceptibility results, rather than specific tests for carbapenemase detection.
 
Conclusion
Our findings provide important insights concerning antibiotic resistance at private hospitals in Hong Kong. Although the overall situation in private hospitals is considered satisfactory, there remains a need for sustained efforts in resistance surveillance, infection control, and antibiotic stewardship.
 
Author contributions
Concept or design: L Lui.
Acquisition of data: L Lui
Analysis or interpretation of data: All authors.
Drafting of the manuscript: L Lui.
Critical revision of the manuscript for important intellectual content: All authors.
 
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have disclosed no conflicts of interest.
 
Acknowledgement
Infection Control Branch would like to express her appreciation to private hospitals for providing the AST data consistently over the years.
 
Membership of The Working Group of Collaboration between CHP and Private Hospitals on Safe Use of Antibiotics and Infection Control (in alphabetical order):
H Chen (Chairperson), Infection Control Branch, Centre for Health Protection, Department of Health, Hong Kong
Raymond WH Yung (Co-Chairperson), Hong Kong
Sanatorium & Hospital, Hong Kong
Ada Chan, Union Hospital, Hong Kong
WC Chan, Hong Kong Sanatorium & Hospital, Hong Kong
YM Cheng, Precious Blood Hospital (Caritas), Hong Kong
T Cheuk, Matilda International Hospital, Hong Kong
Christina Cheung, St Paul’s Hospital, Hong Kong
Eddie Cheung, Hong Kong Adventist Hospital–Stubbs Road, Hong Kong
Gary Cheung, Matilda International Hospital, Hong Kong
Joe Cheung, Hong Kong Adventist Hospital–Stubbs Road, Hong Kong
Billy SH Chui, Evangel Hospital, Hong Kong
August Fok, Hong Kong Adventist Hospital–Tsuen Wan, Hong Kong
Clara DK Kwok, Gleneagles Hospital Hong Kong, Hong Kong
Maggie MK Kwok, St Teresa’s Hospital, Hong Kong
Mooris Lai, Union Hospital, Hong Kong
Conita Lam, St Paul’s Hospital, Hong Kong
Wendy Lam, Canossa Hospital (Caritas), Hong Kong
MY Lau, Precious Blood Hospital (Caritas), Hong Kong
Patrick PL Lau, Hong Kong Baptist Hospital, Hong Kong
Andy Leung, Hong Kong Adventist Hospital–Tsuen Wan, Hong Kong
SL Loke, St Teresa’s Hospital, Hong Kong
L Lui, Infection Control Branch, Centre for Health Protection, Department of Health, Hong Kong
WH Seto, Gleneagles Hospital Hong Kong, Hong Kong
Winnie LH Wan, Evangel Hospital, Hong Kong
Cindy YY Wong, Hong Kong Baptist Hospital, Hong Kong
LC Wong, Infection Control Branch, Centre for Health Protection, Department of Health, Hong Kong
WO Wong, Canossa Hospital (Caritas), Hong Kong
KL Yan, Union Hospital, Hong Kong
PW Yu, Hong Kong Sanatorium & Hospital, Hong Kong
ST Yuen, St Paul’s Hospital, Hong Kong
 
Funding/support
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
 
Ethics approval
This study was approved by the Hong Kong Department of Health Ethics Review Board (Ref: LM 275/2021). The requirement for patient consent was waived by the Ethics Review Board.
 
References
1. Truong WR, Hidayat L, Bolaris MA, Nguyen L, Yamaki J. The antibiogram: key considerations for its development and utilization. JAC Antimicrob Resist 2021;3:dlab060. Crossref
2. Centre for Health Protection, Department of Health, Hong Kong SAR Government. Antibiogram for six selected bacterial isolates from private hospitals by in- and outpatient setting for year 2014-2019. Available from: https://www.chp.gov.hk/files/pdf/antibiotic_sensitivity_table_private_hospitals.pdf. Accessed 21 Jul 2021.
3. Hong Kong SAR Government. Chapter 9 Health. Hong Kong Yearbook, 2019. Available from: https://www.yearbook.gov.hk/2019/en/pdf/E09.pdf. Accessed 6 Nov 2020.
4. Kong X, Yang Y, Gao J, et al. Overview of the health care system in Hong Kong and its referential significance to mainland China. J Chin Med Assoc 2015;78:569-73. Crossref
5. Centers for Disease Control and Prevention, US Department of Health and Human Services. Antibiotic resistance threats in the United States, 2019. Available from: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf. Accessed 6 Nov 2020.
6. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Available from: https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf. Accessed 21 Jul 2021.
7. Lowy FD. Methicillin-resistant Staphylococcus aureus (MRSA) in adults: treatment of bacteremia. UpToDate. Available from: https://www.uptodate.com/contents/methicillin-resistant-staphylococcus-aureus-mrsa-in-adults-treatment-of-bacteremia. Accessed 5 Jul 2021.
8. You JH, Choi KW, Wong TY, et al. Disease burden, characteristics, and outcomes of methicillin-resistant Staphylococcus aureus bloodstream infection in Hong Kong. Asia Pac J Public Health 2017;29:451-61.Crossref
9. Centre for Health Protection, Department of Health, Hong Kong SAR Government. Antimicrobial resistance surveillance. Available from: https://www.chp.gov.hk/en/static/101603.html. Accessed 14 Apr 2021.
10. Chen H, Au KM, Hsu KE, et al. Multidrug-resistant organism carriage among residents from residential care homes for the elderly in Hong Kong: a prevalence survey with stratified cluster sampling. Hong Kong Med J 2018;24:350-60. Crossref
11. Cheng VC, Chen H, Wong SC, et al. Role of hand hygiene ambassador and implementation of directly observed hand hygiene among residents in residential care homes for the elderly in Hong Kong. Infect Control Hosp Epidemiol 2018;39:571-7. Crossref
12. Australian Commission on Safety and Quality in Health Care. AURA 2019: third Australian report on antimicrobial use and resistance in human health. Available from: https:// www.safetyandquality.gov.au/our-work/antimicrobial-resistance/ antimicrobial-use-and-resistance-australia-surveillance- system/aura-2019. Accessed 14 Apr 2021.
13. European Centre for Disease Prevention and Control. Country summaries—antimicrobial resistance in the EU/ EEA 2019. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Country%20summaries-AER-EARS-Net%20202019.pdf. Accessed 28 Jul 2021.
14. Duerden B, Fry C, Johnson AP, Wilcox MH. The control of methicillin-resistant Staphylococcus aureus blood stream infections in England. Open Forum Infect Dis 2015;2:ofv035. Crossref
15. Veterinary Medicines Directorate, HM Government. UK one health report—Joint report on antibiotic use and antibiotic resistance, 2013-2017. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/921039/Ted_Final_version__1318703-v45-One_Health_Report_2019_FINAL-accessible.pdf. Accessed 14 Apr 2021.
16. Cong Y, Yang S, Rao X. Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features. J Adv Res 2019;21:169-76. Crossref
17. S Shariati A, Dadashi M, Chegini Z, et al. The global prevalence of daptomycin, tigecycline, quinupristin/ dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis. Antimicrob Resist Infect Control 2020;9:56. Crossref
18. Centre for Health Protection, Department of Health, Hong Kong SAR Government. Ho PL, Wu TC, editors. Reducing bacterial resistance with IMPACT—Interhospital Multi-disciplinary Programme on Antimicrobial ChemoTherapy. 5th edition. 2017. Available from: http://www.chp.gov.hk/files/pdf/reducing_bacterial_resistance_with_impact.pdf. Accessed 14 Apr 2021.
19. Ho PL, Chow KH, Lai EL, et al. Extensive dissemination of CTX-M-producing Escherichia coli with multidrug resistance to ‘critically important’ antibiotics among food animals in Hong Kong, 2008-10. J Antimicrob Chemother 2011;66:765-8. Crossref
20. Sapugahawatte DN, Li C, Zhu C, et al. Prevalence and characteristics of extended-spectrum-Β-lactamase-producing and carbapenemase-producing Enterobacteriaceae from freshwater fish and pork in wet markets of Hong Kong. mSphere 2020;5:e00107-20. Crossref
21. One Health Antimicrobial Resistance Working Group, Ministry of Health, Singapore. One health report on antimicrobial utilisation and resistance 2017. Available from: https://www.moh.gov.sg/resources-statistics/reports/one-health-report-on-antimicrobial-utilisation-and-resistance- 2017. Accessed 5 Jul 2021.
22. Clinical and Laboratory Standards Institute. CLSI M100- ED30:2020. Performance standards for antimicrobial susceptibility testing, 30th ed. Available from: http://em100.edaptivedocs.net/GetDoc.aspx?doc=CLSI%20M100%20ED30:2020&scope=user. Accessed 6 Nov 2020.
23. Livermore DM, Andrews JM, Hawkey PM, et al. Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? J Antimicrob Chemother 2012;67:1569-77. Crossref
24. Centers for Disease Control and Prevention, US Government. CRE technical information. Available from: https://www.cdc.gov/hai/organisms/cre/technical-info.html#Transmitted. Accessed 14 Apr 2021.
25. Centers for Disease Control and Prevention, US Government. Clinicians play a critical role in helping to identify patients colonized or infected with CRE and preventing its spread. Available from: https://www.cdc.gov/hai/organisms/cre/cre-clinicians.html. Accessed 14 Apr 2021.
26. Public Health Agency of Canada. Canadian antimicrobial resistance surveillance system—Update 2018. Available from: https://www.canada.ca/content/dam/phac-aspc/documents/services/publications/drugs-health-products/canadian-antimicrobial-resistance-surveillance-system-2018-report-executive-summary/pub1-eng.pdf. Accessed 14 Apr 2021.
27. Hospital Authority, Hong Kong SAR Government. Quality and safety annual report 2018. Available from: https://www.ha.org.hk/haho/ho/psrm/EQnSReport2018.pdf. Accessed 5 Jul 2021.
28. Drug Office, Department of Health, Hong Kong SAR Government. Search Drug Database. Available from: https://www.drugoffice.gov.hk/eps/do/en/consumer/search_drug_database.html. Accessed 28 Sep 2021.
29. United States Food and Drug Administration. FDA drug safety communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning. Available from: https:// www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-increased-risk-death-iv-antibacterial-tygacil-tigecycline. Accessed 28 Sep 2021.
30. European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net)—annual epidemiological report for 2019. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/surveillance-antimicrobial-resistance-Europe-2019.pdf. Accessed 28 Jul 2021.
31. Horcajada JP, Montero M, Oliver A, et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin Microbiol Rev 2019;32:e00031-19.Crossref
32. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007;5:939-51.Crossref
33. Public Health England. Cookson B, Gergonne B, Barrett S, et al. Working party guidance on the control of multiresistant Acinetobacter outbreaks. Public Health England. 29 Aug 2006. Available from: https://www.gov.uk/government/publications/acinetobacter-working-party-guidance-on-the-control-of-multi-resistant-acinetobacter-outbreaks/working-party-guidance-on-the-control-of-multi-resistant-acinetobacter-outbreaks. Accessed 6 Nov 2020.
34. Ip M, Chau SS, Chi F, et al. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005. Antimicrobial Agents Chemother 2007;51:2192-4. Crossref
35. Centre for Health Protection, Department of Health, Hong Kong SAR Government. Invasive pneumococcal disease. Available from: https://www.chp.gov.hk/en/features/32346.html. Accessed 14 Apr 2021.
36. Hong Kong Sanatorium & Hospital. Infection control. Available from: https://www.hksh-hospital.com/en/patient-info/infection-control. Accessed 28 Jul 2021.
37. Scientific Committee on Infection Control, Centre for Health Protection, Department of Health, Hong Kong SAR Government. Recommendations on hospital infection control system in Hong Kong. Available from: https://www.chp.gov.hk/files/pdf/recommendations_on_hospital_infection_control_system_in_hong_kong.pdf. Accessed 28 Jul 2021.
38. Weinstein RA, Stone PW, Pogorzelska M, Kunches L, Hirschhorn LR. Hospital staffing and health care–associated infections: a systematic review of the literature. Clin Infect Dis 2008;47:937-44.Crossref
39. Stiller A, Salm F, Bischoff P, Gastmeier P. Relationship between hospital ward design and healthcare-associated infection rates: a systematic review and meta-analysis. Antimicrobial Resist Infect Control 2016;5:51. Crossref
40. Saperston KN, Shapiro DJ, Hersh AL, Copp HL. A comparison of inpatient versus outpatient resistance patterns of pediatric urinary tract infection. J Urol 2014;191:1608-13. Crossref
41. Barlam TF, Cosgrove SE, Abbo LM et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:e51-77. Crossref
42. World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS). Available from: https://www.who.int/initiatives/glass. Accessed 28 Jul 2021.

Patient acceptance of transvaginal sonographic endometrial thickness assessment compared with hysteroscopy and biopsy for exclusion of endometrial cancer in cases of postmenopausal bleeding

Hong Kong Med J 2022 Apr;28(2):133–9  |  Epub 12 Apr 2022
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Patient acceptance of transvaginal sonographic endometrial thickness assessment compared with hysteroscopy and biopsy for exclusion of endometrial cancer in cases of postmenopausal bleeding
Linda WY Fung, FHKAM (Obstetrics and Gynaecology), FHKCOG; Eva CW Cheung, FHKAM (Obstetrics and Gynaecology), FRCOG; Alyssa SW Wong, FHKAM (Obstetrics and Gynaecology), FRCOG; Daljit S Sahota, PhD; Terence TH Lao, MD, FRCOG
Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong
 
Corresponding author: Dr Linda WY Fung (lindafung@cuhk.edu.hk)
 
 Full paper in PDF
 
Abstract
Introduction: Available examinations for women with postmenopausal bleeding include transvaginal sonography to measure endometrial thickness (TVS-ET), and invasive endometrial assessment using hysteroscopy/endometrial biopsy. However, selection of the examination method seldom involves consideration of patient preferences. The aim of this study was to examine patient preferences for the method used to investigate postmenopausal bleeding.
 
Methods: Women were asked to complete an interviewer-administered structured survey before they underwent clinical investigations at a university gynaecology unit from June 2016 to June 2017. Using the standard gamble approach, women were asked to choose between invasive assessment by hysteroscopy/endometrial biopsy (gold standard) or TVS-ET with a risk of missing endometrial cancer. The risk of missing endometrial cancer during TVS-ET was varied until each woman was indifferent to either option.
 
Results: The median detection rate for endometrial cancer required using TVS-ET was 95% (interquartile range=80%-99.9%). In total, 200 women completed the survey, and 77 (38.5%) women required TVS-ET to have a 99.9% detection rate for endometrial cancer. Prior hysteroscopy experience was the only factor that influenced the women’s decisions: a significantly higher detection rate was required by this patient group than by patients without previous hysteroscopy experience (P=0.047).
 
Conclusions: A substantial proportion of women would accept TVS-ET alone for the investigation of postmenopausal bleeding. In the era of patientcentred care, clinicians should incorporate patient preferences and enable women to make informed choices concerning the management of postmenopausal bleeding.
 
 
New knowledge added by this study
  • We assessed patient preferences for the investigational approach used to exclude endometrial cancer in Hong Kong women with postmenopausal bleeding.
  • In our study population, most women would select transvaginal sonography to measure endometrial thickness (TVS-ET) if the endometrial cancer detection rate were >95%; if the TVS-ET detection rate were ≤95%, the women would select the more invasive hysteroscopy/endometrial biopsy approach.
  • Nearly 40% of the women required TVS-ET to detect nearly all endometrial cancers before they would select TVS-ET as the sole investigational approach.
Implications for clinical practice or policy
  • Using an endometrial thickness cut-off value of 3 mm, a substantial proportion of women would accept TVS-ET alone for the investigation of postmenopausal bleeding.
  • Women with previous hysteroscopy experience prefer hysteroscopic assessment unless TVS-ET alone can achieve a nearly identical rate of endometrial cancer detection.
  • Clinicians should incorporate patient preferences concerning the investigation of postmenopausal bleeding to enable an informed choice about invasive testing to exclude endometrial cancer.
 
 
Introduction
Endometrial cancer is among the most common gynaecological malignancies worldwide. Among women with endometrial cancer, 90% initially report postmenopausal bleeding (PMB).1 2 3 4 5 Approximately 10% of postmenopausal women are estimated to experience PMB.1 Generally, there is no harmful underlying cause of PMB; however, women with recurrent PMB require medical assessment to distinguish between benign aetiology (eg, vaginal atrophy, uterine fibroids, and polyps) and endometrial cancer. Endometrial assessment is needed to exclude underlying malignancy.2 6 7 8 9 10
 
The endometrium can be examined non-invasively, using transvaginal sonography (TVS) to measure endometrial thickness (TVS-ET); alternatively, it can be examined invasively via blinded undirected endometrial sampling, saline infusion sonography, or diagnostic hysteroscopy.11 12 13 Although both TVS-ET and blinded endometrial sampling are recommended as first-line investigations,2 6 7 14 15 16 17 18 the gold standard approach for PMB investigation remains diagnostic hysteroscopy with visually guided endometrial sampling; this allows direct visualisation of the uterine cavity and histological investigation.19
 
Importantly, hysteroscopy is invasive and carries risks of complications such as infection, bleeding, uterine perforation, and visceral injury to the cervix or nearby organs (eg, bladder and bowel); it cannot be performed in women with cervical stenosis.20 Additionally, some women report that hysteroscopy is uncomfortable and painful within an out-patient or office setting; thus, hysteroscopy, cervical dilation, and uterine curettage have been performed under general anaesthesia in such cases. Although TVS-ET has become an established investigational tool, there remains a lack of consensus concerning the endometrial thickness (3, 4, or 5 mm) that constitutes ‘abnormal’. Our previous study of 4300 women with PMB demonstrated that 3% of women with PMB and endometrial thickness ≤3 mm had endometrial cancer.21
 
Patient preference regarding investigation approach is an important component of the decision care pathway. Individual women must balance the risks associated with an invasive procedure (eg, diagnostic hysteroscopy) with the risk of missing an endometrial cancer diagnosis if they select a non-invasive assessment (eg, TVS-ET). To our knowledge, the nature of this balance has not been assessed. The aim of the present study was to determine the extent to which women with PMB would accept the risk of missing endometrial cancer if they were to undergo TVS-ET as the first investigation of PMB.
 
Methods
This cross-sectional study was conducted in a tertiary centre in Hong Kong from June 2016 to June 2017. Women referred by either primary or secondary healthcare providers to the One-stop PMB Clinic for assessment and management were invited to participate in the study. Patient assessments included history taking, physical examination, pelvic ultrasound to measure endometrial thickness and screen for other pelvic pathologies, Pap smear (for women without recent Pap smear records), endometrial sampling with or without hysteroscopy. Women were excluded if they had <1 year of amenorrhea; had a prior TVS finding of endometrium thickness ≥5 mm; were aged ≥70 years; had dementia or mental retardation; and/or were unable to read or understand Chinese.
 
Prior to their clinic consultation, study participants completed a structured interview that was administered by an independent interviewer. Women were asked to first read an information leaflet regarding PMB, which described the risk of endometrial cancer, possible investigation options, and the risks associated with each option. The leaflet and interviewer explained that hysteroscopy and endometrial biopsy were expected to achieve a 100% detection rate, but these methods involved risks of pain, bleeding, infection, and uterine perforation related to uterine cavity exploration. The leaflet and interviewer also explained that TVS-ET did not require entry into uterine cavity but would potentially miss some cases of endometrial cancer. The leaflet and interviewer did not disclose the percentage of endometrial cancers that would fail to be detected by TVS-ET. After they had read the leaflet, women were asked to complete a study questionnaire regarding their sociodemographic characteristics and their personal and family histories of gynaecological cancer; they also completed the Chinese version of the 20-item State-Trait Anxiety Inventory to measure their trait and state anxiety levels. The women’s state and trait scores were categorised as above or below the scale midpoint. Women then underwent assessment of utilities regarding examination by either hysteroscopy or TVS-ET and the possibility of a missed cancer diagnosis, using the standard gamble technique.22
 
The standard gamble technique is the gold standard method used to determine utility towards a particular health state when a risk is involved. Individuals are asked to choose whether they prefer to have a certain guaranteed option or health state with a guaranteed outcome and no risk, or whether they would prefer an alternative option which entails some risk. The risks for the two health states are varied until the individual becomes indifferent to either option. At the point of indifference, the ‘utility’ for the health state under consideration is considered equal to ‘p’, while the utility of the alternative health state is considered equal to ‘1–p’.
 
Women were first asked to complete a standard gamble related to blindness, thereby ensuring that they understood the process. Subsequently, they were asked to complete a standard gamble to test their preferences towards the investigations of PMB. Each woman was asked to choose between the following tests: (1) TVS-ET, which is less invasive but involves some risk of missing endometrial cancer (probability of 1–p), or (2) an invasive test with hysteroscopy and endometrial biopsy, which detects 100% of all cancers but carries the risks described during the structured interview. To determine the level of acceptance of missing endometrial cancer during TVS-ET, the women were initially informed that the assumed detection rate of the TVS-ET was 75%; this detection rate was then increased in 5% intervals to 90%, then in 1% intervals to 98%, and finally in 0.1% intervals to 99.9%. We recorded the stated detection rate at which the woman was indifferent to either option. The missed endometrial cancer rate that women would accept to avoid an invasive procedure was defined as 1–detection rate.
 
Sociodemographic characteristics, past and current gynaecological history findings, and anxiety levels are presented as mean ± standard deviation or median and interquartile range; qualitative variables are presented as absolute frequency and percentage. The acceptable rate of endometrial cancer detection by TVS-ET alone, as an alternative to invasive hysteroscopy/biopsy, is presented as median and interquartile range. Differences in scores among sociodemographic groups were compared using the Mann-Whitney U test. SPSS software (Windows version 20; IBM Corp, Armonk [NY], United States) was used for all statistical analyses. A P value of <0.05 was considered statistically significant.
 
Results
During the study period, 202 women agreed to participate in the study; 200 of these women completed the questionnaires and the standard gamble assessments. Table 1 summarises the sociodemographic, obstetric and gynaecological histories, and anxiety levels of these 200 women. Overall, 11 (5.5%) of the 200 women were subsequently diagnosed with cancer or an atypical endometrium: nine had endometrial cancer, one had cervical cancer, and one had atypical hyperplasia. Among 42 patients who underwent Pap smears in our clinic, smear results showed atypical glandular cells in two patients with endometrial cancer, while four patients with endometrial cancer had a shift in vaginal flora suggestive of bacterial vaginosis; the remaining smear results were normal.
 

Table 1. Demographic characteristics of the study participants (n=200)
 
The median endometrial cancer detection rate or utility that women would require for selection of TVS-ET to avoid invasive hysteroscopy examination was 95% (interquartile range=80%-99.9%). Overall, 77 (38.5%) women required TVS-ET to have a 99.9% detection rate for endometrial cancer. Thus, 38.5% of the women in our cohort would require TVS-ET to be comparable with diagnostic hysteroscopy before they would accept TVS-ET as the sole method for examination of the endometrium and uterine cavity.
 
Table 2 summarises the results of univariate analysis of the relationships between patient characteristics and the TVS-ET endometrial cancer detection rate. Women with previous hysteroscopy experience required the endometrial detection rate by TVS-ET to be significantly higher than did women without previous hysteroscopy experience (P=0.047). There were no significant differences in required endometrial cancer detection rates by TVS-ET among other sociodemographic characteristics, past and current obstetric and gynaecological histories, and state or trait anxiety (Table 2).
 

Table 2. Univariate analysis of relationship between patient characteristics and acceptable endometrial cancer detection rate
 
Discussion
To our knowledge, this study is the first to utilise the standard gamble technique to evaluate patient preference with regard to approaches used for the investigation of PMB. Specifically, we assessed the extent to which women would prefer to avoid an invasive investigation (eg, hysteroscopy and biopsy) if a non-invasive alternative were available. Our findings suggested that TVS-ET would need to detect approximately 95% of endometrial cancers (or miss approximately 5% of endometrial cancers) for women to select TVS-ET with the intention of avoiding an invasive investigation. However, our analysis also suggested that nearly 40% of the participants required TVS-ET to detect nearly all endometrial cancers before they would select TVS-ET as the sole investigational approach.
 
There are sparse published data concerning patient preferences for the investigation of PMB. Our literature review revealed a single study by Timmermans et al.23 However, that study was limited to 39 participants and the results were obtained via telephone survey. In contrast to our protocol, Timmermans et al23 only assessed patient preferences after the women’s investigations had been completed; thus, their reported clinical experiences and preferences might have been biased. In the present study, we adopted the standard gambling approach which enabled a more quantitative analysis of patient willingness to select a different investigational approach. The standard gamble method is the gold standard approach for assessment of preferences in an uncertain situation24; it can be used to express the outcomes of different choices. It has been used previously to explore the acceptable risk of miscarriage after a high-risk Down syndrome screening test25 26 27 28; it has also been used to explore patient preferences concerning the risks of other medical treatments.
 
Currently, endometrial thickness cut-off values in endometrial pathology or cancer screening differ among hospitals.2 6 19 The most commonly used cut-off endometrial thickness value is 4 mm2. Our study population of postmenopausal women accepted an endometrial cancer detection rate of 95% when using TVS-ET alone, with the intention of avoiding the more invasive procedure of hysteroscopy/endometrial biopsy. In our previous study, TVS-ET offered endometrial cancer detection rates of 97%, 94.1%, and 93.5% using 3 mm, 4 mm, and 5 mm as respective cut-off values.21 Thus, a TVS-ET cut-off of 3 mm would generally be consistent with the endometrial cancer detection accuracy that women in our study required for TVS-ET to be used as the sole investigational approach. In our study population, women with previous hysteroscopy experience required TVS-ET to have higher detection rates; hence, they preferred hysteroscopic assessment.
 
There were some limitations in our study. First, women aged ≥70 years were excluded because we presumed that they would have difficulty understanding the standard gamble technique and/or completing the study questionnaires without assistance. Second, although our sample size was sufficient to assess our primary goal, it was inadequate for subgroup analysis. Larger studies are needed to explore the relationships of specific patient characteristics with the acceptable rate of endometrial cancer detection by TVS-ET alone, particularly in relation to factors such as personal history of cancer or precancerous conditions. Finally, our findings concerning the acceptable rate of endometrial cancer detection by TVS-ET reflect the preferences of women who participated in our study; they may not be generalisable to populations with different sociodemographic characteristics or clinical management pathways.
 
Conclusions
Clinicians should incorporate patient preferences concerning the investigation of PMB to enable an informed choice about invasive testing to exclude endometrial cancer. Our study population accepted an endometrial cancer detection rate of 95% by TVS-ET alone; this rate could be used to guide the design of future PMB investigation strategies.
 
Author contributions
Concept or design: LWY Fung, ECW Cheung, ASW Wong, DS Sahota.
Acquisition of data: LWY Fung, ECW Cheung, ASW Wong, DS Sahota.
Analysis or interpretation of data: LWY Fung, DS Sahota.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: All authors.
 
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have disclosed no conflicts of interest.
 
Acknowledgement
The authors acknowledge the clinical care provided by gynaecologists and nursing staff at the One-stop Postmenopausal Bleeding Clinic, Prince of Wales Hospital. We thank Miss Jennifer SF Tsang for her help with database management.
 
Funding/support
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
 
Ethics approval
Ethics approval was obtained in August 2015 from The Joint Chinese University of Hong Kong–New Territories East Cluster Clinical Research Ethics Committee (CREC Ref 2015.437).
 
References
1. Astrup K, Olivarius Nde F. Frequency of spontaneously occurring postmenopausal bleeding in the general population. Acta Obstet Gynaecol Scand 2004;83:203-7. Crossref
2. American College of Obstetricians and Gynaecologists. ACOG Committee Opinion No. 426: The role of transvaginal ultrasonography in the evaluation of postmenopausal bleeding. Obstet Gynecol 2009;113:462-4. Crossref
3. Chandavarkar U, Kuperman JM, Muderspach LI, Opper N, Felix JC, Roman L. Endometrial echo complex thickness in postmenopausal endometrial cancer. Gynaecol Oncol 2013;131:109-12. Crossref
4. Jacobs I, Gentry-Maharaj A, Burnell M, et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol 2011;12:38-48. Crossref
5. Hong Kong Cancer Registry, Hospital Authority, Hong Kong SAR Government. Leading cancer sites in Hong Kong. Available from: http://www3.ha.org.hk/cancereg/. Accessed 5 Jun 2015.
6. Renaud MC, Le T, SOGC-GOC-SCC Policy and Practice Guidelines Committee; Special Contributors. Epidemiology and investigations for suspected endometrial cancer. J Obstet Gynaecol Can 2013;35:380-1. Crossref
7. Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Clinical Strategy and Programmes, Health Service Executive. Clinical Practice Guideline. Investigation of Postmenopausal Bleeding. Guideline No. 26, Version 1.0. 2013. Available from: https://rcpi-live-cdn.s3.amazonaws. com/wp-content/uploads/2016/05/21.-Investigation-of-Postmenopausal-Bleeding.pdf. Accessed 5 Jun 2015.
8. Ewies AA, Musonda P. Managing postmenopausal bleeding revisited: what is the best first line investigation and who should be seen within 2 weeks? A cross-sectional study of 326 women. Eur J Obstet Gynaecol Reprod Biol 2010;153:67-71. Crossref
9. Salman MC, Bozdag G, Dogan S, Yuce K. Role of postmenopausal bleeding pattern and women’s age in the prediction of endometrial cancer. Aust N Z J Obstet Gynaecol 2013;53:484-8. Crossref
10. Tarling R, Gale A, Martin-Hirsch P, Holmes L, Kanesalingam K, Dey P. Experiences of women referred for urgent assessment of postmenopausal bleeding (PMB). J Obstet Gynaecol 2013;33:184-7. Crossref
11. van Hanegem N, Breijer MC, Khan KS, et al. Diagnostic evaluation of the endometrium in postmenopausal bleeding: an evidence-based approach. Maturitas 2011;68:155-64. Crossref
12. Dimitraki M, Tsikouras P, Bouchlariotou S, et al. Clinical evaluation of women with PMB. Is it always necessary an endometrial biopsy to be performed? A review of the literature. Arch Gynaecol Obstet 2011;283:261-6. Crossref
13. Clark TJ, Barton PM, Coomarasamy A, Gupta JK, Khan KS. Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies. BJOG 2006;113:502-10. Crossref
14. Karlsson B, Gransberg S, Wikland M, et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding—a Nordic multicenter study. Am J Obstet Gynecol 1995;172:1488-94. Crossref
15. Ferrazzi E, Torri V, Trio D, Zannoni E, Filiberto S, Dordoni D. Sonographic endometrial thickness: a useful test to predict atrophy in patients with postmenopausal bleeding. An Italian multicenter study. Ultrasound Obstet Gynaecol 1996;7:315-21. Crossref
16. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998;280:1510-7. Crossref
17. Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynaecol Scand 2002;81:799-816. Crossref
18. Timmermans A, Opmeer BC, Khan KS, et al. Endometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysis. Obstet Gynaecol 2010;116:160-7. Crossref
19. Investigation of Post-Menopausal Bleeding. A National Clinical Guideline. Scottish Intercollegiate Guidelines Network; 200
20. Genovese F, D’Urso G, Di Guardo F, et al. Failed diagnostic hysteroscopy: analysis of 62 cases. Eur J Obstet Gynecol Reprod Biol 2020;245:193-7. Crossref
21. Wong AS, Lao TT, Cheung CW, et al. Reappraisal of endometrial thickness for the detection of endometrial cancer in postmenopausal bleeding: a retrospective cohort study. BJOG 2016;123:439-46. Crossref
22. Froberg DG, Kane RL. Methodology for measuring health-state preferences–II: Scaling methods. J Clin Epidemiol 1989;42:459-71. Crossref
23. Timmermans A, Opmeer BC, Veersema S, Mol BW. Patients’ preferences in the evaluation of postmenopausal bleeding. BJOG 2007;114:1146-9. Crossref
24. van Osch SM, Stiggelbout AM. The construction of standard gamble utilities. Health Econ 2008;17:31-40. Crossref
25. Chan YM, Sahota DS, Chan OK, Leung TY, Lau TK. Miscarriage after invasive prenatal diagnostic procedures: how much risk our pregnant women are willing to take? Prenat Diagn 2009;29:870-4. Crossref
26. Chan YM, Sahota DS, Leung TY, Choy KW, Chan OK, Lau TK. Chinese women’s preferences for prenatal diagnostic procedure and their willingness to trade between procedures. Prenat Diagn 2009;29:1270-6. Crossref
27. Chan YM, Leung TY, Chan OK, Cheng YK, Sahota DS. Patient’s choice between a non-invasive prenatal test and invasive prenatal diagnosis based on test accuracy. Fetal Diagn Ther 2014;35:193-8. Crossref
28. Chan YM, Chan OK, Cheng YK, Leung TY, Lao TT, Sahota DS. Acceptance towards giving birth to a child with beta-thalassemia major—a prospective study. Taiwan J Obstet Gynecol 2017;56:618-21. Crossref

Knowledge, attitudes, and behaviours of pregnant women towards COVID-19: a cross-sectional survey

Hong Kong Med J 2022 Apr;28(2):124–32  |  Epub 14 Apr 2022
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Knowledge, attitudes, and behaviours of pregnant women towards COVID-19: a cross-sectional survey
WY Lok, FHKAM (Obstetrics and Gynaecology), FHKCOG; CY Chow, MB, ChB; CW Kong, FHKAM (Obstetrics and Gynaecology), FHKCOG; William WK To, FHKAM (Obstetrics and Gynaecology), FHKCOG
Department of Obstetrics and Gynaecology, United Christian Hospital, Hong Kong
 
Corresponding author: Dr WY Lok (happyah2@hotmail.com)
 
 Full paper in PDF
 
Abstract
Introduction: This study investigated the knowledge, attitudes, and behaviours of pregnant women towards coronavirus disease 2019 (COVID-19), as well as obstetric services provided by public hospitals (eg, universal screening) during the pandemic.
 
Methods: This cross-sectional survey was performed in the antenatal clinics of Kowloon East Cluster, Hospital Authority. Questionnaires were distributed to pregnant women for self-completion during follow-up examinations.
 
Results: In total, 623 completed questionnaires were collected from 28 July 2020 to 13 August 2020. Within this cohort, 83.1% of the women expressed high levels of worry (41.9% very worried and 41.3% worried) about contracting COVID-19 during pregnancy, 70.5% believed that maternal COVID-19 could cause intrauterine infection of their fetuses, and 84.3% objected to banning husbands from accompanying wives during labour and delivery. Most women (80.6%) agreed with universal screening for COVID-19 at certain points during pregnancy. Logistic regression modelling showed that women who were very worried about contracting COVID-19 (P=0.005) and women in their third trimester of pregnancy (P=0.009) were more likely to agree with universal screening during pregnancy; women with higher income (P=0.017) and women who planned to deliver in a private hospital (P=0.024) were more likely to disagree with such screening.
 
Conclusion: Pregnant women expressed high levels of worry about contracting COVID-19 during pregnancy; universal screening during pregnancy was acceptable to a large proportion of our participants. Efforts should be made to specifically include pregnant women when launching any population screening programme for COVID-19.
 
 
New knowledge added by this study
  • This study investigated the knowledge, psychosocial behavioural responses, and opinions of pregnant women in Hong Kong towards coronavirus disease 2019 (COVID-19).
  • A large majority of the women in this study expressed worry about COVID-19, despite a lack of comprehensive knowledge about the disease.
  • More than 80% of the women agreed with universal screening for COVID-19 in pregnant women during visits to clinics and hospitals.
Implications for clinical practice or policy
  • Universal screening should be incorporated as part of routine clinical management and in-patient care for pregnant women during the COVID-19 pandemic.
  • Husbands should be allowed to accompany their wives during labour and delivery if a rapid screening method shows that the husbands do not have COVID-19.
  • Online resources should be developed to enhance public knowledge about COVID-19-related complications in pregnancy.
 
 
Introduction
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a worldwide pandemic for more than 2 years. The first reported case of COVID-19 occurred in Wuhan, China in late December 2019.1 2 On 21 January 2020, the first confirmed imported case of COVID-19 in Hong Kong was identified in a mainland Chinese tourist who arrived from Wuhan by high-speed rail.3
 
The dynamics of the current COVID-19 pandemic closely resemble the previous SARS epidemic because each has involved a respiratory disease caused by a coronavirus. Despite various measures and strategies employed by the Hong Kong government and the public in an effort to combat viral spread, a third wave of infections occurred in the middle of 2020, leading to >100 new confirmed COVID-19 cases daily for 12 days consecutively in late July 2020.4 In response, the government announced a variety of new measures to contain the spread of COVID-19.
 
Pregnant women in Hong Kong are particularly worried about the effects of COVID-19 because of their vulnerable immune status during pregnancy, as well as the fear of vertical transmission to the neonate.5 6 During the 2003 SARS epidemic in Hong Kong, 12 pregnant women contracted SARS and three died. Among the survivors, SARS was associated with poor outcomes including high rates of mechanical ventilation and intensive care unit admission, as well as spontaneous miscarriage, preterm delivery, and intrauterine growth restriction. However, there was no evidence of perinatal transmission of SARS to infants.7 In early 2020, the first reports of COVID-19 in Chinese pregnant women were published.8 9 Systematic reviews concerning maternal and perinatal outcomes in cases of COVID-19 have since been published.10 11 12 13
 
To our knowledge, no studies have specifically assessed the basic knowledge and concerns of pregnant women with respect to COVID-19, or their acceptance of universal screening for infection by the causative virus (SARS-CoV-2); such information is important for the establishment of public education campaigns and launching COVID-19 population screening efforts that target pregnant women. This study aimed to evaluate the opinions of pregnant women concerning obstetric services provided during the pandemic, with particular focus on acceptance of universal screening for COVID-19 during pregnancy. The study also explored the knowledge, attitudes, and behaviours of pregnant women towards the COVID-19 pandemic.
 
Methods
This cross-sectional survey was conducted in two antenatal clinics in the Kowloon East Cluster of Hong Kong. The questionnaires were distributed to consecutive pregnant women who attended antenatal follow-up examinations in the two clinics from July 2020 to August 2020.
 
The paper questionnaires were anonymous, self-administered, and available in either Chinese or English. The first section of the questionnaire collected basic demographic data from the recruited women. The remaining sections comprised four domains with 31 total questions; five questions had multiple parts. The four domains included questions regarding (1) knowledge of COVID-19 in pregnancy, (2) attitudes towards COVID-19, (3) social behaviours during the COVID-19 pandemic, and (4) opinions about the provision of obstetric services during the COVID-19 pandemic. The questions were answered in the following formats (as appropriate): binary (Yes/No), three options (Yes/No/unsure), 4-point Likert scale, or selection of available answers (online supplementary Appendix).
 
The study protocol was approved by the Research Ethics Committee of Kowloon East Cluster, Hospital Authority. SPSS software (Windows version 20.0; IBM Corp, Armonk [NY], United States) was used for data entry and analysis. Descriptive categorical data were expressed as numbers and percentages; they were compared and analysed by the Chi squared test or Fisher’s exact test as appropriate. Multivariate logistic regression analysis was used to identify clinical covariates that were significantly associated with pregnant women’s opinions about universal screening for COVID-19. A P value of <0.05 was considered statistically significant.
 
Results
Participants
The questionnaires were distributed to 700 pregnant women for 17 days, from 28 July 2020 to 13 August 2020. Seven women were excluded because they could not understand either version of the questionnaire (ie, Chinese or English), while 54 women refused to participate in the study. Of the 639 women who completed the questionnaire, 16 were excluded because of missing answers; thus, 623 participants were included in the final analysis. Nearly all participants were Chinese (93.3%). Half of the participants (50.2%) had an education level of tertiary or above; 47.5% were in the third trimester of pregnancy (Table 1).
 

Table 1. Maternal characteristics of pregnant women in antenatal clinics in the Kowloon East Cluster of Hong Kong (n=623)
 
Knowledge of COVID-19 in pregnancy
A large proportion of the participants (90.5%) knew that COVID-19 was transmitted by droplets, while more than one-third of participants (38.5%) thought that airborne transmission of COVID-19 was also possible. Additionally, more than one-third of participants (41.9%) thought that they were more likely to contract COVID-19, while 32.6% presumed that pregnant women with COVID-19 would have more severe disease and experience higher mortality rates compared with the general population. Moreover, 73.4% of participants thought that maternal COVID-19 was associated with pregnancy complications such as miscarriage, stillbirth, growth restriction, and preterm birth; 70.5% believed that maternal COVID-19 could be vertically transmitted to the fetus during pregnancy. Substantial proportions of participants were unsure whether COVID-19 in pregnant women could lead to teratogenicity in the fetus (44.5%), or whether women with COVID-19 should be able to perform vaginal delivery (44%) or breastfeed (35.3%) [Table 2].
 

Table 2. Knowledge of COVID-19 among pregnant women (n=623)
 
Attitudes and behaviours of pregnant women during the COVID-19 pandemic
The majority (83.1%) of participants were worried about contracting COVID-19 during pregnancy (41.9% were very worried and 41.3% were worried). Similarly, 87.0% of participants only left home when necessary during the pandemic, while 71.3% of participants were worried about contracting COVID-19 during their antenatal visits in public hospitals (27.1% were very worried and 44.1% were worried). One-third of the participants (33.1%) used extra protective gear other than surgical masks when attending antenatal clinics (eg, N95 masks, goggles, gloves, or face shields), while 28.9% of participants reported cleaning the chair and examination bed with disinfectants before use during an antenatal clinic visit. Almost one-quarter of participants (23.6%) intended to deliver in a private hospital, among which 49.7% (73/147) believed that the risk of contracting COVID-19 was lower when delivering in a private hospital than in a public hospital. Moreover, 61.2% of participants who intended to deliver in a private hospital (90/147) stated that public hospitals no longer permitted husbands to accompany wives during labour and delivery during the COVID-19 pandemic, while private hospitals continued to allow such practices. Seventy-two participants (11.6%) decided not to breastfeed because of the COVID-19 pandemic, of which 77.8% (56/72) believed that COVID-19 could be transmitted to the baby through breast milk even if the mother had asymptomatic illness (Table 3).
 

Table 3. The attitudes and behaviours of pregnant women during the COVID-19 pandemic (n=623)
 
Opinions about the provision of obstetric services during the COVID-19 pandemic
Most participants agreed that antenatal seminars and antenatal exercise classes should be cancelled, and that visitors should not be allowed in postnatal wards and neonatal wards (including husbands and parents). However, a large proportion of participants (84.3%) objected to banning husbands from accompanying wives during labour and delivery in the COVID-19 pandemic; 94.7% of participants agreed that husbands a with negative COVID-19 test results should be allowed to accompany wives during labour, and 65.6% agreed with paying for such a test if the price was ≤HK$300. While 80.6% of participants agreed that pregnant women should undergo universal screening for COVID-19 during pregnancy, their preferences varied regarding the optimal time to perform such screening. The most popular option was screening in every trimester (36.7%), followed by screening when preparing for labour or in labour (36.3%). Almost all participants (92.5%) agreed that hospital staff caring for pregnant women should undergo regular universal COVID-19 screening (Table 4).
 

Table 4. Pregnant women’s opinions about obstetric services during the COVID-19 pandemic (n=623)
 
Factors that affect pregnant women’s opinions about universal screening for COVID-19
Univariate analysis showed that a significantly greater proportion of women who agreed with universal screening had family income <$40 000 (72.7% vs 47.9%, P<0.001), were very worried about contracting COVID-19 during pregnancy (45.0% vs 28.9%, P=0.001), or were in their third trimester (50.8% vs 33.9%, P=0.001). Conversely, women who did not agree with screening were more likely to have an education level of tertiary or above (46.4% vs 66.1%, P<0.001) and intended to deliver in a private hospital (14.3% vs 40.5%, P<0.001). However, no differences were observed in terms of parity, ethnicity, or the proportion of women with advanced maternal age between women who did and did not agree with universal screening (Table 5). Logistic regression analysis showed that women who were very worried about contracting COVID-19 (P=0.005, odds ratio [OR]=1.89) and women in their third trimester of pregnancy (P=0.009, OR=1.77) were more likely to agree with universal screening during pregnancy; women with family income >$40 000 (P=0.017, OR=0.55) and women who planned to deliver in a private hospital (P=0.024, OR=0.57) were more likely to disagree with such screening. Education level was not a significant risk factor according to multivariate analysis (Table 6).
 

Table 5. Factors that affected pregnant women’s opinions about universal screening
 

Table 6. Logistic regression of factors associated with support for universal COVID screening among pregnant women
 
Discussion
To our knowledge, this is the first large study in Hong Kong concerning the knowledge and psychobehavioural responses of pregnant women towards the COVID-19 pandemic. While basic concepts concerning COVID-19 appeared to be understood by our study participants (eg, COVID-19 is primarily spread through droplets and that vaccines were not available at the time of the study), there was the potential for improved knowledge regarding other concepts. For instance, there is evidence that, compared with the general population, pregnant women are not more susceptible to contract COVID-19 and the majority of them do not experience severe complications of COVID-19 in pregnancy; however, it has been suggested that pregnant women may be at higher risk of more severe disease than the non-pregnant women in terms of intensive care unit admission particularly when they are in the third trimester.14 In a systematic review, the rate of severe pneumonia in pregnant women with COVID-19 ranged from 0% to 14%; sporadic maternal death was reported in case reports of patients with severe COVID-19.10 Furthermore, approximately 70% of women in our cohort thought that maternal COVID-19 led to increased pregnancy complications and carried a high rate of vertical transmission, more evidence in these areas are now emerging. Systematic reviews have shown that there could be increased risks of miscarriage and stillbirths in pregnant women with COVID-19; and pregnant women with symptomatic infection had two-to-three-fold increased risks of preterm birth, most of these were iatrogenic.12 13 In contrast, there is no evidence showing increased risk for teratogenicity or intrauterine growth restriction of baby with maternal COVID-19 infection.15 The risks of vertical transmission of COVID-19, which despite remaining controversial, has now been supported by systematic reviews.16 Online resources, such as websites or mobile apps, should be considered to provide updated information regarding the effects of COVID-19 on pregnancy.
 
Our pregnant women demonstrated uncertainties concerning the mode of delivery and breastfeeding should they contract COVID-19, mainly because they feared disease transmission during delivery or via breast milk. While the literature has reported that vertical transmission during vaginal delivery or in the peripartum period could be possible, the actual risks appeared to be very low and caesarean may not prevent vertical transmission.17 Indeed, vaginal delivery is not contra-indicated although high rates of caesarean delivery have been reported in studies, with up to 85.9% of deliveries via caesarean section in a large series of 116 women with COVID-19 (38.8% had COVID-19 pneumonia).18 However, there has been conflicting evidence regarding the safety of breastfeeding.19 According to the Centers for Disease Control and Prevention guidelines, breastfeeding is not contra-indicated when a mother contracts COVID-19 but should be determined by the mother’s overall health status.20 Available data suggest that SARS-CoV-2 is not detectable in breast milk samples from mothers with COVID-19. While some authors have suggested isolation of the mother and baby,21 a large series of 82 neonates roomed with mothers who had COVID-19 in a closed Giraffe isolette (with necessary contact precautions during direct breastfeeding) showed that these neonates remained free of COVID-19.22
 
A large majority of the pregnant women in our cohort expressed worry about contracting COVID-19 during pregnancy or antenatal follow-up examinations in public hospitals. A survey of the psychological and behavioural responses of pregnant women during the SARS epidemic in Hong Kong revealed that pregnant women had slightly greater anxiety during SARS than before the epidemic.23 In addition to their memories of the SARS epidemic, the widespread worry among pregnant women in our cohort could be explained by the timing of our survey, which was conducted during a wave of COVID-19 transmission in Hong Kong. We might have been able to partially alleviate their fears if we had stated that the World Health Organization’s provisional case fatality rate of COVID-19 was 3.7% during the study period, considerably lower than the 10% of SARS.24 A substantial proportion of pregnant women (approximately 20%) in our survey revealed that they had considered subsequent follow-up examinations and delivery in private hospitals, which they believed to be safer; however, this proportion might be an underestimation because women who intended to deliver in a private hospital might not have attended our clinics for any examinations.
 
More than 80% of women objected to banning husbands from accompanying wives during labour and delivery in the COVID-19 pandemic, particularly if those husbands had negative COVID-19 test results. Indeed, many women reported considering delivery in a private hospital for this reason. A previous study conducted in our unit demonstrated that partner companionship during labour could offer emotional support and enhance maternal satisfaction during delivery.25 As extended screening becomes available, husbands should be offered the opportunity to undergo screening when their wives are admitted for labour and delivery to address this need for partner companionship.
 
Because COVID-19 is highly transmissible and COVID-19 carriers may be asymptomatic, universal screening of all patients is important to curb disease spread in the community. In August 2020, the Hong Kong Government announced that a voluntary universal COVID-19 testing programme would be launched. In partnership with the Board of Directors of Yan Chai Hospital, the government’s trial community testing programme for COVID-19 among pregnant women was launched on 10 August 2020, although we did not have data regarding this programme during our study. Around 1 month after our study, the Hospital Authority extended the COVID-19 screening to all asymptomatic in-patients including pregnant women. Our survey showed that approximately 80% of pregnant women agreed with universal screening for COVID-19 in the hospital setting. While their opinions differed concerning the frequency and timing of screening, women in the third trimester of pregnancy generally wanted to confirm that they were COVID-19-free at the time of delivery. However, it is understandable that women with higher family income and women who intended to deliver in a private hospital might not agree with universal screening in public hospitals. In the literature, universal screening for COVID-19 in pregnant women has mainly focused on screening at the time of admission for delivery; this practice was implemented as early as March 2020 in countries where community prevalence rates were considered high. Such universal screening has yielded prevalence rates of 0.43% to 13.7% for asymptomatic COVID-19 in pregnant women, depending on the local epidemiological situation.26 27 28 29 In the latest update, the Royal College of Obstetricians and Gynaecologists recommended all pregnant women admitted to hospitals in England should be offered SARS-CoV-2 testing regardless of symptoms.30 Ideally, such screening enables early identification and cohorting of asymptomatic women with COVID-19, thus protecting other pregnant women, their newborn infants, and healthcare staff. Negative test results can be used to reassure the women and encourage them to practise breastfeeding. The inclusion of universal screening for COVID-19 among pregnant women should be a key aspect of maternity care after considering the need for laboratory support, availability of isolation facilities and personal protective equipment, and (most importantly) the cost-effectiveness of screening based on the estimated community prevalence of COVID-19.
 
There were some limitations in this study. While we performed a small pilot study (involving face-to-face interviews) when designing and refining the survey questions to confirm responses by pregnant women, we did not conduct further formal validation or assessment of internal reliability. The questionnaires were developed around the peak of the third wave in Hong Kong; the results drawn from the survey reflected only the recruited women’s knowledge and opinions at that time point. Thus, our findings might not be generalisable to other populations or other points in the COVID-19 pandemic with different epidemiological characteristics.
 
Conclusion
Among pregnant women, knowledge about COVID-19 during pregnancy should be strengthened through public education that specifically focuses on COVID-19-related complications in pregnancy. A large majority of pregnant women expressed worry about contracting COVID-19 during pregnancy, and most women in the study agreed with universal screening during pregnancy. While the optimal timing for screening in pregnancy requires further consideration, there is a need to specifically include pregnant women in population screening programmes for COVID-19.
 
Author contributions
Concept or design: WY Lok, CW Kong, WWK To.
Acquisition of data: WY Lok, CY Chow.
Analysis or interpretation of data: WY Lok, CW Kong, WWK To.
Drafting of the manuscript: WY Lok, CW Kong.
Critical revision of the manuscript for important intellectual content: All authors
 
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have disclosed no conflicts of interest.
 
Funding/support
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
 
Ethics approval
Ethics approval was obtained from the Kowloon Central/Kowloon East Research Ethics Committees (Ref: KC/KE-20- 0226/ER-3).
 
References
1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33. Crossref
2. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. Crossref
3. Cheung E. China Coronavirus: death toll almost doubles in one day as Hong Kong reports its first two cases. South China Moring Post. 2020 Jan 22. Available from: https://www.scmp.com/news/hong-kong/health-environment/article/3047193/china-coronavirus-first-case-confirmed-hong- kong. Accessed 16 Aug 2020.
4. Ting V, Leung K, Cheung E. Hong Kong third wave: city’s Covid-19 social-distancing measures set to be extended after recent spike in cases. South China Moring Post. 2020 Aug 1. Available from: https://www.scmp.com/news/hongkong/healthenvironment/article/3095642/hong-kong-third-wave-more-100-new-covid-19-cases. Accessed 16 Aug 2020.
5. Dashraath P, Wong JL, Lim MX, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020;222:521-31. Crossref
6. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol 2020;222:415-26. Crossref
7. Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004;191:292-7. Crossref
8. Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med 2020;144:799-805. Crossref
9. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020;395:809-15. Crossref
10. Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol 2020;56:15-27. Crossref
11. Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand 2020;99:823-9. Crossref
12. Kazemi SN, Hajikhani B, Didar H, et al. COVID-19 and cause of pregnancy loss during the pandemic: a systematic review. PLoS One 2021;16:e0255994. Crossref
13. Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ 2021;193:E540-8. Crossref
14. Vousden N, Bunch K, Morris E, et al. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV- 2 infection in the UK from March to September 2020: a national cohort study using the UK Obstetric Surveillance System (UKOSS). PLoS One 2021;16:e0251123. Crossref
15. Mullins E, Hudak ML, Banerjee J, et al. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol 2021;57:573-81. Crossref
16. Musa SS, Bello UM, Zhao S, Abdullahi ZU, Lawan MA, He D. Vertical transmission of SARS-CoV-2: a systematic review of systematic reviews. Viruses 2021;13:1877. Crossref
17. Sinaci S, Ocal DF, Seven B, et al. Vertical transmission of SARS-CoV-2: a prospective cross-sectional study from a tertiary center. J Med Virol 2021;93:5864-72. Crossref
18. Yan J, Guo J, Fan C, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol 2020;223:111.e1-14. Crossref
19. Poon LC, Yang H, Kapur A, et al. Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: information for healthcare professionals. Int J Gynecol Obstet 2020;149:273-86. Crossref
20. Centers for Disease Control and Prevention. Care for breastfeeding people. Interim guidance on breastfeeding and breast milk feeds in the context of COVID-19. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/care-for-breastfeeding-women.html. Accessed 11 Aug 2020.
21. Griffin I, Benarba F, Peters C, et al. The impact of COVID-19 infection on labor and delivery, newborn nursery, and neonatal intensive care unit: prospective observational data from a single hospital system. Am J Perinatol 2020;37:1022-30. Crossref
22. Salvatore CM, Han JY, Acker KP et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health 2020;4:721-7. Crossref
23. Lee DT, Sahotab D, Leung TN, Yip AS, Lee FF, Chung TK. Psychological responses of pregnant women to an infectious outbreak: a case-control study of the 2003 SARS outbreak in Hong Kong. J Psychosom Res 2006;61:707-13. Crossref
24. World Health Organization. Coronavirus disease (COVID-2019) situation reports-204. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200811-covid-19-sitrep-204.pdf?sfvrsn=1f4383dd_2. Accessed 12 Aug 2020.
25. Chung VW, Chiu JW, Chan DL, To WW. Companionship during labour promotes vaginal delivery and enhances maternal satisfaction. Hong Kong J Gynaecol Obstet Midwifery 2017;17:12-7.
26. Sutton D, Fuchs K, D’Alton M, Goffman D. Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med 2020;382:2163-4. Crossref
27. Fassett MJ, Lurvey LD, Yasumura L, et al. Universal SARS-Cov-2 screening in women admitted for delivery in a large managed care organization. Am J Perinatol 2020;37:1110-4. Crossref
28. Tanacana A, Erola SA, Turgay B, et al. The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: experience of a pandemic center in Turkey. Eur J Obstet Gynecol Reprod Biol 2020;253:31-4. Crossref
29. Herraiz I, Folgueira D, Villalaín C, Forcén L, Delgado R, Galindo A. Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid. J Perinat Med 2020;48:981-4. Crossref
30. The Royal College of Obstetricians and Gynaecologists. Principles for the testing and triage of women seeking maternity care in hospital settings, during the COVID-19 pandemic. A supplementary framework for maternity healthcare professionals. version 2. Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/2020-08-10-principles-for-the-testing-and-triage-of-women-seeking-maternity-care-in-hospital-settings-during-the-covid-19-pandemic.pdf. Accessed 2 Oct 2020.

Non-visualisation of fetal gallbladder in a Chinese cohort

Hong Kong Med J 2022 Apr;28(2):116–23  |  Epub 20 Apr 2022
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Non-visualisation of fetal gallbladder in a Chinese cohort
YH Ting, MB, BS, FRCOG1; PL So, MB, BS, MRCOG2; KW Cheung, MB, BS, MRCOG3; TK Lo, MB, BS, FRCOG4; Teresa WL Ma, MB, BS, FRCOG5; TY Leung, MD, FRCOG
1 Fetal Medicine Unit, Department of Obstetrics and Gynaecology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong
2 Fetal Medicine Unit, Department of Obstetrics and Gynaecology, Tuen Mun Hospital, Hong Kong
3 Fetal Medicine Unit, Department of Obstetrics and Gynaecology, Queen Mary Hospital, Hong Kong
4 Fetal Medicine Unit, Department of Obstetrics and Gynaecology, Princess Margaret Hospital, Hong Kong
5 Fetal Medicine Unit, Department of Obstetrics and Gynaecology, Queen Elizabeth Hospital, Hong Kong
 
Corresponding author: Prof TY Leung (tyleung@cuhk.edu.hk)
 
 Full paper in PDF
 
Abstract
Introduction: Non-visualisation of fetal gallbladder (NVFGB) is associated with chromosomal abnormalities, biliary atresia, cystic fibrosis, and gallbladder agenesis in Caucasian fetuses. We investigated the outcomes of fetuses with NVFGB in a Chinese cohort.
 
Methods: This retrospective analysis included cases of NVFGB among Chinese pregnant women at five public fetal medicine clinics in Hong Kong from 2012 to 2019. We compared the incidences of subsequent gallbladder visualisation, chromosomal abnormalities, biliary atresia, cystic fibrosis, and gallbladder agenesis between cases of isolated NVFGB and cases of non-isolated NVFGB.
 
Results: Among 19 cases of NVFGB detected at a median gestational age of 21.3 weeks (interquartile range, 20.0-22.3 weeks), 10 (52.6%) were isolated and nine (47.4%) were non-isolated. Eleven (58.0%) cases had transient non-visualisation, four (21.0%) had gallbladder agenesis, three (15.8%) had chromosomal abnormalities (trisomy 18, trisomy 21, and 22q11.2 microduplication), one (5.2%) had biliary atresia, and none had cystic fibrosis. The incidence of serious conditions was significantly higher in the non-isolated group than in the isolated group (44.4% vs 0%; P=0.029); all three cases with chromosomal abnormalities and the only case of biliary atresia were in the non-isolated group, while all four cases with gallbladder agenesis were in the isolated group. The incidences of transient non-visualisation were similar (55.6% vs 60.0%; P=1.000).
 
Conclusion: Isolated NVFGB is often transient or related to gallbladder agenesis. While investigations for chromosomal abnormalities and biliary atresia are reasonable in cases of NVFGB, testing for cystic fibrosis may be unnecessary in Chinese fetuses unless the NVFGB is associated with consistent ultrasound features, significant family history, or consanguinity.
 
 
New knowledge added by this study
  • Non-visualisation of fetal gallbladder (NVFGB) is associated with chromosomal abnormalities, biliary atresia, cystic fibrosis, and gallbladder agenesis in Caucasian fetuses. A similar pattern of associated conditions was observed in Chinese fetuses with NVFGB, but none had cystic fibrosis.
  • While the incidences of chromosomal abnormalities and biliary atresia were significantly higher in cases of non-isolated NVFGB, isolated NVFGB was generally transient or related to gallbladder agenesis; the risks of chromosomal abnormalities and biliary atresia are presumably low in cases of isolated NVFGB.
  • The chromosomal abnormalities associated with NVFGB include common aneuploidies, microdeletions, and microduplications.
Implications for clinical practice or policy
  • Considering the association with chromosomal abnormalities, amniocentesis is recommended in cases of NVFGB. Chromosomal microarray analysis is more appropriate than karyotyping for the detection of associated microdeletions and microduplications.
  • Amniotic fluid gamma-glutamyl transpeptidase (AFGGT) assay may be useful because low AFGGT level is reportedly a marker for biliary atresia; it is sensitive but not specific, particularly after 22 weeks of gestation.
  • Further testing for cystic fibrosis may be unnecessary in Chinese fetuses unless the NVFGB is associated with consistent ultrasound features, significant family history, or consanguinity.
 
 
Introduction
The fetal gallbladder can be observed by antenatal ultrasound scan at 14 weeks of gestation.1 During the morphology scan at approximately 20 weeks of gestation, >99% of fetal gallbladders can be observed; in 75% of cases of non-visualisation of fetal gallbladder (NVFGB), a gallbladder is clearly present during subsequent scans.2 However, the visualisation rate drops to 75% to 85% after 32 weeks of gestation when the gallbladder becomes contractile.3 4
 
Although sonographic examination of the fetal gallbladder is not technically difficult, the International Society of Ultrasound in Obstetrics and Gynecology and other professional bodies have not yet included the gallbladder as a routine component of the mid-trimester anatomical survey.5 6 7 8 The problem with routine examination of the fetal gallbladder is that non-visualisation of the gallbladder can lead to challenging counselling and antenatal diagnosis because NVFGB is related to a wide spectrum of fetal conditions. While NVFGB may be a transient phenomenon in a normal fetus or the result of gallbladder agenesis (a benign congenital anomaly), it can also be associated with more serious underlying conditions such as biliary atresia, cystic fibrosis, or chromosomal abnormalities. While it is generally simple to identify chromosomal abnormalities and cystic fibrosis by amniocentesis, the antenatal diagnosis of biliary atresia is challenging because no diagnostic antenatal test is currently available. Because biliary atresia can be fatal without early postnatal intervention and may eventually require liver transplantation, uncertainty regarding the antenatal diagnosis of such a condition may cause significant parental anxiety; some parents may even consider termination of pregnancy to avoid the risk of a severe abnormality in their child.9 10
 
A systematic review of isolated NVFGB in Western populations revealed that the incidences of transient non-visualisation, gallbladder agenesis, biliary atresia, cystic fibrosis, and chromosomal abnormalities were 69.4%, 24.7%, 3.5%, 2.4%, and 1.4%, respectively. The incidences of biliary atresia, cystic fibrosis, and chromosomal abnormalities were higher in cases of non-isolated NVFGB with additional sonographic abnormalities: 18.2%, 23.1%, and 20.4%, respectively.11 However, the incidences may differ considerably among Chinese women with NVFGB, as cystic fibrosis is uncommon in Asian populations, while biliary atresia is more prevalent in Chinese individuals.12 13 14 15 16 The aim of this study was to investigate the outcomes of fetuses with NVFGB in a cohort of Chinese women; the findings may provide guidance for the management of NVFGB.
 
Methods
This retrospective review included cases of NVFGB among Chinese pregnant women at five public fetal medicine clinics in Hong Kong from 2012 to 2019. In these clinics, fetal morphology scans were limited to high-risk cases and fetal gallbladder assessment was not routinely performed, in accordance with guidelines from the International Society of Ultrasound in Obstetrics and Gynecology.5 17 When cases of NVFGB were detected incidentally or referred from private clinics, the pregnant women were provided counselling regarding possible differential diagnoses and offered amniocentesis for chromosomal analysis. In cases of serious fetal abnormalities where parents decided for legal termination of pregnancy before 24 weeks of gestation, post-mortem examinations were arranged with parental consent. After birth, babies with NVFGB were referred to paediatricians for further evaluation.
 
The following data were reviewed: demographic information, gestational age at detection of NVFGB, findings during the morphology scan and subsequent scans, results of all amniotic fluid investigations if amniocentesis had been performed, pregnancy outcome, all neonatal imaging reports, operations performed on the baby and intra-operative findings, and autopsy findings in case of termination of pregnancy. The cases were segregated into isolated and non-isolated groups according to the absence or presence of additional sonographic findings. The incidences of subsequent visualisation of gallbladder, gallbladder agenesis, biliary atresia, cystic fibrosis, and chromosomal abnormalities were compared between the two groups.
 
The study protocol was approved by the Joint Chinese University of Hong Kong–New Territories East Cluster Clinical Research Ethics Committee on 3 March 2020 (CREC Ref. No.: 2020.060). This manuscript was written in accordance with STROBE reporting guidelines.
 
Statistical analysis
Fisher’s exact test was used for comparisons between the isolated and non-isolated groups. All statistical analyses were performed using SPSS software (Windows version 22.0; IBM Corp., Armonk [NY], United States). P values <0.05 were considered statistically significant.
 
Results
Among 19 cases of NVFGB detected at a median gestational age of 21.3 weeks (interquartile range, 20.0-22.3 weeks), 10 (52.6%) were isolated and nine (47.4%) were non-isolated. Eleven (58.0%) cases had transient non-visualisation, four (21.0%) had gallbladder agenesis, three (15.8%) had chromosomal abnormalities (trisomy 18, trisomy 21, and 22q11.2 de novo microduplication), and one (5.2%) had biliary atresia. There were no cases with features suggestive of cystic fibrosis (Tables 1 and 2).
 

Table 1. Details of the 19 cases of non-visualisation of fetal gallbladder
 

Table 2. Comparison of characteristics between isolated and non-isolated cases of non-visualisation of fetal gallbladder
 
Non-isolated non-visualisation of fetal gallbladder
Amniocentesis was performed in eight of the nine non-isolated cases; three chromosomal abnormalities (33.3%) were found, including trisomy 18 (case 1), trisomy 21 (case 2), and 22q11.2 de novo microduplication (case 3). Case 1 ended in neonatal death and the parents declined post-mortem investigation. Case 2 was a dichorionic twin pregnancy; selective feticide was performed on the fetus with trisomy 21, but post-mortem investigation could not be performed because of the long interval between selective feticide and delivery of the normal co-twin. Termination of pregnancy was performed in case 3 and gallbladder agenesis was confirmed at autopsy. Termination of pregnancy was also performed in case 4 because of multiple structural abnormalities; chromosomal microarray (CMA) findings were normal and post-mortem investigation revealed normal gallbladder. Live birth occurred in the remaining five cases; in one case, the gallbladder was observed during a subsequent antenatal scan and the postnatal outcome was normal, while NVFGB persisted in the other four cases. Among the four cases with persistent NVFGB, one (11.1%) had biliary atresia that required liver transplantation (case 6); antenatal scans had shown a hepatic hilar cyst (Fig 1), which was highly suggestive of cystic biliary atresia.18 Postnatal examination showed a normal gallbladder in the other three cases. None of the five live births had features suggestive of cystic fibrosis (Table 1 and Fig 2).
 

Figure 1. Antenatal ultrasonogram of Case 4 showing a hepatic hilar cyst (arrow), which was confirmed to be cystic biliary atresia after birth
 

Figure 2. Diagram of the underlying diagnoses in 19 cases of non-visualisation of fetal gallbladder (NVFGB) in our Chinese cohort
 
Isolated non-visualisation of fetal gallbladder
Among the 10 cases of isolated NVFGB, amniocentesis was performed in one, while chorionic villi sampling was performed in the first trimester because of positive Down syndrome screening result in another; CMA findings were normal in both cases. In four cases, gallbladders were observed during subsequent antenatal scans at a mean follow-up interval of 1.0 week (range, 0.3-2.0); NVFGB persisted in the other six cases. Among the six cases with persistent NVFGB, gallbladder agenesis was confirmed in four (66.7%) and gallbladders were observed after birth in two (33.3%). None of the 10 cases had features suggestive of cystic fibrosis after birth (Table 1 and Fig 2).
 
Comparison between the isolated and non-isolated groups
The characteristics of isolated and non-isolated groups are compared in Table 2. The incidence of serious abnormalities (chromosomal abnormalities, biliary atresia) was significantly higher in the non-isolated group than in the isolated group (44.4% vs 0%; P=0.029). Notably, all serious conditions in the cohort (all three cases of chromosomal abnormalities and the only case of biliary atresia) were observed in the non-isolated group, while all benign conditions (all four cases of isolated gallbladder agenesis) were observed in the isolated group. The incidences of transient non-visualisation did not significantly differ between the isolated and non-isolated groups (60.0% vs 55.6%; P=1.000).
 
Discussion
Isolated non-visualisation of fetal gallbladder
In our cohort, cases of isolated NVFGB had a good overall prognosis, with a 60% probability that the gallbladder would be observed in a subsequent scan and a 40% probability of gallbladder agenesis. This incidence of transient non-visualisation (60%) is consistent with findings by Yayla and Bayik2 (75%) and Di Pasquo et al11 (69.4%). In our cases of transient NVFGB, the gallbladder was observed during a subsequent antenatal scan in 40%, and during the postnatal period in the remaining 20%. The mean interval between NVFGB and subsequent antenatal detection of the gallbladder was 1 week. Therefore, a second sonographic examination within 1 week after NVFGB would help to alleviate parental anxiety and avoid the need for further investigations in nearly half of such cases. Even in cases with persistent isolated NVFGB, the prognosis remains good, because the gallbladder is likely to be observed after birth in one-third of cases; while gallbladder agenesis is likely in the remaining cases. Our findings are similar to the results of a recent systematic review of seven studies in Western populations, including 217 cases of isolated NVFGB; most cases had transient non-visualisation (69.4%) and gallbladder agenesis (24.7%), but some cases had serious conditions (biliary atresia [3.5%], cystic fibrosis [2.4%], and chromosomal abnormalities [1.4%]).11 Therefore, further investigations to rule out such serious abnormalities remain important in cases of isolated NVFGB.
 
Non-isolated non-visualisation of fetal gallbladder
In the aforementioned review, the incidences of biliary atresia, cystic fibrosis, and chromosomal abnormalities were much higher when NVFGB occurred in combination with other ultrasound abnormalities (18.2%, 23.1%, and 20.4%, respectively).11 Copy number variants were observed in one of three cases with chromosomal abnormalities in our study and two of 11 such cases in the study by Di Pasquo et al11; these findings support the recommendation for the use of CMA, rather than karyotyping.19 20 21 However, our results differ from the findings reported by Di Pasquo et al11 in that none of our cases had cystic fibrosis, which is unsurprising because cystic fibrosis is rare in Chinese individuals; moreover, our incidence of biliary atresia (11.1%) was much lower than expected, considering that biliary atresia is reportedly threefold more common in Chinese individuals than in Caucasian individuals.12 13 14 15 16
 
Non-visualisation of fetal gallbladder and biliary atresia
Based on the data described above, in cases of non-isolated NVFGB or persistent isolated NVFGB, amniocentesis may help to rule out chromosomal abnormalities; this approach is generally simple with current CMA technology.19 20 However, the antenatal diagnosis of biliary atresia is challenging because fetal bile duct patency cannot be determined by sonographic examination; NVFGB may be the only suggestive sign of biliary atresia. When NVFGB is associated with a hepatic hilar cyst or heterotaxy, a diagnosis of biliary atresia is likely.18 However, it is difficult to differentiate biliary atresia from gallbladder agenesis in cases of isolated NVFGB. Thus, a low amniotic fluid gamma-glutamyl transpeptidase (AFGGT) level has been proposed as an indicator of biliary atresia.22 23 24 Gamma-glutamyl transpeptidase (GGT) is initially derived from the fetal biliary tract, passed into the gastrointestinal tract, and finally excreted into the amniotic fluid. The AFGGT level decreases with increasing gestational age because progressive maturation of the anal sphincter impairs the passage of GGT from the gastrointestinal tract into the amniotic fluid.22 25 26 The anal sphincter muscles become fully mature by 20 weeks of gestation, and the AFGGT level becomes very low after 22 weeks of gestation. Therefore, it may be difficult to distinguish between a low level related to biliary atresia and a low level related to normal development after 22 weeks of gestation.25 26 Using an AFGGT level below the 5th centile, Bardin et al23 reported 100% sensitivity in the detection of biliary atresia, with a false positive rate of 4%, between 17 and 22 weeks of gestation (Table 3). Using AFGGT level and/or intestinal alkaline phosphatase <0.5 multiples of the median, Dreux et al24 also reported 100% sensitivity before 22 weeks of gestation; however, their false positive rate was 20%. Notably, when the test was performed after 22 weeks of gestation, the sensitivity decreased to 20%. Therefore, gestational age at amniocentesis is a critical consideration during the assessment of biliary atresia; if NVFGB is first detected near 22 weeks of gestation, amniocentesis should be performed immediately, rather than waiting for sonographic examination to be repeated. Another limitation of using the AFGGT level to identify biliary atresia is that it has a moderately low positive predictive value: 43% to 75% before 22 weeks of gestation, and 17% thereafter.23 24 Accordingly, a positive AFGGT test result is not diagnostic of biliary atresia, particularly in cases of isolated NVFGB where the incidence of biliary atresia is presumably low. Conversely, the negative predictive value of AFGGT is near 100%; a negative test result is very reassuring, which can help to alleviate parental anxiety and avoid unwarranted termination of pregnancy.23 24 When NVFGB is detected after 22 weeks of gestation, the fetal blood GGT level may be useful for identification of biliary atresia.27 28 However, cordocentesis may be unwarranted, as the procedure-related risk outweighs the possible diagnostic benefit, particularly in cases of isolated NVFGB where the risk of biliary atresia is presumably low.
 

Table 3. Reported efficacies of amniotic fluid enzymes for the prediction of biliary atresia in cases of non-visualisation of fetal gallbladder
 
Non-visualisation of fetal gallbladder and cystic fibrosis
In Caucasian populations, the incidence of cystic fibrosis is 1:2500-3500 live births and the carrier rate is 1:50; in contrast, this hereditary disease is extremely rare among East Asian individuals (1:350000 people in Japan and 1:300000 live births in Hong Kong).15 16 29 Unsurprisingly, we did not observe cystic fibrosis in either group of NVFGB cases. Therefore, in the absence of significant family history, consanguinity, or concurrent ultrasound features suggestive of cystic fibrosis (eg, echogenic or dilated bowel), amniocentesis for genetic testing for cystic fibrosis is not recommended in cases of NVFGB in Hong Kong. Assessment of the parental CFTR gene mutation status may be a useful alternative.
 
Management protocol for non-visualisation of fetal gallbladder
Based on our findings and the results of previous studies, we propose the following approach for the management of NVFGB. When NVFGB is detected, a detailed morphology scan should be performed to identify associated abnormalities, such as hepatic hilar cyst and heterotaxy (indicative of biliary atresia) or echogenic and dilated bowel (suggestive of cystic fibrosis). A sonographic examination of the gallbladder should be repeated within 1 week. Considering the potential for chromosomal abnormalities (even in cases of isolated NVFGB), amniocentesis is recommended for CMA analysis in cases of persistent NVFGB. The AFGGT assay can also be performed before 22 weeks of gestation; counselling prior to the test should involve an explanation of the moderately low positive predictive value for identification of biliary atresia. Beyond 22 weeks of gestation, the AFGGT level is not useful for identifying biliary atresia, but cordocentesis for GGT level may be useful. However, cordocentesis is generally not recommended because the procedure-related risk outweighs the possible diagnostic benefit, particularly in cases of isolated NVFGB where the risk of biliary atresia is presumably low. Further testing for cystic fibrosis may be unnecessary in Chinese fetuses unless the NVFGB is associated with other ultrasound features suggestive of cystic fibrosis, significant family history, or consanguinity. Further research is needed concerning AFGGT reference values and the ability of the AFGGT level to identify biliary atresia in Chinese fetuses with NVFGB.
 
Limitations and strength
Similar to other reports regarding NVFGB, our study was limited by its retrospective design and small cohort size. Because fetal gallbladder examination has not been a routine practice in Hong Kong, we cannot calculate the prevalence of NVFGB. To our knowledge, this is the first report of NVFGB in a Chinese cohort. Moreover, our results differed from findings in Caucasian populations in that we did not observe cystic fibrosis in our cohort; such information may be useful during antenatal counselling in cases of NVFGB.
 
Conclusion
The prognosis of isolated NVFGB is generally good because the non-visualisation is either transient or related to gallbladder agenesis. While investigations of chromosomal abnormalities and biliary atresia are reasonable in cases of NVFGB, testing for cystic fibrosis may be unnecessary in Chinese fetuses unless the NVFGB is associated with consistent ultrasound features, significant family history, or consanguinity.
 
Author contributions
Concept or design: YH Ting, TY Leung.
Acquisition of data: YH Ting, PL So, KW Cheung, TK Lo, TWL Ma.
Analysis or interpretation of data: YH Ting.
Drafting of the manuscript: YH Ting, TY Leung.
Critical revision of the manuscript for important intellectual content: All authors.
 
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have disclosed no conflicts of interest.
 
Declaration
The research was presented as poster in the 30th World Congress on Ultrasound in Obstetrics and Gynecology, 16-18 October 2020, and was published as an abstract in Ultrasound in Obstetrics & Gynecology (Ting Y, Leung T, Law K, Lo T, Cheung K, So P. VP09.12: Non-visualisation of fetal gall bladder in a Chinese cohort. Ultrasound Obstet Gynecol 2020;56(S1):84).
 
Funding/support
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
 
Ethics approval
The study protocol was approved by the Joint Chinese University of Hong Kong–New Territories East Cluster Clinical Research Ethics Committee on 3 March 2020 (CREC Ref. No.: 2020.060).
 
References
1. Goldstein I, Tamir A, Weisman A, Jakobi P, Copel JA. Growth of the fetal gall bladder in normal pregnancies. Ultrasound Obstet Gynecol 1994;4:289-93. Crossref
2. Yayla M, Bayik RN. Undetectable gall bladder in fetus: what to do? Perinat J 2016;24:11-9. Crossref
3. Hertzberg BS, Kliewer MA, Maynor C, et al. Nonvisualization of the fetal gallbladder: frequency and prognostic importance. Radiology 1996;199:679-82. Crossref
4. Lehtonen L, Svedström E, Kero P, Korvenranta H. Gall bladder contractility in preterm infants. Arch Dis Child 1993;68(1 Spec No):43-5. Crossref
5. Salomon LJ, Alfirevic Z, Berghella V, et al. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 2011;37:116-26. Crossref
6. Australasian Society for Ultrasound in Medicine. Guidelines for the performance of second (mid) trimester ultrasound. 2018. Available from: https://www.asum.com. au/files/public/SoP/curver/Obs-Gynae/Guidelines-for-the-Performance-of-Second-Mid-Trimester-Ultrasound.pdf. Accessed 24 Aug 2020.
7. NHS Mid and South Essex, University Hospitals Group. NHS Fetal Anomaly Screening Programme: National Standards and Guidance for England. Guidelines for performing the 18 weeks and 0 days to 20 weeks and 6 days gestation fetal anomaly scan. 2015. Available from: https://www.meht.nhs.uk/EasysiteWeb/getresource.axd?AssetID=17955&type=Full&servicetype=Attachment. Accessed 24 Aug 2020.
8. Cargill Y, Morin L. No. 223—Content of a complete routine second trimester obstetrical ultrasound examination and report. J Obstet Gynaecol Can 2017;39:e144-9. Crossref
9. Chan YM, Leung TN, Leung TY, Fung TY, Chan LW, Lau TK. The utility assessment of Chinese pregnant women towards the birth of a baby with Down syndrome compared to a procedure-related miscarriage. Prenat Diagn 2006;26:819-24. Crossref
10. Chan YM, Chan OK, Cheng YK, Leung TY, Lao TT, Sahota DS. Acceptance towards giving birth to a child with beta-thalassemia major—a prospective study. Taiwan J Obstet Gynecol 2017;56:618-21. Crossref
11. Di Pasquo E, Kuleva M, Rousseau A, et al. Outcome of non-visualization of fetal gallbladder on second-trimester ultrasound: cohort study and systematic review of literature. Ultrasound Obstet Gynecol 2019;54:582-8. Crossref
12. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet 2009;374:1704-13. Crossref
13. Hsiao CH, Chang MH, Chen HL, et al. Universal screening for biliary atresia using an infant stool color card in Taiwan. Hepatology 2008;47:1233-40. Crossref
14. Zhan J, Chen Y, Wong KK. How to evaluate diagnosis and management of biliary atresia in the era of liver transplantation in China. World Jnl Ped Surgery 2018;1:e000002. Crossref
15. Mirtajani SB, Farnia P, Hassanzad M, Ghanavi J, Farnia P, Velayati AA. Geographical distribution of cystic fibrosis; the past 70 years of data analysis. Biomed Biotechnol Res J 2017;1:105-12. Crossref
16. Leung GK, Ying D, Mak CC, et al. CFTR founder mutation causes protein trafficking defects in Chinese patients with cystic fibrosis. Mol Genet Genomic Med 2016;5:40-9. Crossref
17. Chen M, Leung TY, Sahota DS, et al. Ultrasound screening for fetal structural abnormalities performed by trained midwives in the second trimester in a low-risk population—237-an appraisal. Acta Obstet Gynecol Scand 2009;88:713-9. Crossref
18. Chalouhi GE, Muller F, Dreux S, Ville Y, Chardot C. Prenatal non-visualization of fetal gallbladder: beware of biliary atresia! Ultrasound Obstet Gynecol 2011;38:237-40. Crossref
19. Chau MH, Cao Y, Kwok YK, et al. Characteristics and mode of inheritance of pathogenic copy number variants in prenatal diagnosis. Am J Obstet Gynecol 2019;221:493. e1-11. Crossref
20. Zhu X, Chen M, Wang H, et al. Clinical utility of expanded noninvasive prenatal screening and chromosomal microarray analysis in high risk pregnancies. Ultrasound Obstet Gynecol 2021;57:459-465. Crossref
21. Grati FR, Molina Gomes D, Ferreira JC, et al. Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenat Diagn 2015;35:801-9. Crossref
22. Muller F, Gauthier F, Laurent J, Schmitt M, Boué J. Amniotic fluid GGT and congenital extrahepatic biliary damage. Lancet 1991;337:232-3. Crossref
23. Bardin R, Ashwal E, Davidov B, Danon D, Shohat M, Meizner I. Nonvisualization of the fetal gallbladder: can levels of gamma-glutamyl transpeptidase in amniotic fluid predict fetal prognosis? Fetal Diagn Ther 2016;39:50-5. Crossref
24. Dreux S, Boughanim M, Lepinard C, et al. Relationship of non-visualization of the fetal gallbladder and amniotic fluid digestive enzymes analysis to outcome. Prenat Diagn 2012;32:423-6. Crossref
25. Burc L, Guibourdenche J, Luton D, et al. Establishment of reference values of five amniotic fluid enzymes. Analytical performances of the Hitachi 911. Application to complicated pregnancies. Clin Biochem 2001;34:317-22. Crossref
26. Bardin R, Danon D, Tor R, Mashiach R, Vardimon D, Meizner I. Reference values for gamma-glutamyl-transferase in amniotic fluid in normal pregnancies. Prenat Diagn 2009;29:703-6. Crossref
27. Muller F, Bernard P, Salomon LJ, et al. Role of fetal blood sampling in cases of non-visualization of fetal gallbladder. Ultrasound Obstet Gynecol 2015;46:743-4. Crossref
28. Ruiz A, Robles A, Salva F, et al. Prenatal nonvisualization of the gallbladder: a diagnostic and prognostic dilemma. Fetal Diagn Ther 2017;42:150-2. Crossref
29. Chan YM, Leung TY, Cao Y, et al. Expanded carrier screening using next generation sequencing of 123 Hong Kong Chinese families: a pilot study. Hong Kong Med J 2021;27:177-83. Crossref

Surgical treatment of pelvic organ prolapse in women aged ≥75 years in Hong Kong: a multicentre retrospective study

Hong Kong Med J 2022 Apr;28(2):107–15  |  Epub 31 Mar 2022
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE  CME
Surgical treatment of pelvic organ prolapse in women aged ≥75 years in Hong Kong: a multicentre retrospective study
Daniel Wong, MB, BS, FHKAM (Obstetrics and Gynaecology)1; YT Lee, MB, ChB, FHKAM (Obstetrics and Gynaecology)2; Grace PY Tang, MB, BS, FHKAM (Obstetrics and Gynaecology)3; Symphorosa SC Chan, MD, FRCOG4
1 Department of Obstetrics and Gynaecology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
2 Department of Obstetrics and Gynaecology, Prince of Margaret Hospital, Hong Kong
3 Department of Obstetrics and Gynaecology, Kwong Wah Hospital, Hong Kong
4 Department of Obstetrics and Gynaecology, Prince of Wales Hospital, Hong Kong
 
Corresponding author: Dr Daniel Wong (dlwhk@yahoo.com)
 
 Full paper in PDF
 
Abstract
Introduction: Pelvic organ prolapse (POP) is common among older women. With the increasing lifespan and emphasis on quality of life worldwide, older women increasingly prefer surgical treatment for POP. We reviewed the surgical treatment of POP in older women to characterise its safety, effectiveness, and the type most often selected.
 
Methods: This multicentre, retrospective study was conducted at four hospitals between 2013 and 2018. Included patients were aged ≥75 years and had undergone POP surgery. We compared patient demographic characteristics, POP severity, and surgical outcomes between reconstructive and obliterative surgeries; these comparisons were also made among vaginal hysterectomy plus pelvic floor repair (VHPFR), transvaginal mesh surgery (TVM), vaginal hysterectomy (VH) plus colpocleisis, and colpocleisis alone.
 
Results: In total, 343 patients were included; 84.3% and 15.7% underwent reconstructive and obliterative surgeries, respectively. Overall, 246 (71.7%), 43 (12.5%), 20 (5.8%), and 34 (9.9%) patients underwent VHPFR, TVM, VH plus colpocleisis, and colpocleisis alone, respectively. Patients who were older (81.9 vs 79.6 y; P=0.001), had vault prolapse (38.9% vs 3.5%; P<0.001), and had medical co-morbidities (37% vs 4.8%; P<0.001) chose obliterative surgery more frequently than reconstructive surgery. Obliterative surgeries had shorter operative time (73.5 min vs 107 min; P<0.001) and fewer surgical complications (9.3% vs 28.0%; P=0.003). Vaginal hysterectomy plus pelvic floor repair had the highest rate of surgical complications (most were minor), while colpocleisis alone had the lowest rate (30.1% vs 8.8%; P=0.01).
 
Conclusions: Pelvic organ prolapse surgeries were safe and effective for older women. Colpocleisis may be appropriate as primary surgery for fragile older women.
 
 
New knowledge added by this study
  • The most common type of pelvic organ prolapse (POP) surgery was vaginal hysterectomy plus pelvic floor repair. Patients who were older (81.9 vs 79.6 y; P=0.001), had medical co-morbidities (37% vs 4.8%; P<0.001), had a history of pelvic floor repair surgery (13% vs 1.7%; P=0.001), and had vaginal vault prolapse (38.9% vs 3.5%; P<0.001) chose obliterative surgery more frequently than reconstructive surgery.
  • Because all types of POP surgery were associated with no mortality and generally had self-limiting surgical complications, they are safe for women aged ≥75 years. However, fluid replacement should be cautiously administered in fragile patients and in patients susceptible to fluid overload.
  • Colpocleisis alone had the shortest operative time (60 min; P<0.001), least blood loss (50 mL; P<0.001), and fewest surgical complications (8.8%; P=0.01). Moreover, 76.5% of procedures comprising colpocleisis alone were performed under spinal anaesthesia (P<0.001).
Implications for clinical practice or policy
  • All four types of POP surgeries are safe and effective for the treatment of POP in older women.
  • The incidence of carcinoma of the corpus uteri (Ca corpus) was 0.3% in this study. To reduce the risk of missing Ca corpus, preoperative transvaginal ultrasound (to assess endometrial thickness) and endometrial aspiration should be considered women who plan to undergo uterine-preserving surgery.
  • Comparison of vaginal hysterectomy plus colpocleisis and colpocleisis alone showed that the combined treatment had a longer operative time and greater blood loss, but a comparable rate of complications. Therefore, vaginal hysterectomy plus colpocleisis remains a valid treatment option. Both methods involving colpocleisis lead to difficulty in assessment of the cervix and uterus regardless of pathology.
  • Colpocleisis alone had the shortest operative time, least blood loss, and fewest surgical complications. These excellent results suggest that colpocleisis may be appropriate as primary surgery for fragile older women who do not engage in sexual intercourse.
 
 
Introduction
The incidence of pelvic organ prolapse (POP) is reportedly near 50% and the lifetime risk of POP requiring surgery is approximately 20%.1 2 With the increasing lifespan and emphasis on quality of life worldwide, older women increasingly prefer surgical treatment, instead of vaginal pessaries, as definitive treatment for POP.3 Surgical treatment options are either reconstructive or obliterative. Reconstructive surgery comprises native tissue repair (mainly vaginal hysterectomy [VH]), pelvic floor repair, and mesh-related repair; obliterative surgery comprises colpocleisis with or without concomitant VH.
 
Older women who undergo urogynaecological surgery have a higher surgical risk, regardless of fragility index; they have lower risks of prolapse recurrence and repeated surgery.4 Although the World Health Organization has defined old age as ≥65 years,5 a threshold of ≥75 years may be more appropriate for older women in terms of fragility and need for care. A previous Hospital Authority ageing projection6 indicated that the number of individuals aged 75 to 84 years will substantially increase in Hong Kong, while the numbers of individuals aged ≥85 years or ≤74 years will remain comparatively stable. A threshold of ≥75 years for geriatric medicine may be reasonable because most chronic, complex disabling disease occurs among individuals in this age-group.7
 
To our knowledge, despite the increasing number of women aged ≥75 years and the need for surgical treatment of POP among these individuals, there is limited evidence regarding the risks and benefits of the available surgical options. This multicentre, retrospective study was performed to review the surgical treatment of POP in women aged ≥75 years; we aimed to characterise its safety, effectiveness, and the type most often selected. We hope that the findings will help clinicians to counsel older women with POP who are considering surgical treatment.
 
Methods
Patients
This multicentre, retrospective cohort study was conducted at Kwong Wah Hospital, Pamela Youde Nethersole Eastern Hospital, Princess Margaret Hospital, and Prince of Wales Hospital. We included patients aged ≥75 years, all of whom underwent surgical treatment of POP in one of the above four gynaecological units between 2013 and 2018. We reviewed patient information from the Clinical Data Analysis and Reporting System and Clinical Medical System; for patients with incomplete data in the Clinical Medical System, we reviewed paper-based medical records. Ethical approvals were obtained from the Institutional Review Boards of all four Clusters including Hong Kong East Cluster, Kowloon Central Cluster, Kowloon West Cluster and New Territories East Cluster.
 
Examination and treatment selection
Demographic data and symptoms of prolapse were collected during each patient’s first visit to a participating gynaecology unit. Physical examinations were conducted to confirm POP, stage of prolapse, and the compartments involved; all examinations were performed using the International Continence Society Pelvic Organ Prolapse Quantification (POP-Q) staging system.7 Patients were offered vaginal pessary management or surgical treatment. Patients who opted for surgical treatment were scheduled for surgery with or without a trial period of vaginal pessary management. Preoperative urodynamics studies were performed if indicated. During the preoperative assessment, each patient underwent a comprehensive evaluation that included patient-reported symptoms of prolapse, as well as urinary, intestinal, and sexual statuses; they also underwent prolapse assessment using POP-Q staging. Thorough counselling was provided regarding reconstructive and obliterative treatment options, including a discussion of the potential benefits and risks of both procedures, as well as the need for concomitant VH or mid-urethral sling transobturator tape (TVT-O) for urodynamic stress incontinence.
 
Surgical procedures
Reconstructive procedures involved native tissue repair and mesh-related surgery. Native tissue repair mainly comprised vaginal hysterectomy followed by pelvic floor repair (VHPFR; eg, anterior and/or posterior colporrhaphy). In addition, sacrospinous ligament fixation was performed for stage ≥III uterine prolapse or vaginal vault prolapse. Patients with stage ≥III anterior compartment prolapse were offered anterior vaginal mesh repair. Obliterative surgery comprised colpocleisis with or without concomitant VH. Anterior vaginal mesh repair and colpocleisis were only offered to patients who were sexually inactive before surgery or agreed not to engage in sexual intercourse. Combinations of concomitant procedures were performed in the following order, using only the procedures selected by each patient and their surgeon: VH, mesh placement and sacrospinous fixation, native tissue repair, and TVT-O placement. All native tissue repair procedures were performed or supervised by a gynaecological specialist; all sacrospinous ligament fixation or anterior vaginal mesh repair procedures were performed or supervised by urogynaecologists. One dose of prophylactic intravenous antibiotic was administered during anaesthesia induction. In patients who underwent reconstructive surgery, one piece of vaginal gauze was placed to achieve haemostasis for 1 day. A Foley catheter was placed to ensure urinary drainage for 1 to 2 days according to the procedures used in each unit. Operative time, intra-operative blood loss, perioperative complications, and postoperative adverse events were recorded. Postoperative fever was defined as ≥2 readings of temperature ≥38°C with no positive culture or identifiable cause. A diagnosis of urinary tract infection was made on the basis of positive midstream urine culture results. A diagnosis of urinary retention was made when a patient could not void and required catheterisation. All instances of postoperative haematoma were diagnosed by imaging (ultrasound or computed tomography scan). When available, pathology reports were also reviewed.
 
Postoperative assessments
All patients underwent the same postoperative assessment, which was structured using a standardised datasheet. Follow-up visits were scheduled at 6 to 12 weeks and 1 year after surgery, then annually until 5 years after surgery. Each follow-up visit evaluation included assessments of urinary and intestinal function; symptoms of prolapse, vaginal pain and dyspareunia; and symptoms of mesh erosion. Vaginal examinations and POP-Q assessments were performed to identify instances of POP recurrence or mesh-related complications, in accordance with the recommendations of the International Continence Society and the International Urogynecological Association.9 Prolapse recurrence was defined as the presence of subjective symptoms of prolapse or a POP-Q stage of ≥II in a clinical examination.
 
Statistical analysis
We compared patient demographic characteristics, POP severity, and surgical outcomes between two groups: reconstructive and obliterative surgeries. These comparisons were also made among four subgroups: VHPFR, transvaginal mesh surgery (TVM), VH plus colpocleisis, and colpocleisis alone. Statistical analyses were performed using SPSS (Windows version 26.0; IBM Corp, Armonk [NY], United States). Descriptive statistics were used to summarise demographic and clinical characteristics. Continuous variables were expressed as mean (standard deviation) or median (interquartile range); they were analysed by independent-samples t tests or the Mann-Whitney U test (comparison of two groups)/one-way analysis of variance or Kruskal–Wallis H test (comparison of ≥3 groups), depending on the normality of the data assessed by Shaprio–Wilk test. Categorical data were expressed as numbers and percentages; the Chi squared test and Fisher’s exact test were used for categorical data analysis. A P value of <0.05 was considered statistically significant.
 
Results
In total, 343 patients underwent surgery for POP from 2013 to 2018 in the study hospitals. The types of surgical treatment at each hospital are shown in Table 1. Vaginal hysterectomy plus pelvic floor repair procedures were evenly distributed among all four hospitals. However, 93% of TVM procedures, 95% of VH plus colpocleisis procedures, and 50% of procedures comprising colpocleisis alone were performed in Prince of Wales Hospital, Princess Margaret Hospital, and Pamela Youde Nethersole Eastern Hospital, respectively.
 

Table 1. Type of surgical treatment performed in women aged ≥75 years with pelvic organ prolapse in the study hospitals
 
Among the 343 patients, 216 (63%), 90 (26.2%), and 37 (10.8%) had stages II, III, and IV POP, respectively (Table 2). Furthermore, 289 (84.3%) patients underwent reconstructive surgery and 54 (15.7%) patients underwent obliterative surgery. Of the 289 reconstructive surgeries, 246 (71.7%) were native tissue repair procedures (mainly VHPFR), while 43 (12.5%) were TVM (36 had concomitant VH); among the 54 obliterative surgeries, 20 (5.8%) were colpocleisis plus VH, while the remaining 34 (9.9%) were colpocleisis alone (Table 3).
 

Table 2. Comparison of demographic and clinical characteristics between reconstructive and obliterative surgery groups
 

Table 3. Comparison of demographic and clinical characteristics among the four surgical subgroups
 
Table 2 compares demographic and clinical characteristics between the reconstructive and obliterative surgery groups. Patients with more advanced age chose obliterative surgery, rather than reconstructive surgery (81.9 vs 79.6 y; P=0.001). Other variables including parity, number of vaginal births, number of instrumental deliveries, body mass index, smoking, and coital activity were comparable between the two groups.
 
More patients with vaginal vault prolapse opted for obliterative surgery, rather than reconstructive surgery (38.9% vs 3.5%; P<0.001) [Table 2]. The difference was more striking when the colpocleisis alone group was compared with all patients who underwent reconstructive surgery (61.8%; P<0.001) [Table 3]. Moreover, the number of patients who had medical co-morbidities (eg, hypertension, diabetes mellitus, heart disease, or history of stroke) was greater in the obliterative surgery group than in the reconstructive surgery group (37% vs 4.8%, P<0.001) [Table 2].
 
Concerning patients with stage III/IV POP, more patients underwent TVM, rather than VHPFR, in the reconstructive surgery group (100% vs 16.7%; P<0.001); in the obliterative surgery group, more patients with stage III/IV POP underwent VH plus colpocleisis, rather than colpocleisis alone (100% vs 67.6%; P<0.004) [Table 3].
 
One case of carcinoma of the corpus uteri (Ca corpus) was confirmed from the pathology report of a patient who underwent VH. Thus, the incidence of Ca corpus was 0.3% (1/312). The affected woman was an asymptomatic patient in the TVM group; she had incidental findings of endometrial thickening during preoperative assessment. The results of endometrial aspiration could not exclude a diagnosis of hyperplasia. The patient underwent postoperative contrast-enhanced computed tomography of the abdomen and pelvis 2 months after surgery; there were no signs of distant metastasis. After detailed counselling, the patient refused further surgery or adjuvant therapy. For 25 months of follow-up, the patient’s cancer has remained in remission.
 
Table 4 shows surgical outcomes in both groups and all subgroups. Compared with obliterative surgeries, fewer reconstructive surgeries were performed under spinal anaesthesia (57.4% vs 38.1%; P=0.008). Notably, 76.5% of procedures comprising colpocleisis alone were performed under spinal anaesthesia (P<0.001). Obliterative surgeries had a shorter operative time (73.5 min vs 107 min; P<0.001) and fewer surgical complications (9.3% vs 28.0%; P=0.003) than did reconstructive surgeries. Among the four subgroups, colpocleisis alone had the shortest operative time (60 min; P<0.001) and least blood loss (50 mL; P<0.001).
 

Table 4. Comparison of surgical outcomes between reconstructive and obliterative surgery groups and among the four surgical subgroups
 
Analysis of surgical complications (Table 4) showed that the VHPFR group had the highest intra- and peri-operative complication rate (30.1%; P=0.01), compared with the other subgroups. In the VHPFR group, four (1.6%) patients required conversion to laparoscopy/laparotomy (two had dense adhesion, one had large uterine size, and one had difficulty achieving haemostasis). There were three (1.2%) bladder injuries; all underwent primary repair with good recovery and did not experience long-term consequences. Four (1.6%) patients in the VHPFR group required intensive care unit (ICU) admission after surgery (one had fluid overload, one had respiratory acidosis, one had cardiac problems, and one had metabolic acidosis). In all, 29 (11.8%) patients had fever of unknown cause; 90% of them resolved by oral antibiotics. Ten (4.1%) patients had postoperative wound or pelvic haematoma, and 10 (4.1%) patients had urinary tract infection. In the TVM group, one (2.3%) patient required ICU admission because of fluid overload, while three (7%) patients had urinary retention after surgery. The VH plus colpocleisis and colpocleisis alone groups both included one patient with wound haematoma. In the TVM group, 32.6% of patients had concomitant TVT-O placement; 12.2%, 5%, and 2.9% of patients had concomitant TVT-O placement in the VHPFR, VH plus colpocleisis, and colpocleisis alone groups, respectively (P=0.001) [Table 4].
 
The median durations of follow-up were 13 and 17 months in the reconstructive and obliterative surgery groups, respectively (Table 4). The TVM group had a significantly longer median follow-up duration (25 months; P<0.001); this was consistent with the need to monitor any mesh complications. There was only one patient was lost to follow-up throughout the study period. Although there tended to be fewer instances of recurrence in the obliterative surgery group than in the reconstructive surgery group (7.4% vs 16.3%; P=0.092), the difference was not statistically significant. There also tended to be a higher rate of prolapse recurrence in the VHPFR group than in the TVM, VH plus colpocleisis, or colpocleisis alone groups (VHPFR 18%, TVM 7%, VH plus colpocleisis 5%, and colpocleisis alone 8.8%), but this trend was not statistically significant (P=0.091). Finally, few patients in each group underwent surgery for prolapse recurrence or stress urinary incontinence after surgery.
 
Discussion
To our knowledge, this is the first multicentre retrospective study in Hong Kong concerning POP surgery for women aged ≥75 years. Overall analysis of demographic characteristics indicated that most patients underwent VHPFR because the largest proportion of patients had stage II POP. Most patients were sexually inactive (only four of 343 patients reported sexual activity), multiparous (median of four births overall), and had a history of exclusively vaginal delivery. The mean body mass index overall was 25.3 kg/m2. Compared with reconstructive surgery, obliterative surgery was more frequently selected by patients who were older, had medical co-morbidities, had a history of pelvic floor repair surgery, and had vaginal vault prolapse.
 
In this study, we found that surgical treatment was a safe option for older women who sought to improve their quality of life. The postoperative mortality rate was zero, consistent with the low mortality rate 4.1% in a previous study.4 Notably, prior studies10 11 in Chinese populations suggested that poor quality of life and complications associated with vaginal pessary management lead to an increased likelihood of surgical treatment. In our study, over 80% of patients in the obliterative surgery group had an unsatisfactory vaginal pessary outcome; nearly half of the patients also had urinary retention. Therefore, it is reasonable that these patients chose POP surgery, despite their advanced age.
 
In studies from other countries, the reported rates of surgical complications associated with POP surgery in women aged ≥75 years were 30% to 40%.12 13 Although the VHPFR group had the highest rate of surgical complications among all subgroups in the present study, the rate of 30.1% was comparable to the rates in studies from other countries. However, 1.7% of patients in the reconstructive surgery group were admitted to the ICU after surgery; this was higher than the reported rate of 0.45% in a large cohort study with a mean patient age of 62.7 years.14 Because older women are more likely to experience fluid overload—it was present in 40% of the patients who required postoperative ICU care in our study—perioperative fluid replacement should be cautiously administered.
 
Patients in the obliterative surgery group had fewer surgical complications than did patients in the reconstructive surgery group. When the four types of surgeries were compared, the proportion of surgeries performed under spinal anaesthesia was greatest for procedures comprising colpocleisis alone; these procedures also had the least blood loss, shortest operative time, and fewest complications. Furthermore, the hospital stay in the colpocleisis alone group was comparable with the lengths in other groups, although significantly larger proportions of patients in the colpocleisis alone group had medical co-morbidities and were older.
 
Theoretically, colpocleisis with concomitant VH is superior to colpocleisis alone because it avoids the possibility of missing Ca corpus during surgery or later in the patient’s life15 16; however, it is associated with a longer operative time and increased blood loss.17 18 Our results were consistent with the findings in previous studies from other countries. Patients aged ≥75 years are beyond the peak incidence of Ca corpus: according to the Hong Kong Cancer Registry, the median age of patients with Ca corpus is 55 years.19 In the present study, one patient in the TVM group had Ca corpus; thus, the rate of incidental malignancy was 0.3%, which was comparable to the rate of 0.26% previously reported in Hong Kong.20 Currently, pelvic ultrasound is not a routine component of preoperative assessment. To reduce the risk of missing Ca corpus, preoperative transvaginal ultrasound (to assess endometrial thickness) and endometrial aspiration should be considered in women who have abnormal vaginal bleeding or plan to undergo uterine-preserving surgery.20
 
Although TVM is a more complex surgery than VHPFR, the rate of perioperative surgical complications was lower in the TVM group; hospital stays were comparable between the two groups. However, the operative time was longer and blood loss was greater in the TVM group. Compared with patients in the VHPFR group, patients in the TVM group had a lower rate of POP recurrence (all recurrences occurred in patients with stage III/IV POP) and a significantly longer follow-up duration. The mesh erosion rate in this study (2.3%) was lower than in another study in Hong Kong (8.9%), which had a longer follow-up duration of 40 months and included younger patients.21 When proper counselling is provided, TVM is a safe option for healthier patients with stage III/IV POP because stage III/IV POP is a risk factor for recurrence.22
 
Strengths and limitations
Notable strengths of this study included its multicentre design and focus on POP surgery among older women in the Hong Kong Chinese population, which has not been previously explored. Patients in this study included all women aged ≥75 years who underwent POP surgery in a 6-year period at four hospitals; these hospitals are jointly accredited as a single urogynaecological training centre under the Hong Kong College of Obstetricians and Gynaecologists, and they have extensive experience performing all types of POP surgery (Table 1). Furthermore, the electronic medical record system of the Hospital Authority facilitated complete data collection and retrieval. However, there were a few limitations in this study. First, it was a retrospective study. Second, we did not perform quality of life assessment or investigate the presence of guilt concerning colpocleisis surgery. Because few patients reported sexual activity before surgery, we presume that most older women in Hong Kong would not regret the selection of colpocleisis because of its effects on sexual activity. Third, although the median follow-up period was <18 months, it may have been insufficient to fully characterise prolapse recurrence and gynaecological malignancy. Finally, the levels of independence and family support may be important factors for older women to consider before making any surgical decision; however, we did not have access to such data. These factors could be examined in future studies.
 
Conclusion
This multicentre retrospective study showed that multiple types of POP surgeries were safe and effective for women aged ≥75 years. Most surgical complications were self-limiting and the recurrence rate was low. The excellent results suggest that colpocleisis may be appropriate as primary surgery for fragile older women. These findings will facilitate preoperative counselling for older women with POP who are considering surgical treatment.
 
Author contributions
Concept or design: D Wong, SSC Chan
Acquisition of data: All authors.
Analysis or interpretation of data: D Wong, SSC Chan.
Drafting of the article: D Wong, SSC Chan.
Critical revision for important intellectual content: All authors.
 
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have disclosed no conflicts of interest.
 
Acknowledgement
We would like to express our gratitude to Ms LL Lee, Dr TH Chan and Dr CW Chu for data collection and entry.
 
Funding/support
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
 
Ethics approval
This study was approved by the Hong Kong East Cluster Ethics Committee (HKECREC-2020-069), the Kowloon Central Cluster Ethics Committee (KC/KE-20-0223/ER-2), the Kowloon West Cluster Ethics Committee (EX-20-108[150-02]), and the New Territories East Cluster Ethics Committee (NTEC-2020-138).
 
References
1. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501-6. Crossref
2. Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol 2010;116:1096-100. Crossref
3. Griebling TL. Vaginal pessaries for treatment of pelvic organ prolapse in elderly women. Curr Opin Urol 2016;26:201-6. Crossref
4. Sung VW, Weitzen S, Sokol ER, Rardin CR, Myers DL. Effect of patient age on increasing morbitity and mortality following urogynecologic surgery. Am J Obstet Gynecol 2006;194:1411-7. Crossref
5. World Health Organization. Global recommendations on physical activity for health. 2010. Available from: https://www.who.int/publications/i/item/9789241599979. Accessed 21 Mar 2022.
6. Hospital Authority, Hong Kong SAR Government. Strategic service framework for elderly patients. 26 April 2012. Available from: https://www.ha.org.hk/ho/corpcomm/Strategic%20Service%20Framework/Elderly%20Patients.pdf. Accessed 21 Mar 2022.
7. Kong TK. Hospital service for the elderly in Hong Kong—present and future. J Hong Kong Geriatr Soc 1990;1:16-20.
8. Haylen BT, Maher CF, Barber MD, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J 2016;27:165-94. Crossref
9. Toozs-Hobson P, Freeman R, Barber M, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for reporting outcomes of surgical procedures for pelvic organ prolapse. Int Urogynecol J 2012;23:527-35. Crossref
10. Chan SS, Cheung RY, Yiu AK, et al. Chinese validation of pelvic floor distress inventory and pelvic floor impact questionnaire. Int Urogynecol J 2011;22:1305-12. Crossref
11. Chan SS, Cheung RY, Yiu KW, Lee LL, Pang AW, Chung TK. Symptoms, quality of life, and factors affecting women’s treatment decisions regarding pelvic organ prolapse. Int Urogynecol J 2012;23:1027-33. Crossref
12. Friedman WH, Gallup DG, Burke JJ 2nd, Meister EA, Hoskins WJ. Outcomes of octogenarians and nonagenarians in elective major gynecologic surgery. Am J Obstet Gynecol 2006;195:547-52. Crossref
13. Stepp KJ, Barber MD, Yoo EH, Whiteside JL, Paraiso MF, Walters MD. Incidence of perioperative complications of urogynecologic surgery in elderly women. Am J Obstet Gynecol 2005;192:1630-6. Crossref
14. Mairesse S, Chazard E, Giraudet G, Cosson M, Bartolo S. Complications and reoperation after pelvic organ prolapse, impact of hysterectomy, surgical approach and surgeon experience. Int Urogynecol J 2020;31:1755-61. Crossref
15. Elkattah R, Brooks A, Huffaker RK. Gynecologic malignancies post-lefort colpocleisis. Case Rep Obstet Gynecol 2014;2014:846745. Crossref
16. Frick AC, Walters MD, Larkin KS, Barber MD. Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse. Am J Obstet Gynecol 2010;202:507.e1-4. Crossref
17. FitzGerald MP, Richter HE, Siddique S, Thompson P, Zyczynski H, Ann Weber for the Pelvic Floor Disorders Network. Colpocleisis: a review. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:261-71. Crossref
18. Bochenska K, Leader-Cramer A, Mueller M, Davé B, Alverdy A, Kenton K. Perioperative complications following colpocleisis with and without concomitant vaginal hysterectomy. Int Urogynecol J 2017;28:1671-5.Crossref
19. Hong Kong Cancer Registry, Hospital Authority, Hong Kong SAR Government. Cancer in 2018. Available from: https://www3.ha.org.hk/cancereg/pdf/factsheet/2018/corpus_2018.pdf. Accessed 29 Dec 2020.
20. Wan OY, Cheung RY, Chan SS, Chung TK. Risk of malignancy in women who underwent hysterectomy for uterine prolapse. Aust N Z J Obstet Gynaecol 2013;53:190-6. Crossref
21. Wan OY, Chan SS, Cheung RY, Chung TK. Mesh-related complications from reconstructive surgery for pelvic organ prolapse in Chinese patients in Hong Kong. Hong Kong Med J 2018;24:369-77. Crossref
22. Friedman T, Eslick GD, Dietz HP. Risk factors for prolapse recurrence: systematic review and meta-analysis. Int Urogynecol J 2018;29:13-21. Crossref

Surgical treatment of pelvic organ prolapse in women aged ≥75 years in Hong Kong: a multicentre retrospective study

Hong Kong Med J 2022;28:Epub 31 Mar 2022
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Surgical treatment of pelvic organ prolapse in women aged ≥75 years in Hong Kong: a multicentre retrospective study
Daniel Wong, MB, BS, FHKAM (Obstetrics and Gynaecology)1; YT Lee, MB, ChB, FHKAM (Obstetrics and Gynaecology)2; Grace PY Tang, MB, BS, FHKAM (Obstetrics and Gynaecology)3; Symphorosa SC Chan, MD, FRCOG4
 
Corresponding author: Dr D Wong (dlwhk@yahoo.com)
 
 Full paper in PDF
 
Abstract
Introduction: Pelvic organ prolapse (POP) is common among older women. With the increasing lifespan and emphasis on quality of life worldwide, older women increasingly prefer surgical treatment for POP. We reviewed the surgical treatment of POP in older women to characterise its safety, effectiveness, and the type most often selected.
 
Methods: This multicentre, retrospective study was conducted at four hospitals between 2013 and 2018. Included patients were aged ≥75 years and had undergone POP surgery. We compared patient demographic characteristics, POP severity, and surgical outcomes between reconstructive and obliterative surgeries; these comparisons were also made among vaginal hysterectomy plus pelvic floor repair (VHPFR), transvaginal mesh surgery (TVM), vaginal hysterectomy (VH) plus colpocleisis, and colpocleisis alone.
 
Results: In total, 343 patients were included; 84.3% and 15.7% underwent reconstructive and obliterative surgeries, respectively. Overall, 246 (71.7%), 43 (12.5%), 20 (5.8%), and 34 (9.9%) patients underwent VHPFR, TVM, VH plus colpocleisis, and colpocleisis alone, respectively. Patients who were older (81.9 vs 79.6 y; P=0.001), had vault prolapse (38.9% vs 3.5%; P<0.001), and had medical co-morbidities (37% vs 4.8%; P<0.001) chose obliterative surgery more frequently than reconstructive surgery. Obliterative surgeries had shorter operative time (73.5 min vs 107 min; P<0.001) and fewer surgical complications (9.3% vs 28.0%; P=0.003). Vaginal hysterectomy plus pelvic floor repair had the highest rate of surgical complications (most were minor), while colpocleisis alone had the lowest rate (30.1% vs 8.8%; P=0.01).
 
Conclusions: Pelvic organ prolapse surgeries were safe and effective for older women. Colpocleisis may be appropriate as primary surgery for fragile older women.
 
 
New knowledge added by this study
  • The most common type of pelvic organ prolapse (POP) surgery was vaginal hysterectomy plus pelvic floor repair. Patients who were older (81.9 vs 79.6 y; P=0.001), had medical co-morbidities (37% vs 4.8%; P<0.001), had a history of pelvic floor repair surgery (13% vs 1.7%; P=0.001), and had vaginal vault prolapse (38.9% vs 3.5%; P<0.001) chose obliterative surgery more frequently than reconstructive surgery.
  • Because all types of POP surgery were associated with no mortality and generally had self-limiting surgical complications, they are safe for women aged ≥75 years. However, fluid replacement should be cautiously administered in fragile patients and in patients susceptible to fluid overload.
  • Colpocleisis alone had the shortest operative time (60 min; P<0.001), least blood loss (50 mL; P<0.001), and fewest surgical complications (8.8%; P=0.01). Moreover, 76.5% of procedures comprising colpocleisis alone were performed under spinal anaesthesia (P<0.001).
Implications for clinical practice or policy
  • All four types of POP surgeries are safe and effective for the treatment of POP in older women.
  • The incidence of carcinoma of the corpus uteri (Ca corpus) was 0.3% in this study. To reduce the risk of missing Ca corpus, preoperative transvaginal ultrasound (to assess endometrial thickness) and endometrial aspiration should be considered women who plan to undergo uterine-preserving surgery.
  • Comparison of vaginal hysterectomy plus colpocleisis and colpocleisis alone showed that the combined treatment had a longer operative time and greater blood loss, but a comparable rate of complications. Therefore, vaginal hysterectomy plus colpocleisis remains a valid treatment option. Both methods involving colpocleisis lead to difficulty in assessment of the cervix and uterus regardless of pathology.
  • Colpocleisis alone had the shortest operative time, least blood loss, and fewest surgical complications. These excellent results suggest that colpocleisis may be appropriate as primary surgery for fragile older women who do not engage in sexual intercourse.
 
 
Introduction
The incidence of pelvic organ prolapse (POP) is reportedly near 50% and the lifetime risk of POP requiring surgery is approximately 20%.1 2 With the increasing lifespan and emphasis on quality of life worldwide, older women increasingly prefer surgical treatment, instead of vaginal pessaries, as definitive treatment for POP.3 Surgical treatment options are either reconstructive or obliterative. Reconstructive surgery comprises native tissue repair (mainly vaginal hysterectomy [VH]), pelvic floor repair, and mesh-related repair; obliterative surgery comprises colpocleisis with or without concomitant VH.
 
Older women who undergo urogynaecological surgery have a higher surgical risk, regardless of fragility index; they have lower risks of prolapse recurrence and repeated surgery.4 Although the World Health Organization has defined old age as ≥65 years,5 a threshold of ≥75 years may be more appropriate for older women in terms of fragility and need for care. A previous Hospital Authority ageing projection6 indicated that the number of individuals aged 75 to 84 years will substantially increase in Hong Kong, while the numbers of individuals aged ≥85 years or ≤74 years will remain comparatively stable. A threshold of ≥75 years for geriatric medicine may be reasonable because most chronic, complex disabling disease occurs among individuals in this age-group.7
 
To our knowledge, despite the increasing number of women aged ≥75 years and the need for surgical treatment of POP among these individuals, there is limited evidence regarding the risks and benefits of the available surgical options. This multicentre, retrospective study was performed to review the surgical treatment of POP in women aged ≥75 years; we aimed to characterise its safety, effectiveness, and the type most often selected. We hope that the findings will help clinicians to counsel older women with POP who are considering surgical treatment.
 
Methods
Patients
This multicentre, retrospective cohort study was conducted at Kwong Wah Hospital, Pamela Youde Nethersole Eastern Hospital, Princess Margaret Hospital, and Prince of Wales Hospital. We included patients aged ≥75 years, all of whom underwent surgical treatment of POP in one of the above four gynaecological units between 2013 and 2018. We reviewed patient information from the Clinical Data Analysis and Reporting System and Clinical Medical System; for patients with incomplete data in the Clinical Medical System, we reviewed paper-based medical records. Ethical approvals were obtained from the Institutional Review Boards of all four Clusters including Hong Kong East Cluster, Kowloon Central Cluster, Kowloon West Cluster and New Territories East Cluster.
 
Examination and treatment selection
Demographic data and symptoms of prolapse were collected during each patient’s first visit to a participating gynaecology unit. Physical examinations were conducted to confirm POP, stage of prolapse, and the compartments involved; all examinations were performed using the International Continence Society Pelvic Organ Prolapse Quantification (POP-Q) staging system.7 Patients were offered vaginal pessary management or surgical treatment. Patients who opted for surgical treatment were scheduled for surgery with or without a trial period of vaginal pessary management. Preoperative urodynamics studies were performed if indicated. During the preoperative assessment, each patient underwent a comprehensive evaluation that included patient-reported symptoms of prolapse, as well as urinary, intestinal, and sexual statuses; they also underwent prolapse assessment using POP-Q staging. Thorough counselling was provided regarding reconstructive and obliterative treatment options, including a discussion of the potential benefits and risks of both procedures, as well as the need for concomitant VH or mid-urethral sling transobturator tape (TVT-O) for urodynamic stress incontinence.
 
Surgical procedures
Reconstructive procedures involved native tissue repair and mesh-related surgery. Native tissue repair mainly comprised vaginal hysterectomy followed by pelvic floor repair (VHPFR; eg, anterior and/or posterior colporrhaphy). In addition, sacrospinous ligament fixation was performed for stage ≥III uterine prolapse or vaginal vault prolapse. Patients with stage ≥III anterior compartment prolapse were offered anterior vaginal mesh repair. Obliterative surgery comprised colpocleisis with or without concomitant VH. Anterior vaginal mesh repair and colpocleisis were only offered to patients who were sexually inactive before surgery or agreed not to engage in sexual intercourse. Combinations of concomitant procedures were performed in the following order, using only the procedures selected by each patient and their surgeon: VH, mesh placement and sacrospinous fixation, native tissue repair, and TVT-O placement. All native tissue repair procedures were performed or supervised by a gynaecological specialist; all sacrospinous ligament fixation or anterior vaginal mesh repair procedures were performed or supervised by urogynaecologists. One dose of prophylactic intravenous antibiotic was administered during anaesthesia induction. In patients who underwent reconstructive surgery, one piece of vaginal gauze was placed to achieve haemostasis for 1 day. A Foley catheter was placed to ensure urinary drainage for 1 to 2 days according to the procedures used in each unit. Operative time, intra-operative blood loss, perioperative complications, and postoperative adverse events were recorded. Postoperative fever was defined as ≥2 readings of temperature ≥38°C with no positive culture or identifiable cause. A diagnosis of urinary tract infection was made on the basis of positive midstream urine culture results. A diagnosis of urinary retention was made when a patient could not void and required catheterisation. All instances of postoperative haematoma were diagnosed by imaging (ultrasound or computed tomography scan). When available, pathology reports were also reviewed.
 
Postoperative assessments
All patients underwent the same postoperative assessment, which was structured using a standardised datasheet. Follow-up visits were scheduled at 6 to 12 weeks and 1 year after surgery, then annually until 5 years after surgery. Each follow-up visit evaluation included assessments of urinary and intestinal function; symptoms of prolapse, vaginal pain and dyspareunia; and symptoms of mesh erosion. Vaginal examinations and POP-Q assessments were performed to identify instances of POP recurrence or mesh-related complications, in accordance with the recommendations of the International Continence Society and the International Urogynecological Association.9 Prolapse recurrence was defined as the presence of subjective symptoms of prolapse or a POP-Q stage of ≥II in a clinical examination.
 
Statistical analysis
We compared patient demographic characteristics, POP severity, and surgical outcomes between two groups: reconstructive and obliterative surgeries. These comparisons were also made among four subgroups: VHPFR, transvaginal mesh surgery (TVM), VH plus colpocleisis, and colpocleisis alone. Statistical analyses were performed using SPSS (Windows version 26.0; IBM Corp, Armonk [NY], United States). Descriptive statistics were used to summarise demographic and clinical characteristics. Continuous variables were expressed as mean (standard deviation) or median (interquartile range); they were analysed by independent-samples t tests or the Mann-Whitney U test (comparison of two groups)/one-way analysis of variance or Kruskal–Wallis H test (comparison of ≥3 groups), depending on the normality of the data assessed by Shaprio–Wilk test. Categorical data were expressed as numbers and percentages; the Chi squared test and Fisher’s exact test were used for categorical data analysis. A P value of <0.05 was considered statistically significant.
 
Results
In total, 343 patients underwent surgery for POP from 2013 to 2018 in the study hospitals. The types of surgical treatment at each hospital are shown in Table 1. Vaginal hysterectomy plus pelvic floor repair procedures were evenly distributed among all four hospitals. However, 93% of TVM procedures, 95% of VH plus colpocleisis procedures, and 50% of procedures comprising colpocleisis alone were performed in Prince of Wales Hospital, Princess Margaret Hospital, and Pamela Youde Nethersole Eastern Hospital, respectively.
 

Table 1. Type of surgical treatment performed in women aged ≥75 years with pelvic organ prolapse in the study hospitals
 
Among the 343 patients, 216 (63%), 90 (26.2%), and 37 (10.8%) had stages II, III, and IV POP, respectively (Table 2). Furthermore, 289 (84.3%) patients underwent reconstructive surgery and 54 (15.7%) patients underwent obliterative surgery. Of the 289 reconstructive surgeries, 246 (71.7%) were native tissue repair procedures (mainly VHPFR), while 43 (12.5%) were TVM (36 had concomitant VH); among the 54 obliterative surgeries, 20 (5.8%) were colpocleisis plus VH, while the remaining 34 (9.9%) were colpocleisis alone (Table 3).
 

Table 2. Comparison of demographic and clinical characteristics between reconstructive and obliterative surgery groups
 

Table 3. Comparison of demographic and clinical characteristics among the four surgical subgroups
 
Table 2 compares demographic and clinical characteristics between the reconstructive and obliterative surgery groups. Patients with more advanced age chose obliterative surgery, rather than reconstructive surgery (81.9 vs 79.6 y; P=0.001). Other variables including parity, number of vaginal births, number of instrumental deliveries, body mass index, smoking, and coital activity were comparable between the two groups.
 
More patients with vaginal vault prolapse opted for obliterative surgery, rather than reconstructive surgery (38.9% vs 3.5%; P<0.001) [Table 2]. The difference was more striking when the colpocleisis alone group was compared with all patients who underwent reconstructive surgery (61.8%; P<0.001) [Table 3]. Moreover, the number of patients who had medical co-morbidities (eg, hypertension, diabetes mellitus, heart disease, or history of stroke) was greater in the obliterative surgery group than in the reconstructive surgery group (37% vs 4.8%, P<0.001) [Table 2].
 
Concerning patients with stage III/IV POP, more patients underwent TVM, rather than VHPFR, in the reconstructive surgery group (100% vs 16.7%; P<0.001); in the obliterative surgery group, more patients with stage III/IV POP underwent VH plus colpocleisis, rather than colpocleisis alone (100% vs 67.6%; P<0.004) [Table 3].
 
One case of carcinoma of the corpus uteri (Ca corpus) was confirmed from the pathology report of a patient who underwent VH. Thus, the incidence of Ca corpus was 0.3% (1/312). The affected woman was an asymptomatic patient in the TVM group; she had incidental findings of endometrial thickening during preoperative assessment. The results of endometrial aspiration could not exclude a diagnosis of hyperplasia. The patient underwent postoperative contrast-enhanced computed tomography of the abdomen and pelvis 2 months after surgery; there were no signs of distant metastasis. After detailed counselling, the patient refused further surgery or adjuvant therapy. For 25 months of follow-up, the patient’s cancer has remained in remission.
 
Table 4 shows surgical outcomes in both groups and all subgroups. Compared with obliterative surgeries, fewer reconstructive surgeries were performed under spinal anaesthesia (57.4% vs 38.1%; P=0.008). Notably, 76.5% of procedures comprising colpocleisis alone were performed under spinal anaesthesia (P<0.001). Obliterative surgeries had a shorter operative time (73.5 min vs 107 min; P<0.001) and fewer surgical complications (9.3% vs 28.0%; P=0.003) than did reconstructive surgeries. Among the four subgroups, colpocleisis alone had the shortest operative time (60 min; P<0.001) and least blood loss (50 mL; P<0.001).
 

Table 4. Comparison of surgical outcomes between reconstructive and obliterative surgery groups and among the four surgical subgroups
 
Analysis of surgical complications (Table 4) showed that the VHPFR group had the highest intra- and peri-operative complication rate (30.1%; P=0.01), compared with the other subgroups. In the VHPFR group, four (1.6%) patients required conversion to laparoscopy/laparotomy (two had dense adhesion, one had large uterine size, and one had difficulty achieving haemostasis). There were three (1.2%) bladder injuries; all underwent primary repair with good recovery and did not experience long-term consequences. Four (1.6%) patients in the VHPFR group required intensive care unit (ICU) admission after surgery (one had fluid overload, one had respiratory acidosis, one had cardiac problems, and one had metabolic acidosis). In all, 29 (11.8%) patients had fever of unknown cause; 90% of them resolved by oral antibiotics. Ten (4.1%) patients had postoperative wound or pelvic haematoma, and 10 (4.1%) patients had urinary tract infection. In the TVM group, one (2.3%) patient required ICU admission because of fluid overload, while three (7%) patients had urinary retention after surgery. The VH plus colpocleisis and colpocleisis alone groups both included one patient with wound haematoma. In the TVM group, 32.6% of patients had concomitant TVT-O placement; 12.2%, 5%, and 2.9% of patients had concomitant TVT-O placement in the VHPFR, VH plus colpocleisis, and colpocleisis alone groups, respectively (P=0.001) [Table 4].
 
The median durations of follow-up were 13 and 17 months in the reconstructive and obliterative surgery groups, respectively (Table 4). The TVM group had a significantly longer median follow-up duration (25 months; P<0.001); this was consistent with the need to monitor any mesh complications. There was only one patient was lost to follow-up throughout the study period. Although there tended to be fewer instances of recurrence in the obliterative surgery group than in the reconstructive surgery group (7.4% vs 16.3%; P=0.092), the difference was not statistically significant. There also tended to be a higher rate of prolapse recurrence in the VHPFR group than in the TVM, VH plus colpocleisis, or colpocleisis alone groups (VHPFR 18%, TVM 7%, VH plus colpocleisis 5%, and colpocleisis alone 8.8%), but this trend was not statistically significant (P=0.091). Finally, few patients in each group underwent surgery for prolapse recurrence or stress urinary incontinence after surgery.
 
Discussion
To our knowledge, this is the first multicentre retrospective study in Hong Kong concerning POP surgery for women aged ≥75 years. Overall analysis of demographic characteristics indicated that most patients underwent VHPFR because the largest proportion of patients had stage II POP. Most patients were sexually inactive (only four of 343 patients reported sexual activity), multiparous (median of four births overall), and had a history of exclusively vaginal delivery. The mean body mass index overall was 25.3 kg/m2. Compared with reconstructive surgery, obliterative surgery was more frequently selected by patients who were older, had medical co-morbidities, had a history of pelvic floor repair surgery, and had vaginal vault prolapse.
 
In this study, we found that surgical treatment was a safe option for older women who sought to improve their quality of life. The postoperative mortality rate was zero, consistent with the low mortality rate 4.1% in a previous study.4 Notably, prior studies10 11 in Chinese populations suggested that poor quality of life and complications associated with vaginal pessary management lead to an increased likelihood of surgical treatment. In our study, over 80% of patients in the obliterative surgery group had an unsatisfactory vaginal pessary outcome; nearly half of the patients also had urinary retention. Therefore, it is reasonable that these patients chose POP surgery, despite their advanced age.
 
In studies from other countries, the reported rates of surgical complications associated with POP surgery in women aged ≥75 years were 30% to 40%.12 13 Although the VHPFR group had the highest rate of surgical complications among all subgroups in the present study, the rate of 30.1% was comparable to the rates in studies from other countries. However, 1.7% of patients in the reconstructive surgery group were admitted to the ICU after surgery; this was higher than the reported rate of 0.45% in a large cohort study with a mean patient age of 62.7 years.14 Because older women are more likely to experience fluid overload—it was present in 40% of the patients who required postoperative ICU care in our study—perioperative fluid replacement should be cautiously administered.
 
Patients in the obliterative surgery group had fewer surgical complications than did patients in the reconstructive surgery group. When the four types of surgeries were compared, the proportion of surgeries performed under spinal anaesthesia was greatest for procedures comprising colpocleisis alone; these procedures also had the least blood loss, shortest operative time, and fewest complications. Furthermore, the hospital stay in the colpocleisis alone group was comparable with the lengths in other groups, although significantly larger proportions of patients in the colpocleisis alone group had medical co-morbidities and were older.
 
Theoretically, colpocleisis with concomitant VH is superior to colpocleisis alone because it avoids the possibility of missing Ca corpus during surgery or later in the patient’s life15 16; however, it is associated with a longer operative time and increased blood loss.17 18 Our results were consistent with the findings in previous studies from other countries. Patients aged ≥75 years are beyond the peak incidence of Ca corpus: according to the Hong Kong Cancer Registry, the median age of patients with Ca corpus is 55 years.19 In the present study, one patient in the TVM group had Ca corpus; thus, the rate of incidental malignancy was 0.3%, which was comparable to the rate of 0.26% previously reported in Hong Kong.20 Currently, pelvic ultrasound is not a routine component of preoperative assessment. To reduce the risk of missing Ca corpus, preoperative transvaginal ultrasound (to assess endometrial thickness) and endometrial aspiration should be considered in women who have abnormal vaginal bleeding or plan to undergo uterine-preserving surgery.20
 
Although TVM is a more complex surgery than VHPFR, the rate of perioperative surgical complications was lower in the TVM group; hospital stays were comparable between the two groups. However, the operative time was longer and blood loss was greater in the TVM group. Compared with patients in the VHPFR group, patients in the TVM group had a lower rate of POP recurrence (all recurrences occurred in patients with stage III/IV POP) and a significantly longer follow-up duration. The mesh erosion rate in this study (2.3%) was lower than in another study in Hong Kong (8.9%), which had a longer follow-up duration of 40 months and included younger patients.21 When proper counselling is provided, TVM is a safe option for healthier patients with stage III/IV POP because stage III/IV POP is a risk factor for recurrence.22
 
Strengths and limitations
Notable strengths of this study included its multicentre design and focus on POP surgery among older women in the Hong Kong Chinese population, which has not been previously explored. Patients in this study included all women aged ≥75 years who underwent POP surgery in a 6-year period at four hospitals; these hospitals are jointly accredited as a single urogynaecological training centre under the Hong Kong College of Obstetricians and Gynaecologists, and they have extensive experience performing all types of POP surgery (Table 1). Furthermore, the electronic medical record system of the Hospital Authority facilitated complete data collection and retrieval. However, there were a few limitations in this study. First, it was a retrospective study. Second, we did not perform quality of life assessment or investigate the presence of guilt concerning colpocleisis surgery. Because few patients reported sexual activity before surgery, we presume that most older women in Hong Kong would not regret the selection of colpocleisis because of its effects on sexual activity. Third, although the median follow-up period was <18 months, it may have been insufficient to fully characterise prolapse recurrence and gynaecological malignancy. Finally, the levels of independence and family support may be important factors for older women to consider before making any surgical decision; however, we did not have access to such data. These factors could be examined in future studies.
 
Conclusion
This multicentre retrospective study showed that multiple types of POP surgeries were safe and effective for women aged ≥75 years. Most surgical complications were self-limiting and the recurrence rate was low. The excellent results suggest that colpocleisis may be appropriate as primary surgery for fragile older women. These findings will facilitate preoperative counselling for older women with POP who are considering surgical treatment.
 
Author contributions
Concept or design: D Wong, SSC Chan
Acquisition of data: All authors.
Analysis or interpretation of data: D Wong, SSC Chan.
Drafting of the article: D Wong, SSC Chan.
Critical revision for important intellectual content: All authors.
 
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have disclosed no conflicts of interest.
 
Acknowledgement
We would like to express our gratitude to Ms LL Lee, Dr TH Chan and Dr CW Chu for data collection and entry.
 
Funding/support
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
 
Ethics approval
This study was approved by the Hong Kong East Cluster Ethics Committee (HKECREC-2020-069), the Kowloon Central Cluster Ethics Committee (KC/KE-20-0223/ER-2), the Kowloon West Cluster Ethics Committee (EX-20-108[150-02]), and the New Territories East Cluster Ethics Committee (NTEC-2020-138).
 
References
1. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501-6. Crossref
2. Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol 2010;116:1096-100. Crossref
3. Griebling TL. Vaginal pessaries for treatment of pelvic organ prolapse in elderly women. Curr Opin Urol 2016;26:201-6. Crossref
4. Sung VW, Weitzen S, Sokol ER, Rardin CR, Myers DL. Effect of patient age on increasing morbitity and mortality following urogynecologic surgery. Am J Obstet Gynecol 2006;194:1411-7. Crossref
5. World Health Organization. Global recommendations on physical activity for health. 2010. Available from: https://www.who.int/publications/i/item/9789241599979. Accessed 21 Mar 2022.
6. Hospital Authority, Hong Kong SAR Government. Strategic service framework for elderly patients. 26 April 2012. Available from: https://www.ha.org.hk/ho/corpcomm/Strategic%20Service%20Framework/Elderly%20Patients.pdf. Accessed 21 Mar 2022.
7. Kong TK. Hospital service for the elderly in Hong Kong—present and future. J Hong Kong Geriatr Soc 1990;1:16-20.
8. Haylen BT, Maher CF, Barber MD, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J 2016;27:165-94. Crossref
9. Toozs-Hobson P, Freeman R, Barber M, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for reporting outcomes of surgical procedures for pelvic organ prolapse. Int Urogynecol J 2012;23:527-35. Crossref
10. Chan SS, Cheung RY, Yiu AK, et al. Chinese validation of pelvic floor distress inventory and pelvic floor impact questionnaire. Int Urogynecol J 2011;22:1305-12. Crossref
11. Chan SS, Cheung RY, Yiu KW, Lee LL, Pang AW, Chung TK. Symptoms, quality of life, and factors affecting women’s treatment decisions regarding pelvic organ prolapse. Int Urogynecol J 2012;23:1027-33. Crossref
12. Friedman WH, Gallup DG, Burke JJ 2nd, Meister EA, Hoskins WJ. Outcomes of octogenarians and nonagenarians in elective major gynecologic surgery. Am J Obstet Gynecol 2006;195:547-52. Crossref
13. Stepp KJ, Barber MD, Yoo EH, Whiteside JL, Paraiso MF, Walters MD. Incidence of perioperative complications of urogynecologic surgery in elderly women. Am J Obstet Gynecol 2005;192:1630-6. Crossref
14. Mairesse S, Chazard E, Giraudet G, Cosson M, Bartolo S. Complications and reoperation after pelvic organ prolapse, impact of hysterectomy, surgical approach and surgeon experience. Int Urogynecol J 2020;31:1755-61. Crossref
15. Elkattah R, Brooks A, Huffaker RK. Gynecologic malignancies post-lefort colpocleisis. Case Rep Obstet Gynecol 2014;2014:846745. Crossref
16. Frick AC, Walters MD, Larkin KS, Barber MD. Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse. Am J Obstet Gynecol 2010;202:507.e1-4. Crossref
17. FitzGerald MP, Richter HE, Siddique S, Thompson P, Zyczynski H, Ann Weber for the Pelvic Floor Disorders Network. Colpocleisis: a review. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:261-71. Crossref
18. Bochenska K, Leader-Cramer A, Mueller M, Davé B, Alverdy A, Kenton K. Perioperative complications following colpocleisis with and without concomitant vaginal hysterectomy. Int Urogynecol J 2017;28:1671-5.Crossref
19. Hong Kong Cancer Registry, Hospital Authority, Hong Kong SAR Government. Cancer in 2018. Available from: https://www3.ha.org.hk/cancereg/pdf/factsheet/2018/corpus_2018.pdf. Accessed 29 Dec 2020.
20. Wan OY, Cheung RY, Chan SS, Chung TK. Risk of malignancy in women who underwent hysterectomy for uterine prolapse. Aust N Z J Obstet Gynaecol 2013;53:190-6. Crossref
21. Wan OY, Chan SS, Cheung RY, Chung TK. Mesh-related complications from reconstructive surgery for pelvic organ prolapse in Chinese patients in Hong Kong. Hong Kong Med J 2018;24:369-77. Crossref
22. Friedman T, Eslick GD, Dietz HP. Risk factors for prolapse recurrence: systematic review and meta-analysis. Int Urogynecol J 2018;29:13-21. Crossref

Health behaviour practices and expectations for a local cancer survivorship programme: a crosssectional study of survivors of childhood cancer in Hong Kong

Hong Kong Med J 2022 Feb;28(1):33–44  |  Epub 25 Jan 2022
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE
Health behaviour practices and expectations for a local cancer survivorship programme: a cross-sectional study of survivors of childhood cancer in Hong Kong
YT Cheung, PhD1; LS Yang, BPharm, MCP1; Justin CT Ma, HBSc1; Patricia HK Woo, BPharm1; Sammy MS Luk, BPharm1; Thomas CH Chan, BPharm1; Vivian WY Lee, DPharm2; Nelson CY Yeung, PhD3; CK Li, MB, BS, MD4
1 School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
2 Centre for Learning Enhancement and Research, The Chinese University of Hong Kong, Hong Kong
3 JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
4 Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Children’s Hospital
 
Corresponding author: Prof YT Cheung (yinting.cheung@cuhk.edu.hk)
 
 Full paper in PDF
 
Abstract
Introduction: Lifestyle choices may influence health outcomes in cancer survivors. This study of childhood cancer survivors in Hong Kong investigated factors associated with health-protective and health-damaging behaviours; it also examined expectations of a survivorship programme.
 
Methods: This cross-sectional study recruited survivors of childhood cancer ≥2 years after treatment. Survivors completed a structured questionnaire to report their health practices and the perceived values of survivorship programme components. Multivariable logistic regression analysis was conducted to identify factors associated with health behaviours.
 
Results: Two hundred survivors were recruited (mean age=23.4 ± 8.8 years; mean duration since treatment, 13.4 ± 7.6 years). Comparatively few survivors exercised ≥4 days/week (16.0%), used sun protection (18.0%), and had a balanced diet (38.5%). Furthermore, comparatively few survivors reported that they had not undergone any immunisation (24.5%) or were unsure (18.5%) about their immunisation history. Most adult survivors were never-drinkers (71.0%) and never-smokers (93.0%). Brain tumour survivors were more likely to have unhealthy eating habits, compared with haematological malignancy survivors (odds ratio [OR]=2.45; 95% confidence interval [CI]=1.29-4.68). Lower socioeconomic status was associated with inadequate sun protection (OR=0.20; 95% CI=0.05-0.83), smoking (OR=5.13; 95% CI=1.48-17.75), and exposure to second-hand smoke (OR=3.52; 95% CI=1.42-8.69). Late-effects screening (78.5%) and psychosocial services to address psychological distress (77%) were considered essential components of a survivorship programme.
 
Conclusions: Despite the low prevalences of health-damaging behaviours, local survivors of childhood cancer are not engaging in health-protective behaviours. A multidisciplinary programme addressing late effects and psychosocial aspects may address the multifaceted needs of this special population.
 
 
New knowledge added by this study
  • Despite the low prevalences of health-damaging behaviours, engagement in health-protective behaviours among survivors of childhood cancer in Hong Kong was unsatisfactory, particularly with regard to participation in regular physical activity, consumption of a balanced diet, and the use of sun protection.
  • Indicators of lower socioeconomic status (ie, lower education attainment and monthly household income) were collectively identified as predictors of smoking, poor dietary habits, and lack of immunisation.
  • Survivors of childhood cancer regarded services concerning health issues (eg, education and screening for late effects) as the most important aspects of survivorship care. They also preferred enrolment into a survivorship programme early in the cancer care continuum.
Implications for clinical practice or policy
  • A potential intervention opportunity may involve engaging survivors and families in a structured comprehensive survivorship programme during their transition to survivorship. The centralisation of paediatric oncology services in the new Hong Kong Children’s Hospital has provided an unprecedented opportunity for oncologists and allied health professionals to initiate a formal paediatric cancer survivorship programme that is tailored to the healthcare system in Hong Kong.
  • A multidisciplinary and interactive programme addressing late effects and psychosocial aspects may help survivors of childhood cancer take age-appropriate ownership of their health and function as active partners with their health providers during the survivorship phase.
  • Underserved survivors may require special navigation services and care coordination to promote adherence to surveillance, preventive care, and health-protective behaviours.
 
 
Introduction
Advancements in diagnostic and treatment strategies have led to substantial improvements in treatment prognoses for children with cancer. The 5-year survival rate of childhood cancers has increased dramatically in high-resource settings, from <50% in the 1970s to >80% in the past decade.1 Consequently, there has been a global surge in the population of survivors of childhood cancer, especially in developed regions such as Hong Kong. According to the Hospital Authority Cancer Registry, from 2001 to 2017 in Hong Kong, approximately 180 paediatric patients <19 years of age were diagnosed with cancer each year.2 It is unquestionably necessary to further improve survival rates, and recent efforts and resources have been dedicated to improving the quality of life and health outcomes of survivors of childhood cancer in Hong Kong.3 4 5
 
Cancer survivors are susceptible to developing a spectrum of late effects because of their previous treatment exposures.6 7 Studies have shown that histories of specific treatment exposures, coupled with continued engagement in health-damaging behaviours during survivorship, may accelerate or exacerbate the development of late effects.8 9 The Children’s Oncology Group (COG)10 provide details of common health-damaging behaviours and their potential impacts on various treatment-related chronic conditions.
 
Adult and paediatric oncology research has suggested that cancer survivors and their families are often highly receptive to education regarding optimal lifestyles during the early survivorship period.11 Thus, the COG and other international oncology groups have specified that an ideal cancer survivorship programme should comprise recommended screening/surveillance protocols to detect recurrence and late effects, health promotion activities, specialty referrals, and psychosocial interventions.7 12 One systematic review reported that a comprehensive cancer survivorship care programme is associated with positive behavioural change and better health outcomes in survivors.3
 
In Hong Kong, a recent study by Chan et al13 showed that, although the rates of smoking and alcohol consumption were low among local survivors of childhood cancer, survivors were less likely than their healthy siblings to participate in cancer screening. However, the study did not examine frequencies of engagement in other health-protective behaviours, such as participation in physical activity, undergoing immunisation, using sunscreen, and consuming a balanced diet. Furthermore, survivors’ expectations of a comprehensive survivorship programme have not been investigated. The identification of predictors of poor health-behaviour practices and elucidation of survivors’ needs will presumably assist clinicians in developing targeted interventions to address the needs of this special population.
 
The primary aim of this study was to identify factors associated with engagement in health-protective and health-damaging behaviours among local survivors of childhood cancer. The secondary aim was to examine cancer survivors’ expectations of a comprehensive survivorship programme in Hong Kong.
 
Methods
Study design and population
This prospective, observational study was conducted at the paediatric oncology/haematology long-term follow-up clinic of the Prince of Wales Hospital, Hong Kong. Eligible participants were recruited through convenience sampling. Between June 2019 and March 2020, the study investigators obtained the list of patients who were scheduled to attend follow-up consultations at the long-term follow-up clinic; this clinic was typically held once per week. Patients were then screened for eligibility using the in-house electronic patient record system (Clinical Management System). All eligible patients who subsequently attended the long-term follow-up clinic were invited to participate in the study.
 
The inclusion criteria were as follows: diagnosis with primary cancer before 18 years of age; treatment in any medical institutions in Hong Kong; survival for at least 2 years since the completion of cancer treatment or 5 years since diagnosis; and ability to communicate in Cantonese. A parent was recruited if the survivor was aged ≤16 years, or if the survivor was cognitively impaired. Patients were excluded if they were diagnosed with non-cancer conditions (eg, aplastic anaemia, thalassemia), did not understand Cantonese, were still on active treatment, or had incomplete treatment data.
 
Data collection
Clinical data regarding cancer diagnosis, treatment history, commodities, and relapse status were retrieved from survivors’ electronic health records. A 20-minute structured questionnaire was interviewer-administered. Participants self-reported their socioeconomic information (ie, highest education attainment, medical insurance, and monthly family income).
 
Health behaviours were measured using a version of the 2013 National Youth Risk Behaviour Survey14 that had been modified and translated into Traditional Chinese. To adapt the survey for use within the study population, questions pertaining to the healthy behaviour practices of young adult cancer survivors were added. These additional questions were developed based on the health behaviours and practices most frequently reported in studies of survivors of childhood cancer in other countries.9 15 16 Health-protective behaviours refer to engagement in physical activity, balanced diet, sun protection, and immunisation programmes. Health-damaging practices refer to alcohol consumption, smoking, and exposure to second-hand smoke. Alcohol consumption and smoking practices were evaluated in adult survivors only, as the legal age for purchasing tobacco and alcoholic products is 18 years in Hong Kong.
 
Participants were asked to rate the perceived values of recommended components of a comprehensive survivorship programme12 in the categories of health, psychosocial, parenting, and financial issues. Ratings were conducted using a 5-point Likert scale (1=least important, 5=most important). Participants were also asked to report their preferred time of enrolment into a survivorship programme and modes of services.
 
Sample size
The current analysis is part of a broader study17 that aimed to evaluate the effect of an educational intervention on improving awareness of personal health risks among survivors (primary outcome), as well as general health literacy and health behaviours among survivors (auxiliary outcomes). The tailored educational intervention included a review of the survivor’s cancer treatment summary and teaching materials that contained simplified health promotion messages derived from the COG Health Links.10 Sample size was determined based on the primary outcome (awareness of personal health risks). A similar study by Landier et al18 showed that the proportion of survivors of childhood cancer who adequately understood their health risks (defined as awareness of >75% of treatment-related late effects for which they were at risk) was approximately 55% after two sessions of the tailored intervention (ie, θ=0.55). At α=0.05, the required sample size for achieving 80% power to detect a difference in proportion (target θ0=0.45) between pre- and post-intervention assessments was 195. The current analysis reported the health behavioural practices of participants who provided baseline, pre-intervention assessments.
 
Statistical analysis
The SAS University Edition (version 2015; SAS Institute Inc, Cary [NC], US) software was used for all statistical analyses. Descriptive statistics were used to summarise participants’ demographics, clinical characteristics, and frequencies of health behaviours. Multivariable logistic regression analysis was conducted to identify factors that were associated with health behaviours. Associations were presented using odds ratios (ORs) and 95% confidence intervals (95% CIs). Based on a literature review,9 15 19 20 the hypothesised predictors comprised demographics and clinical characteristics (sex, age, cancer diagnosis, and time since diagnosis), as well as socioeconomic status (medical insurance status, monthly household income, and highest education attainment [in adult survivors only]). Finally, descriptive statistics were used to summarise participants’ preferences for the components of a comprehensive survivorship programme.
 
Results
Participant characteristics
In total, 252 survivors were screened for eligibility; 39 were excluded for <2 years since treatment or <5 years since diagnosis, the presence of non-cancer diagnoses (eg, benign ovarian teratoma), inability to understand Chinese, or treatment performed outside of Hong Kong. Subsequently, 213 eligible participants were approached. Eight survivors declined to participate, while the remaining 205 eligible survivors provided informed consent and completed the study. Five participants were subsequently excluded because of incomplete treatment records. Finally, data from 200 participants were analysed (response rate 93.9%) [Fig 1].
 

Figure 1. Recruitment flowchart
 
The mean (± standard deviation) ages at interview were 26.9 ± 6.4 years and 11.1 ± 3.6 years among adult and paediatric survivors, respectively (Table 1). The mean age at cancer diagnosis was 7.3 ± 5.2 years. The mean time since treatment completion was 13.4 ± 7.6 years; 41.0% (n=82) of survivors were within 10 years after treatment. The most common diagnoses were leukaemia (n=78, 39.0%), lymphoma (n=28, 14.0%), and bone tumour (n=18, 9.0%). In total, 185 survivors (92.5%) had undergone chemotherapy, 130 survivors (65.0%) had received radiation, and 85 survivors (42.5%) had undergone surgery. Only 30 survivors (15.0%) had received hematopoietic stem cell transplantation.
 

Table 1. Characteristics of study population of survivors of childhood cancer (n=200)
 
All paediatric survivors were students. Among adult survivors, 107 (69.0%) had completed post-secondary education. Only 32 survivors (16.0%) reported a monthly household income of less than HKD$15 000, and 86 survivors (43.0%) had private medical insurance.
 
Interviews for paediatric survivors (n=45) were completed by parents (Table 1). The mean age of parents was 43.4 ± 7.7 years, and 43 (95.6%) parents had completed secondary school or higher education.
 
Health behaviour practices
The health-protective and health-damaging behaviours of survivors are summarised in Table 2. The least frequently practised health-protective health-protective behaviour was physical activity. Only 16 survivors (8%) met the World Health Organisation recommendation of engagement in 20 minutes of aerobic physical activity for ≥4 days per week. Of the survivors, 104 (52.0%) reported that they exercised rarely (≤1 day per week) and 135 (67.5%) applied sunscreen rarely. Fewer than 40% of survivors “always” and “frequently” had a balanced diet. In terms of immunisation practice, 49 (24.5%) survivors reported that they did not undergo any immunisation and 37 (18.5%) were unsure about their immunisation history.
 

Table 2. Engagement in health-protective and health-damaging behaviours among survivors of childhood cancer (n=200)
 
Among 155 adult survivors, 110 (71.0%) were never-drinkers, whereas 45 (29.0%) identified themselves as social drinkers. These social drinkers met the “moderate” and “low-risk” drinker definitions established by the National Institute on Alcohol Abuse and Alcoholism.21 Of the 155 adult survivors, 144 (92.9%) were never-smokers and three (1.9%) were ever-smokers. Only eight survivors (5.2%) were current smokers; they smoked a median of 7.5 cigarettes per day (interquartile range=5-10). Of the survivors, 85 (42.5%) were exposed to second-hand smoke; 41 (20.5%) from family members and 29 (14.5%) from colleagues.
 
Factors associated with health behaviours
Compared with survivors of central nervous system (CNS) tumours, survivors who had been diagnosed with haematological malignancies were more likely to adopt a balanced diet (OR=2.45; 95% CI=1.29-4.68). Younger age at interview was also a significant predictor of adoption of a balanced diet (OR=0.95; 95% CI=0.91-0.99) [Table 3].
 

Table 3. Factors associated with engagement in protective health behaviours among survivors of childhood cancer
 
Female survivors had more than fivefold greater odds of regular sunscreen use, compared with male survivors (OR=5.66; 95% CI=2.40-13.34). Lower education level in adult survivors (OR=0.20; 95% CI=0.05-0.83) and lower monthly household income (OR=0.35; 95% CI=0.15-0.84) were associated with inadequate sun protection (Table 3).
 
Older survivors were less likely than younger survivors to participate in immunisation programmes (OR=0.76; 95% CI=0.53-0.97). Although the difference was not statistically significant (P=0.051), immunisation practices tended to be less common in survivors who did not have private medical insurance, compared with survivors who did (OR=0.78; 95% CI=0.45-1.06).
 
In terms of health-damaging behaviours (Table 4), compared with survivors who had completed education to a higher level than secondary school, adult survivors with a lower education level had greater odds of being current or ever-smokers (OR=5.13; 95% CI=1.48-17.75) and of being exposed to second-hand smoke (OR=3.52; 95% CI=1.42-8.69).
 

Table 4. Factors associated with engagement in health-damaging behaviours among survivors of childhood cancer
 
Expectations of a survivorship programme
Nearly all participants stated that the provision of survivorship education (n=168, 84%) and late-effects screening services (n=157, 78.5%) would be the most important components of a survivorship programme (Fig 2). Moreover, helping survivors to understand and confront the fear of relapse (n=161, 80.5%) and addressing psychological distress (n=154, 77%) were the most popular psychosocial services. Among parents (n=45), learning how to parent a child with cancer (n=36, 80%) and psychosocial support for parents (n=33, 73.3%) were regarded as essential components.
 

Figure 2. Expectations of survivorship programme among adult survivors and parents of paediatric survivors of childhood cancer (n=200)
 
Most participants (n=81, 40.5%) stated that their preferred enrolment time into a survivorship programme would be at the initiation of cancer treatment; some participants (n=58, 29.0%) stated that their preferred enrolment time would be during the transition from active treatment to follow-up (Table 5). In terms of modes of services, most respondents preferred dialogue sessions with healthcare professionals (n=156, 78.0%), interactive platforms (n=100, 50.0%), and support groups (n=101, 50.5%) [Table 5].
 

Table 5. Preferred mode of services and preferred enrolment time for survivorship programme
 
Discussion
Health-protective behaviours
There is growing evidence that physical activity is a therapeutic strategy that may reduce the risks of systemic recurrence and mortality in cancer survivors.22 Similar to findings from other countries, we found that physical inactivity was highly prevalent among survivors of childhood cancer.9 23 This observation was not surprising, considering that the rate of physical activity is low among the general population in Hong Kong; only 40% to 46% of children and youth met physical activity guidelines for a mean duration of 60 minutes of moderate-to-vigorous physical activity per day.24 Although we did not identify any significant predictors of physical inactivity, this large proportion of inactive survivors indicates the need to further explore the reasons for this phenomenon and devise interventions to address them. For example, interventions targeting the survivor–parent dyad may promote common lifestyle behaviours within the families of survivors.25 Moreover, local adventure-based training and experiential learning programmes may enhance self-efficacy in survivors, thereby empowering them to initiate and maintain a physically active lifestyle.26 27
 
Our study found that only 38% of survivors reported frequently consuming a balanced diet. For example, survivors of CNS tumours were more likely to have poor dietary habits, compared with survivors of non-CNS malignancies. This is concerning because patients with CNS tumours are more vulnerable to developing metabolic syndromes related to complications associated with cranial radiation and neurosurgery. Poor dietary habits may further exacerbate the disease course of these late effects.28 This finding suggests that dietitians should give advice regarding stricter dietary control to optimise the health of CNS cancer survivors in Hong Kong.
 
Despite the extensive promotion of the seasonal influenza vaccination programme by the Hong Kong Special Administrative Region Government,29 only 30% of survivors indicated that they had received the influenza vaccine in the past year. Younger survivors were more likely to have participated in vaccination programmes, probably because school-age children are generally enrolled into the government immunisation programme that provides the hepatitis B, pneumococcal, and annual influenza vaccines, as well as the recently added human papillomavirus (HPV) vaccine.30 We acknowledge that our findings must be interpreted with caution because survivors might inaccurately recall or report their vaccination histories. However, these results have two important implications that warrant attention from the medical community. First, there is a need to educate survivors regarding the role of vaccination in preventing severe complications from infection (eg, influenza and pneumococcal vaccines for preventing seasonal flu and pneumonia, respectively) and other malignancies (eg, HPV vaccine for preventing cervical cancer). In particular, collaborations among schools and community physicians may help promote the uptake of HPV vaccines among adolescent female survivors.31 32 Second, children treated with chemotherapy for childhood malignancies reportedly may develop acquired immunological defects in both cell-mediated and humoral immunity, resulting in the loss of protection conferred by prior vaccinations.33 Future work should involve the development of clinical consensus guidelines regarding vaccination administration schedules for non-transplant survivors of childhood cancer, particularly survivors who have received intensive chemotherapy treatment.
 
Health-damaging behaviours
Similar to the findings of Chan et al,13 we found that health-damaging practices are uncommon among local survivors. Both drinking and smoking rates were lower in this study than in studies from other developed countries.9 19 34 However, the reported rate (20.5%) of exposure to second-hand smoke in the home was surprisingly high. We speculate that this high rate is because the smoking rates of individuals above the age of 40 years remain relatively high in the general population (16.9% to 26.2% in men and 1.3% to 5.1% in women).35 Older family members, particularly men, might remain the main source of second-hand smoke for survivors. This observation underscores the need for continual efforts to encourage survivors to abstain from harmful health practices (particularly during the early survivorship phase) and the need for smoking cessation interventions to be provided for the comparatively few survivors and family members who are current smokers.
 
Socioeconomic factors
In this study, lower socioeconomic status was significantly associated with poor health practices. The association between possession of private medical insurance and immunisation practice was close to statistically significant, further suggesting that socioeconomic disparities hinder access to preventive care among cancer survivors. Underserved survivors may require special navigation services to support their adherence to surveillance, preventive care, and health-protective behaviours.36 Considering that only half of the survivors had private health insurance, collaborations between clinicians and policymakers could enable the establishment of a universal vaccination and late-effects screening programme for cancer survivors. Local research is needed to identify barriers to—and facilitators of—quality care and effective methods of outreach to underserved survivors.
 
Survivorship care
Most survivors indicated that they would prefer to be enrolled into a survivorship programme early in the cancer care continuum. This is a promising prospect because survivors who had early access to structured survivorship programmes reportedly were more aware of their late effects, visited emergency departments less frequently, had higher cancer-specific health literacy, and tended to experience less emotional stress.3 Therefore, a structured survivorship programme is recommended to include cancer and late-effects screening, a specialist referral network, and psychosocial services for survivors and caregivers (Fig 3).4 12 In Hong Kong, the five major institutions that provide paediatric oncology care typically include these core services in their long-term follow-up programmes, although the specific services offered may differ among institutions. Overall, the centralisation of paediatric oncology services in the new Hong Kong Children’s Hospital has provided an unprecedented opportunity for oncologists and allied health professionals to initiate a formal paediatric cancer survivorship programme in Hong Kong. This will facilitate the development of a survivorship care model that is tailored to the healthcare system in Hong Kong.
 

Figure 3. Recommended core services provided by long-term follow-up programmes for survivors of childhood cancer
 
Our participants regarded services concerning health issues (eg, education and screening for late effects) as the most important aspects of survivorship care. The COG has developed a set of “risk-based” guidelines, which refer to a personalised systematic plan of regular screening, surveillance, and prevention strategies based on a patient’s treatment, cancer experience, and personal factors.5 10 In an effort to improve the awareness of health issues in Chinese cancer survivors, we collaborated with the COG and launched a Chinese version of the Health Links patient education materials in May 2020.10 To our knowledge, this is the first set of publicly available authoritative resources regarding late effects that is written in a native Chinese language. Such initiatives are anticipated to assist survivors in taking age-appropriate ownership of their health and engaging as active partners with their health providers during the survivorship phase.
 
Limitations
Our findings should be considered in the context of the following limitations. First, this single-centre study comprised a moderately small sample of survivors who were recruited through a convenience sampling approach. Moreover, eligible participants were identified from a long-term follow-up clinic that had a mean loss to follow-up rate of 15% to 20%. This is a recognised challenge in survivorship research because this population is often lost to follow-up from primary paediatric clinics as a result of their growing independence and mobility during advancement into adulthood.37 These study limitations may have introduced sampling bias because our participants may have been more likely to be health conscious than non-participants and survivors who had been lost to follow-up. Hence, the true uptake of health-protective behaviours among local survivors may be lower than the rates reported in this study, and our findings might not be generalisable to other survivors of childhood cancer in Hong Kong. Second, social desirability and recall bias may have affected the accuracy of the self-reported results. Future studies should adopt validated and more sensitive instruments to achieve a more objective evaluation of health behaviour. For example, physical activity and sleep can be better measured with actigraphy studies. Finally, the multiple predictors and covariates analysed in this study may have increased the risk of a Type I error. However, lifestyle itself is a complex phenotype that is likely to be influenced by intrinsic and extrinsic factors. Our findings should be validated using a larger-scale study that involves the prospective collection of outcome data to better reflect the trajectory of health behaviour changes and correlate these findings with the results in local cancer survivors.
 
Conclusion
Despite the low prevalences of health-damaging behaviours, the frequencies with which Hong Kong survivors of childhood cancer engaged in health-protective behaviours were unsatisfactory. These findings highlight the need to empower survivors to adopt health-protective behaviours. A potential intervention opportunity may involve engaging survivors and families in a structured comprehensive survivorship programme during their transition to survivorship. A multidisciplinary and interactive programme addressing late effects and psychosocial aspects may address the multifaceted needs of Hong Kong survivors of childhood cancer. Future work should aim to improve preventive care for underserved groups through advocacy and care coordination.
 
Author contributions
Concept or design: All authors.
Acquisition of data: YT Cheung, LS Yang, JCT Ma, PHK Woo, TCH Chan, SMS Luk.
Analysis or interpretation of data: YT Cheung, LS Yang, JCT Ma, PHK Woo, TCH Chan, SMS Luk.
Drafting of the manuscript: YT Cheung, TCH Chan, SMS Luk.
Critical revision of the manuscript for important intellectual content: All authors.
 
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have disclosed no conflicts of interest.
 
Acknowledgement
We thank Dr Smita Bhatia and Dr Wendy Landier from the Institute for Cancer Outcomes and Survivorship, The University of Alabama in Birmingham, for serving as consultants on this project.
 
Declaration
A portion of this work was presented at the 52nd Congress of the International Society of Paediatric Oncology (SIOP)–Virtual conference (14-17 October 2020), as well as the HKPS/HKCOP/HKPNA/HKCPN Joint Annual Scientific Meeting on 7 November 2020.
 
Funding/support
This study was supported by the Health and Medical Research Fund Research Fellowship, the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region (Ref 03170047).
 
Ethics approval
The study protocol was approved by The Joint Chinese University of Hong Kong–New Territories East Cluster Clinical Research Ethics Committee (Ref: 2018.338). Written informed consent was obtained from all participants.
 
References
1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review (CSR) 1975-2014. Available from: https://seer.cancer.gov/archive/csr/1975_2014/. Accessed 3 Sep 2020.
2. Hong Kong Cancer Registry, Hospital Authority, Hong Kong SAR Government. Cancer in children and adolescents (0-18 years). Available from: https://www3.ha.org.hk/cancereg/children.asp. Accessed 3 Sep 2020.
3. Signorelli C, Wakefield CE, Fardell JE, et al. The impact of long-term follow-up care for childhood cancer survivors: a systematic review. Crit Rev Oncol Hematol 2017;114:131-8. Crossref
4. Children’s Oncology Group Nursing Discipline Clinical Practice Subcommittee/Survivorship in collaboration with the Late Effects Committee. Establishing and enhancing services for childhood cancer survivors. Long-term follow-up program resource guide. 2007. Available from: http://www.survivorshipguidelines.org/pdf/LTFUResourceGuide.pdf. Accessed 3 Sep 2020.
5. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for paediatric cancer survivors: the Children’s Oncology Group long-term follow-up guidelines from the Children’s Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004;22:4979-90. Crossref
6. Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013;309:2371-81. Crossref
7. Poon LH, Yu CP, Peng L, et al. Clinical ascertainment of health outcomes in Asian survivors of childhood cancer: a systematic review. J Cancer Surviv 2019;13:374-96. Crossref
8. Dixon SB, Bjornard KL, Alberts NM, et al. Factors influencing risk-based care of the childhood cancer survivor in the 21st century. CA Cancer J Clin 2018;68:133-52. Crossref
9. Ford JS, Barnett M, Werk R. Health behaviours of childhood cancer survivors. Children (Basel) 2014;1:355-73. Crossref
10. Children’s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers, version 5.0. October 2018. Available from: http://www.survivorshipguidelines.org/pdf/2018/COG_LTFU_Guidelines_v5.pdf. Accessed 3 Sep 2020.
11. George SM, Smith AW. Commentary: understanding risk behaviour among adolescent cancer survivors–are they more like healthy adolescents or is cancer a teachable moment? A commentary on Klosky and colleagues’ article on health behaviours in survivors of childhood cancer and their siblings. J Pediatr Psychol 2012;37:647-9. Crossref
12. Nekhlyudov L, Ganz PA, Arora NK, Rowland JH. Going beyond being lost in transition: a decade of progress in cancer survivorship. J Clin Oncol 2017;35:1978-81. Crossref
13. Chan CW, Choi KC, Chien WT, et al. Health behaviours of Chinese childhood cancer survivors: a comparison study with their siblings. Int J Environ Res Public Health 2020;17:6136. Crossref
14. Centres for Disease Control and Prevention, US Department of Health & Human Services. Youth risk behaviour surveillance–United States, 2013. Available from: https://www.cdc.gov/nchhstp/dear_colleague/2014/dcl-061314-hiv-prep.html. Accessed 4 Sep 2020.
15. Lown EA, Hijiya N, Zhang N, et al. Patterns and predictors of clustered risky health behaviours among adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 2016;122:2747-56. Crossref
16. Klosky JL, Howell CR, Li Z, et al. Risky health behaviour among adolescents in the childhood cancer survivor study cohort. J Pediatr Psychol 2012;37:634-46. Crossref
17. Health and Medical Research Fund, Food and Health Bureau, Hong Kong SAR Government. Research Fellowship Scheme Approved Projects since 2016-17. Ref 03170047: Personalized risk-based care and education for early survivors of childhood cancer in Hong Kong. Available from: https://rfs2.fhb.gov.hk/images/fundedproject/Approved_Projects_Fellowship.pdf. Accessed 5 Jan 2021.
18. Landier W, Chen Y, Namdar G, et al. Impact of tailored education on awareness of personal risk for therapy-related complications among childhood cancer survivors. J Clin Oncol 2015;33:3887-93. Crossref
19. Lown EA, Goldsby R, Mertens AC, et al. Alcohol consumption patterns and risk factors among childhood cancer survivors compared to siblings and general population peers. Addiction 2008;103:1139-48. Crossref
20. Devine KA, Mertens AC, Whitton JA, et al. Factors associated with physical activity among adolescent and young adult survivors of early childhood cancer: a report from the childhood cancer survivor study (CCSS). Psychooncology 2018;27:613-9. Crossref
21. National Institute on Alcohol Abuse and Alcoholism, National Institute of Health, US Government. Drinking levels defined. Available from: https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking. Accessed 3 Sep 2020.
22. Cormie P, Zopf EM, Zhang X, Schmitz KH. The impact of exercise on cancer mortality, recurrence, and treatment-related adverse effects. Epidemiol Rev 2017;39:71-92. Crossref
23. Ness KK, Leisenring WM, Huang S, et al. Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer 2009;115:1984-94. Crossref
24. Huang WY, Wong SH, Sit CH, et al. Results from the Hong Kong’s 2018 report card on physical activity for children and youth. J Exerc Sci Fit 2019;17:14-9. Crossref
25. Badr H, Paxton RJ, Ater JL, Urbauer D, Demark-Wahnefried W. Health behaviours and weight status of childhood cancer survivors and their parents: similarities and opportunities for joint interventions. J Am Diet Assoc 2011;111:1917-23. Crossref
26. Li HC, Chung OK, Ho KY, Chiu SY, Lopez V. Effectiveness of an integrated adventure-based training and health education program in promoting regular physical activity among childhood cancer survivors. Psychooncology 2013;22:2601-10. Crossref
27. Ruble K, Scarvalone S, Gallicchio L, Davis C, Wells D. Group physical activity intervention for childhood cancer survivors: a pilot study. J Phys Act Health 2016;13:352-9. Crossref
28. Smith WA, Li C, Nottage KA, et al. Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer 2014;120:2742-50. Crossref
29. Centre for Health Protection, Department of Health, Hong Kong SAR Government. Vaccination subsidy scheme–general public. Available from: https://www.chp.gov.hk/en/features/46107.html. Accessed 14 Sep 2020.
30. Family Health Service, Department of Health, Hong Kong SAR Government. Child health. Schedule of Hong Kong Childhood Immunisation Programme. Available from: https://www.fhs.gov.hk/english/main_ser/child_health/child_health_recommend.html. Accessed 14 Sep 2020.
31. Chau JP, Lo SH, Choi KC, et al. Effects of a multidisciplinary team-led school-based human papillomavirus vaccination health-promotion programme on improving vaccine acceptance and uptake among female adolescents: a cluster randomized controlled trial. Medicine (Baltimore) 2020;99:e22072. Crossref
32. Yuen WW, Lee A, Chan PK, Tran L, Sayko E. Uptake of human papillomavirus (HPV) vaccination in Hong Kong: facilitators and barriers among adolescent girls and their parents. PLoS One 2018;13:e0194159. Crossref
33. Han JH, Harmoney KM, Dokmeci E, et al. Dynamic re-immunization of off-treatment childhood cancer survivors: an implementation feasibility study. PLoS One 2018;13:e0191804. Crossref
34. Gibson TM, Liu W, Armstrong GT, et al. Longitudinal smoking patterns in survivors of childhood cancer: an update from the Childhood Cancer Survivor Study. Cancer 2015;121:4035-43. Crossref
35. Census and Statistics Department, Hong Kong SAR Government. Pattern of smoking. In: Census and Statistics Department, The Government of the Hong Kong Special Administrative Region. Hong Kong Monthly Digest of Statistics January 2019. Available from: https://www.statistics.gov.hk/pub/B10100022019MM01B0100.pdf. Accessed 14 Sep 2020.
36. Lee Smith J, Hall IJ. Advancing health equity in cancer survivorship: opportunities for public health. Am J Prev Med 2015;49:S477-82. Crossref
37. Rokitka DA, Curtin C, Heffler JE, Zevon MA, Attwood K, Mahoney MC. Patterns of loss to follow-up care among childhood cancer survivors. J Adolesc Young Adult Oncol 2017;6:67-73. Crossref

Clinical outcomes of fast-track total knee arthroplasty for patients aged >80 years

Hong Kong Med J 2022 Feb;28(1):7–15  |  Epub 18 Feb 2022
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE  CME
Clinical outcomes of fast-track total knee arthroplasty for patients aged >80 years
TP Leung, MB, ChB; CH Lee, FHKCOS, FHKAM (Orthopaedic Surgery); Esther WY Chang, MSc; QJ Lee, FHKCOS, FHKAM (Orthopaedic Surgery); YC Wong, FHKCOS, FHKAM (Orthopaedic Surgery)
Joint Replacement Centre, Yan Chai Hospital, Hong Kong
 
Corresponding author: Dr TP Leung (fos.markleung@gmail.com)
 
 Full paper in PDF
 
Abstract
Introduction: Because of the ageing population in Hong Kong, there is an increasing incidence of total knee arthroplasties (TKA) conducted in patients aged >80 years.
 
Methods: This retrospective case-control study enrolled all patients who were aged >80 years and underwent fast-track primary TKA between 2011 and 2015. Their outcomes were compared with the outcomes of a matched control group of younger patients who underwent fast-track TKA in the same period.
 
Results: In total, 220 patients were included in this study with a follow-up period of at least 2 years (mean=3.2 years; range, 2-5 years); 112 (51%) were octogenarians and 108 (49%) were non-octogenarians. Greater improvement in Knee Society Score was found in the octogenarian group at 1 year after surgery (46 ± 19 vs 39 ± 16, P=0.018). The incidence of complications was higher in the octogenarian group (15.2% vs 4.6%, P=0.009). There were no significant differences in the incidence of major complications, the rate of intensive care unit admission, or the 1-year mortality rate between the two groups. After adjustment for confounding factors, Charlson Comorbidity Index >5, history of major cerebrovascular accident, and history of peptic ulcer disease were predictive of complications after fast-track TKA (P=0.039, P=0.016, and P=0.007, respectively); octogenarian status was not predictive of complications.
 
Conclusions: Octogenarians had greater improvement in Knee Society Score at 1 year after fast-track TKA, compared with non-octogenarians, but there were no significant differences in the incidences of mortality or major complications.
 
 
New knowledge added by this study
  • The octogenarian group exhibited greater improvement in functional outcomes after fast-track total knee arthroplasty, compared with younger patients.
  • Charlson Comorbidity Index >5, history of major cerebrovascular accident, and history of peptic ulcer disease were predictive of complications after fast-track total knee arthroplasty.
Implications for clinical practice or policy
  • Age alone should not be a contra-indication to total knee arthroplasty because there were no significant differences in major complications or mortality rate for patients aged >80 years who underwent fast-track total knee arthroplasty.
  • Fast-track total knee arthroplasty could be useful for managing the growing osteoarthritis burden among older adults in Hong Kong, thus improving their quality of life.
 
 
Introduction
Because of the ageing population in Hong Kong, the incidence of total knee arthroplasty (TKA) for patients aged >80 years is expected to increase.1 2 The optimal age for arthroplasty has generally been regarded as between 60 and 80 years. Age was previously identified as an independent risk factor for mortality and major complications after TKA. For example, Kreder et al3 reported a 2.5-fold increase in the risk of acute myocardial infarction and a 3.4-fold increase in mortality among octogenarians undergoing TKA, compared with a cohort aged 65 to 79 years. Arthroplasties in patients aged >80 years were declined by surgeons or patients because of the expected high rates of postoperative morbidity and mortality.4 5 6
 
With preoperative preparations intended to minimise perioperative complications and blood loss, a recent study suggested that TKA could be a safe procedure among patients aged >80 years.7 The incidences of TKA in patients aged >80 years have been increasing in various knee registries.8 9 10 11 12 However, the traditional approach of declining knee arthroplasties in patients aged >80 years remains popular in Hong Kong. This approach does not meet the increasing needs of the ageing population.
 
The current study investigated whether octogenarians could achieve similar clinical outcomes after TKA, compared with younger patients. The null hypothesis was that short-term function and complications would not significantly differ between patients aged >80 years and patients aged ≤80 years after fast-track primary TKA.
 
Methods
Study design and setting
This retrospective case-control study was carried out in the Total Joint Replacement Centre in Yan Chai Hospital in Hong Kong between 2011 and 2015. The results of TKA procedures performed in the institute during the study period were reviewed; all patients were followed up for at least 2 years (mean=3.2 years; range, 2-5 years).
 
Study population
All patients who were aged >80 years and underwent primary TKA during the study period were included in the analysis. Their outcomes were compared with the outcomes in a similar number of younger patients (aged ≤80 years) with a matched sex ratio and body mass index (BMI). The indications for TKA were primary osteoarthritis of the knee and rheumatoid arthritis of the knee. The exclusion criteria in this study were revision TKA and simultaneous bilateral TKA. The contra-indications for TKA in both groups included active local or remote infection, poor skin condition, recent stroke and myocardial infarction (ie, within 1 year), poor cardiopulmonary reserve (eg, congestive heart failure and chronic obstructive pulmonary disease), and cirrhosis. For patients who had undergone percutaneous coronary intervention involving dual antiplatelet therapy, TKA was delayed for 1 year.
 
Data retrieval and measurement
Data retrieval was performed using the Clinical Management System in our institute. The procedure code for retrieval was ‘81.54 total knee replacement’. All operative records and out-patient records were reviewed. All outcome measurements were performed by independent observers (ie, orthopaedic specialist nurses) who were blinded to the details of treatment.
 
Baseline characteristic and outcome variables
Baseline characteristics were compared between the two groups; these included age, sex, BMI, co-morbidities, Charlson Comorbidity Index, preoperative haemoglobin level, and type of anaesthesia. Primary outcome measures included the knee range of motion (ROM), Knee Society Score (KSS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), complication rates, and mortality rates. Secondary outcome measures included the need for blood transfusion, postoperative admission to the intensive care unit (ICU), length of hospitalisation ,and postoperative ambulatory status.
 
Fast-track protocol
Using the fast-track protocol, a multidisciplinary approach was adopted in the perioperative period (Fig 1). Patients were examined in the pre-admission clinic by an orthopaedic surgeon, an anaesthetist, and an orthopaedic specialty nurse. Preoperative workups with blood tests (eg, complete blood count, liver function test, renal function test, random glucose, and haemoglobin), chest X-rays, and electrocardiography were performed in the pre-admission clinic. Blood pressure and BMI measurements were also conducted in the pre-admission clinic; blood pressure <160/90 mm Hg was required. The presence of local skin problems and other acute infections (eg, skin, oral, or urinary tract) were ruled out. Previous histories of deep vein thrombosis (DVT), bleeding tendency, gastrointestinal bleeding, and haemorrhagic stroke were recorded. Finally, other pre-existing medical conditions (eg, thyroid disease and obstructive sleep apnoea) were evaluated in the pre-admission clinic. The anaesthetist carried out a preoperative assessment and determined the anaesthesia modality (general or spinal); spinal anaesthesia was preferred unless contra-indicated. If patients had poorly controlled hypertension and diabetes, they were referred to a fast-track pathway for assessment by a family physician to optimise and titrate medical therapy for hypertension and diabetes. Fast-track echocardiography was also conducted with support from cardiologists to assess baseline cardiac function and suspected valvular problems. After patients had received explanations of TKA, as well as its benefits and risks, they provided written informed consent to undergo the surgical procedure.
 

Figure 1. Fast-track total knee arthroplasty pathway
 
Education to manage patient expectations was conducted by a nursing specialist. Prior to surgery, a physiotherapist provided patients with education concerning the rehabilitation pathway (ie, exercise, home care, and the arrangement of walking aids). An occupational therapist performed an Activities of Daily Living assessment and conducted appropriate home modifications. A medical social worker performed a psychosocial assessment and discharge planning; for patients with anticipated discharge problems, short-term placement was arranged prior to surgery. The aim of this multidisciplinary preoperative preparation protocol was to reduce the in-patient period and promote early postoperative ambulation for successful rehabilitation.
 
Most patients were admitted for same-day surgery. If the anaesthetist requested a short period of monitored preoperative optimisation, patients were admitted for next-day surgery. The criteria for next-day surgery included the presence of insulin-dependent diabetes mellitus requiring overnight dextrose-potassium-insulin infusion, the presence of chronic obstructive pulmonary disease, and the need for pacemaker adjustment prior to surgery.
 
Surgical techniques and perioperative management
All arthroplasties were performed via the medial parapatellar approach using a tourniquet, a posterior-stabilised implant, and a bone plug in the intramedullary canal or navigation without canal violation, followed by cementation, haemostasis with a tourniquet, a compression bandage, and low-suction pressure drainage at 200 mm Hg for 24 hours. For 4 days after surgery, the analgesic regimen included acetaminophen 1 g 4 times daily and sustained-release oral diclofenac 100 mg daily for 4 days. Patients were provided a patient-controlled analgesia pump with intravenous morphine. Continuous femoral nerve block was performed. Patients were reviewed by Acute Pain Service staff beginning on postoperative day 0. The complete blood count was checked on postoperative day 1. For patients with a haemoglobin level <8 g/dL, blood transfusion was initiated until the haemoglobin level reached 10 g/dL (Fig 2). Ice therapy, walking, and ROM exercise were initiated on day 1. A foot pump was used for mechanical DVT prophylaxis throughout the hospital stay. Pharmacological prophylaxis for DVT was initiated only in patients with a history of venous thromboembolism. Nursing specialists assessed the wound, dressing, and drain; they also conducted fall risk assessment and prevention. Physiotherapists and occupational therapists worked in a coordinated manner to facilitate ROM exercise, gait rehabilitation, activities of daily living maintenance, and early caregiver training. Basic requirements for discharge included knee flexion range of 90°, quadriceps muscles strength of grade 3, and stable walking ability.
 

Figure 2. Protocol for perioperative blood transfusion in fast-track total knee arthroplasty15
 
All patients were assessed by a nurse in the clinic at 2 weeks after surgery to evaluate the wound status and remove staples. They were then evaluated by surgeons at 1, 3, 6, 12, and 24 months after surgery, via clinical and radiographic examinations.
 
Statistical analysis
Data analysis was performed using SPSS (Windows version 20.0; IBM Corp, Armonk [NY], United States). Normal distributions of the data were assessed by the Shapiro–Wilk normality test for each series of measurements. Univariate analysis was performed using the Chi squared test and unpaired t tests, respectively, for categorical and numerical data with normal distributions. Comparisons of parameters with non-normal distributions were performed using the Mann–Whitney U test. To adjust for the confounding effects of multiple variables (eg, type of anaesthesia, Charlson Comorbidity Index, and other baseline co-morbidities), multivariate analysis was performed with multiple logistic regressions. The high-risk group was defined as Charlson Comorbidity Index >5, on the basis of previous findings regarding the risk of complications in TKA.13 Data were reported as mean ± standard deviation unless otherwise specified. Statistical significance was defined as P<0.05. In addition, power analysis to determine the sample size was performed using G*Power (version 3.1.9.1),14 assuming that power >0.80 was indicative of an appropriate sample size.
 
Results
Patient characteristics
In total, 1788 patients underwent primary TKA during the study period (Table 1). Of these patients, 112 (6.3%) were aged >80 years (octogenarian group; mean age, 82.7 ± 1.6 years; range, 81-89); 80 patients (71.4%) in the octogenarian group were women. From the remaining patients, 108 sex- and BMI-matched patients aged ≤80 years (mean age, 66.4 ± 8.7 years; range, 43-80) were selected at random and assigned to the control group (ie, non-octogenarian group). The mean follow-up interval for all patients was 3.2 years (range, 2-5 years).
 

Table 1. Demographic characteristics and surgical data of patients selected from 1788 patients who underwent total knee arthroplasty between 2011 and 2015
 
The indication for TKA in most patients (218 patients, 99.1%) was primary osteoarthritis of the knee joint. Two patients (0.9%) had rheumatoid arthritis of the knee joint. There was no significant difference between groups in the number of patients with rheumatoid arthritis. The octogenarian group had a significantly higher Charlson Comorbidity Index (4.9 ± 1.0 vs 2.5 ± 1.2, P<0.001), along with higher incidences of renal impairment and congestive heart failure.
 
More cases were performed with spinal anaesthesia in both groups. The ratio of general to spinal anaesthesia was lower in the octogenarian group (26:86 vs 40:68, P=0.025). Tourniquet time was significantly lower in the octogenarian group than in the non-octogenarian group (89.20 ± 17.25 mins vs 99.62 ± 23.94 min, P=0.001). Preoperative and postoperative haemoglobin levels were both significantly lower in the octogenarian group. Both groups exhibited similar degrees of reduction in haemoglobin levels. More blood transfusions were recorded in the octogenarian group (16.1% vs 0.9%, P<0.001).
 
Length of stay and changes in functional outcomes
The length of stay did not significantly differ between groups (octogenarian: 8.9 ± 5.6 d vs non-octogenarian: 7.5 ± 2.6 d, P=0.096) [Table 2]. Significantly more patients in the octogenarian group required a walking aid upon discharge (83.3% vs 59.3%, P<0.001). At 2 years after surgery, more patients in the octogenarian group continued to require a walking aid (81.6% vs 35.8%, P<0.001).
 

Table 2. Postoperative findings and follow-up assessments
 
The octogenarian group exhibited a worse preoperative ROM (94 ± 18° vs 100 ± 17°, P=0.009) and WOMAC score (48 ± 20 vs 53 ± 17, P=0.018), but the improvements in these outcomes at 12 months after surgery were identical in both groups. In contrast, greater improvement in KSS was observed in the octogenarian group at 12 months after surgery (46 ± 19 vs 39 ± 16, P=0.018), despite a similar preoperative score. Importantly, our sample size of 112 octogenarian patients and 108 non-octogenarian patients exhibited 83.7% power to detect a difference in the primary outcome of KSS improvement after surgery between groups when such a difference was present.
 
Complications and mortality
The incidence of major complications tended to be greater in the octogenarian group, although this difference was not statistically significant (2.7% vs 0%, P=0.087) [Table 2]. The incidence of overall complications was significantly higher in the octogenarian group (15.2% vs 4.6%, P=0.009). Despite the higher preoperative Charlson Comorbidity Index in the octogenarian group, there were no significant differences in the individual incidences of falls, urinary tract infection, proximal DVT, pulmonary embolism, confusion, and congestive heart failure, or in the rates of ICU admission and 1-year mortality. Notably, urinary catheterisation tended to occur more frequently in the octogenarian group, although this difference was not statistically significant (11.6% vs 4.6%, P=0.059).
 
Logistic regression was performed to ascertain the effects of octogenarian status, Charlson Comorbidity Index >5, anaesthesia type, tourniquet time, preoperative ROM, and histories of multiple conditions (ie, renal impairment, congestive heart failure, major cerebrovascular accident, ischaemic heart disease, and peptic ulcer disease) on the likelihood that patients would experience complications after fast-track TKA. The model explained 26.7% (Nagelkerke R2) of the variance in complications and correctly classified 90.0% of patients. Patients with Charlson Comorbidity Index >5 were 5.69-fold more likely to exhibit complications than were patients with a Charlson Comorbidity Index ≤5 (P=0.039; odds ratio [OR]=5.69; 95% confidence interval [CI]=1.09-32.60). A history of major cerebrovascular accident (P=0.016; OR=45.03; 95% CI=2.05-991.54) and a history of peptic ulcer disease (P=0.007; OR=5.51; 95% CI=1.58-19.17) were also significantly associated with an increased likelihood of exhibiting complications (Table 3).
 

Table 3. Multivariate analysis of the risks of complications after fast-track total knee arthroplasty with octogenarian status after adjustment for confounding factors
 
Discussion
To our knowledge, this is the first study in Hong Kong concerning the clinical outcomes of fast-track TKA for patients aged >80 years. We found higher incidences of preoperative co-morbidities, anaemia, postoperative transfusion, and postoperative complications. Importantly, the improvements in functional outcomes at 1 year after fast-track TKA among octogenarians were comparable with or better than the improvements among younger patients. Our findings support the use of fast-track TKA in this older group of patients; they indicate small and acceptable increases in the risks for such patients. This study focused on patient outcomes in our centre from 2011 to 2015. Because of protocol improvements in subsequent years, including opioid-sparing analgesia, local infiltrative anaesthesia, the use of oral tranexamic acid, and 1 year of physiotherapy, the length of stay and the patient outcomes are expected to improve.
 
Haemoglobin reduction and blood product management
In this study, the octogenarian group exhibited a lower preoperative haemoglobin level. The higher incidence of anaemia among octogenarians in the general population may be related to ageing, particularly because of reduced erythropoietin production, as well as anaemia secondary to iron, nutritional deficiency, or chronic disease.14 These factors presumably contributed to the significant increases in the rates of transfusion and ‘type and screen’ in the octogenarian group, despite a similar haemoglobin reduction and the use of 8 g/dL as the transfusion threshold in both groups.15 Because perioperative anaemia and allogenic blood transfusion have been associated with an increased risk of postoperative infection, longer hospital stay, and greater mortality,16 iron supplements and autologous transfusion were used to increase the preoperative haemoglobin level and reduce the postoperative transfusion rate. Our fast-track protocol-driven blood management with a single transfusion threshold provides a good balance between adequate treatment of perioperative anaemia and unnecessary blood transfusion. This balance was reflected by the absence of significant increases in periprosthetic infection and mortality in the octogenarian group.
 
Length of stay
The length of stay tended to be greater in the octogenarian group in the present study. Maiorano et al17 suggested that the mean length of stay was shorter in patients with a higher modified Barthel Index Score; better functional status may lead to more rapid rehabilitation progress. Furthermore, we observed a better preoperative WOMAC score in younger patients (53 ± 17 vs 48 ± 20, P<0.05), consistent with the findings by Maiorano et al.17 A phenomenon unique to Hong Kong is the confined living area in most homes, which may increase the difficulty in using a walking aid at home. In the present study, 83.3% of patients in the octogenarian group required a walking aid upon discharge. Additionally, temporary residential service was required more frequently upon discharge; this arrangement might have contributed to the increased length of stay. However, prior anticipation of discharge difficulty and the multidisciplinary approach in our fast-track TKA protocol helped to limit the length of stay, leading to an increase of only 1.4 days in the octogenarian group.
 
Functional outcomes
In this study, both groups had comparable outcomes at 12 months after surgery in terms of improvements in ROM and WOMAC score. The octogenarian group exhibited greater improvement in KSS at 12 months after surgery. These results support the use of TKA among octogenarian patients. Good functional outcomes without pain are important for ensuring that patients maintain independence in the activities of daily living. Such independence relieves the caretaker burden and helps patients return to the community.
 
Mortality and complication rate
In this analysis of fast-track TKA, there was no significant difference between octogenarian and non-octogenarian groups in terms of the 1-year mortality rate, although the octogenarian group had a higher Charlson Comorbidity Index. Notably, the all-cause mortality rate within 1 year after surgery was 1.79% in the octogenarian group; this was lower than the annual all-cause mortality rates for the Hong Kong general population in 2013 among men and women aged 80 to 84 years (6.1% and 3.7%18, respectively). In the fast-track protocol, all patients were assessed by an anaesthetist, an orthopaedic surgeon, and an orthopaedic nurse. Patients with suboptimally controlled medical condition were rapidly referred for out-patient treatment by the appropriate department. For instance, fast-track echocardiography was arranged for patients with suspected valvular problems; fast-track management of poorly controlled hypertension was performed by family medicine specialists.
 
Significantly more patients in the octogenarian group developed complications. Most patients exhibited minor complication. There were no significant differences between groups in terms of major complications (eg, proximal DVT, pulmonary embolism, and congestive heart failure). Furthermore, postoperative confusion was rare, in contrast to the incidence rate of 6.7% reported by Kuo et al.19 Postoperative maintenance of good pain control and normal cognitive status is crucial for rehabilitation and ensuring safety.20 A multimodel analgesic regimen in the 4 days after surgery was implemented in our centre to achieve the greatest degree of analgesia with the fewest side-effects. Each patient was provided patient-controlled analgesia comprising morphine infusion, paracetamol, and nonsteroidal anti-inflammatory drugs.
 
After adjustment for confounding factors, patients with Charlson Comorbidity Index >5 were 5.69-fold more likely to develop postoperative complications. The Charlson Comorbidity Index has been widely used in large studies to predict functional outcome, implant survival, mortality, and length of stay after TKA.21 22 Our results were consistent with the findings by Marya et al13 that a Charlson Comorbidity Index of >5 was associated with major complications after bilateral simultaneous TKA. In addition, we found that patients with past histories of major cerebrovascular accident and peptic ulcer disease were more likely to have postoperative complications. Previous stroke has been identified as a predictive factor for perioperative acute ischaemic stroke after TKA,23 whereas peptic ulcer disease has been associated with periprosthetic fracture after primary TKA.24 After adjustment for confounding factors, we found that octogenarian status alone was not associated with significantly greater risk of complications after fast-track TKA. Surgeons should consider patient risk during TKA on the basis of their individual co-morbidities, rather than age alone.
 
Urinary catheterisation
There was a considerably higher incidence of urinary catheterisation in the octogenarian group. Lingaraj et al25 suggested that 8% of all patients undergoing TKA develop urinary retention. There is a need to identify postoperative urinary retention to reduce the risks of periprosthetic joint infection and renal impairment. As part of our fast-track protocol, a protocol-driven management approach was used for each patient with acute urine retention. Bladder scans were performed by nurses to assess post-micturition volume; catheterisation was performed in patients with any bladder distention. Stimulant laxative treatment was used to avoid constipation and alleviate urine retention.
 
Limitations
There were some limitations in this study. First, the study was small and the follow-up period was short (mean, 3.2 years). However, there are generally few patients aged >80 years who have sufficient life expectancy for a longer period of follow-up. Second, this was a retrospective cohort study, with the inherent limitations of the retrospective design. Although a prospective randomised controlled trial is preferable, ethical considerations prohibit the allocation of octogenarian patients to a non-fast-track protocol because of their higher operative risks. Third, although coronal plane deformity and the degree of soft tissue balance may contribute to differences in knee functional performance, these parameters were not measured. Future studies should include such assessments to more fully characterise the factors that influence TKA outcomes.
 
Conclusion
Compared with non-octogenarians, octogenarians had greater improvement in KSS at 1 year after fast-track TKA, despite similar preoperative KSS. Octogenarians had a higher incidence of complications after TKA. After adjustment for confounding factors, we found that Charlson Comorbidity Index >5, history of major cerebrovascular accident, and history of peptic ulcer disease were predictive of complications after fasttrack TKA; importantly, octogenarian status was not predictive of complications. There were no significant differences in the length of hospitalisation, incidence of major complications, rate of ICU admission, or the 1-year mortality rate between the octogenarian and non-octogenarian groups. Thus, age alone should not be a contra-indication to TKA.
 
Author contributions
Concept or design: All authors.
Acquisition of data: CH Lee, EWY Chang.
Analysis or interpretation of data: CH Lee, EWY Chang.
Drafting of the manuscript: TP Leung, CH Lee, QJ Lee.
Critical revision of the manuscript for important intellectual content: All authors.
 
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
All authors have disclosed no conflicts of interest.
 
Funding/support
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
 
Ethics approval
This study was approved by the Kowloon West Cluster Research Ethics Committee (Ref: KW/EX-20-068(147-03)).
 
References
1. Census and Statistics Department, Hong Kong SAR Government. Hong Kong Population Projection 2012-2041. Available from: https://www.censtatd.gov.hk/media_workers_corner/pc_rm/hong_kong_population_projections_2012_2041/index.jsp. Accessed 31 Jul 2012.
2. Yuen W. Osteoarthritis of knees: the disease burden in Hong Kong and means to alleviate it. Hong Kong Med J 2014;20:5-6. Crossref
3. Kreder HJ, Berry GK, Mcmurtry IA, Halman SI. Arthroplasty in the octogenarian: quantifying the risks. J Arthroplasty 2005;20:289-93. Crossref
4. Jämsen E, Puolakka T, Eskelinen A, et al. Predictors of mortality following primary hip and knee replacement in the aged. A single-center analysis of 1998 primary hip and knee replacements for primary osteoarthritis. Acta Orthop 2012;84:44-53. Crossref
5. Scott JE, Mathias JL, Kneebone AC. Postoperative cognitive dysfunction after total joint arthroplasty in the elderly: a meta-analysis. J Arthroplasty 2014;29:261-7.e1. Crossref
6. Mnatzaganian G, Ryan P, Norman PE, Davidson DC, Hiller JE. Total joint replacement in men: old age, obesity and in-hospital complications. ANZ J Surg 2012;83:376-81. Crossref
7. Klasan A, Putnis SE, Yeo WW, Fritsch BA, Coolican MR, Parker DA. Advanced age is not a barrier to total knee arthroplasty: a detailed analysis of outcomes and complications in an elderly cohort compared with average age total knee arthroplasty patients. J Arthroplasty 2019;34:1938-45. Crossref
8. Petruccelli D, Rahman WA, de Beer J, Winemaker M. Clinical outcomes of primary total joint arthroplasty among nonagenarian patients. J Arthroplasty 2012;27:1599-603. Crossref
9. Shah AK, Celestin J, Parks ML, Levy RN. Long-term results of total joint arthroplasty in elderly patients who are frail. Clin Orthop Relat Res 2004;425:106-9. Crossref
10. Hernández-Vaquero D, Fernández-Carreira JM, Pérez-Hernández D, Fernández-Lombardía J, García-Sandoval MA. Total knee arthroplasty in the elderly. Is there an age limit? J Arthroplasty 2006;21:358-61.
11. Joshi AB, Markovic L, Gill G. Knee arthroplasty in octogenarians: results at 10 years. J Arthroplasty 2003;18:295-8. Crossref
12. Berend ME, Thong AE, Faris GW, Newbern G, Pierson JL, Ritter MA. Total joint arthroplasty in the extremely elderly: hip and knee arthroplasty after entering the 89th year of life. J Arthroplasty 2003;18:817-21. Crossref
13. Marya SK, Amit P, Singh C. Impact of Charlson indices and comorbid conditions on complication risk in bilateral simultaneous total knee arthroplasty. Knee 2016;23:955-9. Crossref
14. Partridge J, Harari D, Gossage J, Dhesi J. Anaemia in the older surgical patient: a review of prevalence, causes, implications and management. J R Soc Med 2013;106:269-77. Crossref
15. Lee QJ, Mak WP, Yeung ST, Wong YC, Wai YL. Blood management protocol for total knee arthroplasty to reduce blood wastage and unnecessary transfusion. J Orthop Surg (Hong Kong) 2015;23:66-70. Crossref
16. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010;113:482-95. Crossref
17. Maiorano E, Bodini BD, Cavaiani F, Pelosi C, Sansone V. Length of stay and short-term functional outcomes after total knee arthroplasty: can we predict them? Knee 2017;24:116-20. Crossref
18. Census and Statistics Department, Hong Kong SAR Government. Hong Kong Monthly Digest of Statistics November 2014. The mortality trend in Hong Kong, 1981 to 2013. Available from: https://www.statistics.gov.hk/pub/B71411FB2014XXXXB0100.pdf. Accessed 17 Nov 2014.
19. Kuo FC, Hsu CH, Chen WS, Wang JW. Total knee arthroplasty in carefully selected patients aged 80 years or older. J Orthop Surg Res 2014;9:61. Crossref
20. Lynch EP, Lazor MA, Gellis JE, Orav J, Goldman L, Marcantonio ER. The impact of postoperative pain on the development of postoperative delirium. Anesth Analg 1998;86:781-5. Crossref
21. Kreder HJ, Grosso P, Williams JI, et al. Provider volume and other predictors of outcome after total knee arthroplasty: a population study in Ontario. Can J Surg 2003;46:15-22.
22. Bjorgul K, Novicoff WM, Saleh KJ. Evaluating comorbidities in total hip and knee arthroplasty: available instruments. J Orthop Traumatol 2010;11:203-9. Crossref
23. Menendez ME, Greber EM, Schumacher CS, Lowry Barnes C. Predictors of acute ischemic stroke after total knee arthroplasty. J Surg Orthop Adv 2017;26:148-53. Crossref
24. Singh JA, Lewallen DG. Association of peptic ulcer disease and pulmonary disease with risk of periprosthetic fracture after primary total knee arthroplasty. Arthritis Care Res (Hoboken) 2011;63:1471-6. Crossref
25. Lingaraj K, Ruben M, Chan YH, Das SD. Identification of risk factors for urinary retention following total knee arthroplasty: a Singapore hospital experience. Singapore Med J 2007;48:213-6.

Prevalence of unruptured intracranial aneurysms in the Hong Kong general population and comparison with individuals with symptoms or history of cerebrovascular disease

© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
 
ORIGINAL ARTICLE  CME
Prevalence of unruptured intracranial aneurysms in the Hong Kong general population and comparison with individuals with symptoms or history of cerebrovascular disease
A paper from the Hong Kong Society of Interventional and Therapeutic Neuroradiology Endorsed by the Hong Kong Stroke Society
Simon CH Yu, MD, FRCR1,2; PW Cheng, FRCR3; Gregory E Antonio, MD, FHKCR3; Sabrina CC Chan, MPhil1,2; Tiffany WW Lau, MSc1,2; Hector TG Ma, MD, FHKCR3; for The Hong Kong Society of Interventional and Therapeutic Neuroradiology
1 Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong
2 Vascular and Interventional Radiology Foundation Clinical Science Centre, The Chinese University of Hong Kong
3 Scanning Department, St Teresa’s Hospital, Hong Kong
 
Corresponding author: Prof Simon CH Yu (simonyu@cuhk.edu.hk)
 
 Full paper in PDF
 
Abstract
Introduction: We aimed to estimate the prevalence of unruptured intracranial aneurysms among the general population in Hong Kong, which has not yet been determined; we also estimated its prevalence among individuals who have symptoms or history of cerebrovascular disease.
 
Methods: This retrospective cross-sectional study included the first cerebral magnetic resonance angiography (MRA) records of Hong Kong citizens who underwent MRA in a single hospital between July 1994 and December 2009. Records were excluded for individuals with repeat examination or a personal/family history of intracranial aneurysm. The overall prevalence of unruptured intracranial aneurysms in Hong Kong was estimated from the sex- and age-specific prevalences in the General group, as well as census data regarding the sex and age composition of the Hong Kong population.
 
Results: In total, data on 6637 individuals were included. Asymptomatic individuals were assumed to represent the general public and allocated into a General group (n=3597); the remaining individuals were allocated into a Symptom group (n=2409) or a cerebrovascular disease (CVD) group (n=707). The prevalence of unruptured intracranial aneurysms was significantly lower in the General group (176/3597, 4.9%) than in the Symptom group (152/2409, 6.3%; P=0.018). The prevalences in women and men were 5.9% (107/1809) and 3.9% (69/1788), respectively, in the General group (P=0.004). These prevalences generally increased with age. The prevalences did not significantly differ between the General and CVD groups.
 
Conclusions: The estimated overall prevalence of unruptured intracranial aneurysm in the Hong Kong population was 3.6%. The prevalence of unruptured intracranial aneurysm was significantly higher in the Symptom group than in the General group.
 
 
New knowledge added by this study
  • The estimated overall prevalence of unruptured intracranial aneurysm in the Hong Kong population is 3.6%, according to the study findings and census data regarding the current sex and age composition of the Hong Kong population.
  • The prevalence of unruptured intracranial aneurysm in individuals with any single or combination of symptoms related to intracranial aneurysms, with or without a history of cerebrovascular disease, is significantly higher than the prevalence in individuals without any such symptoms or history of cerebrovascular disease.
  • Among all groups and subgroups, the prevalence of unruptured intracranial aneurysm was consistently higher in women than in men.
Implications for clinical practice or policy
  • This analysis of unruptured intracranial aneurysm prevalence in individuals with symptoms and individuals with a known history of cerebrovascular disease provides useful information for physicians who must counsel such patients.
  • Estimation of the overall prevalence of unruptured intracranial aneurysm in the Hong Kong population provides useful information for medical service planning by health authorities.
 
 
Introduction
Intracranial aneurysms constitute approximately 80% of all nontraumatic subarachnoid haemorrhages.1 Aneurysmal subarachnoid haemorrhage could be associated with 30-day mortality of 45%, and approximately half of the survivors will have irreversible brain damage.2 Knowledge of the intracranial aneurysm prevalence in a population allows health authorities to assess the severity of the problem and formulate appropriate healthcare policies. The prevalence of unruptured intracranial aneurysm has considerably varied among studies according to the detection method used.3 4 5 6 7 8 9 10 11 12 13 14 15 Notably, the prevalence of unruptured intracranial aneurysm generally increases with imaging sensitivity. Studies that used three-dimensional time-of-flight magnetic resonance angiography (MRA) with 3-T magnetic resonance imaging (MRI) showed a prevalence of 7.0% in a general population of Chinese adults age 35 to 75 years.14 Time-of-flight MRA is an ideal imaging technique for the analysis of intracranial aneurysm prevalence because of its non-invasive nature and its diagnostic accuracy, which is comparable to the accuracy of digital subtraction angiography.16 17 Information concerning the prevalence of intracranial aneurysms in the general population is important but has been unavailable in Hong Kong. We aimed to determine the prevalences of unruptured intracranial aneurysms in the Hong Kong population, individuals with symptoms related to intracranial aneurysms, and individuals with cerebrovascular disease (CVD).
 
Methods
Study design
Data on cerebral MRA examinations of Hong Kong residents conducted at St Teresa’s Hospital, a private community hospital that serves patients throughout Hong Kong, were extracted from hospital electronic records. Data were excluded if they were repeat MRA examinations or if the individual had a known history of ruptured/unruptured aneurysm or a family history of cerebral aneurysm.
 
Magnetic resonance angiography was the first-line imaging method used for assessment of intracranial vessels at St Teresa’s Hospital during the study period. Information retrieved from clinical records included the indication for MRA, presenting symptoms, medical history, family history, and MRA findings. Three groups were formed for analysis: a Symptom group that consisted of individuals who presented with any single symptom or combination of symptoms such as headache, any neurological symptoms related to intracranial aneurysms such as localised pain above or behind the eye, nausea, vomiting, or any visual symptom related to intracranial aneurysms (eg, diplopia, vision blurring, proptosis, or ptosis); a General group that consisted of individuals without any symptoms that were criteria for inclusion in the Symptom group and without a known history of CVD; and a CVD group that consisted of individuals with a known history of ischaemic stroke, transient ischaemic attack, intracranial stenosis, a history of intracerebral haemorrhage, arteriovenous malformation, or any other CVD other than cerebral aneurysm. The prevalences of cerebral aneurysm within these groups were recorded and compared among groups. The characteristics of aneurysms in the General group were extensively characterised.
 
Magnetic resonance angiography
The usual contra-indications for MRI were adopted.18 Magnetic resonance angiography was performed with a Siemens MAGNETOM MRI scanner (1.5T Vision, 1.5T Sonata, 1.5T Avanto, 3T Trio) using non-contrast time-of-flight sequence (repetition time 21-40 ms, echo time 3.8-7.2 ms, flip angle 18°-25°, matrix 195×512 to 250×512, field of view 200-230, slab 3-6, slices per slab 36-48, slice thickness 0.5-0.6 mm, acquisition time 4.32-8.45 minutes, with or without magnetic transfer). All MRI examinations were performed and reported by the same team of radiographers and radiologists; each member had at least 5 years of experience. The diagnosis of aneurysms in each participant was based on definite findings in the radiology report. Cases involving an inconclusive diagnosis of aneurysm without confirmatory computed tomography angiography or digital subtraction angiography findings were not included. Aneurysm types were saccular or fusiform. Aneurysm sizes were recorded as ≤5 mm, >5 mm to <10 mm, 10 to 20 mm, or >20 mm. Aneurysm locations were internal carotid artery, middle cerebral artery, anterior cerebral artery, posterior cerebral artery, or vertebrobasilar artery. Anterior communicating artery aneurysms were included in the anterior cerebral artery location category. Posterior communicating artery aneurysms were included in the posterior cerebral artery location category.
 
Analysis of aneurysm prevalence
Prevalence analysis was based on participants, rather than aneurysms. In the General group, sex- and age-specific prevalences were analysed. The age threshold that demarcated the greatest change in prevalence was identified using odds ratio (OR) for the General group overall, as well as for all male participants and for all female participants within the General group. The prevalences in the General group overall, as well as its sex- and age-specific subgroups, were compared with the prevalences in the Symptom and CVD groups. The sizes and locations of unruptured intracranial aneurysms were analysed in the General group. For participants with multiple aneurysms, the largest aneurysm was selected for size and location analysis. The prevalence in the Hong Kong population was estimated from the sex- and age-specific prevalence in the General group in this study, with reference to the sex and age composition of the Hong Kong population. Because this cross-sectional analysis involved a long study period (ie, 15 years), a separate analysis of the sex- and age-specific prevalences of aneurysms among participants examined in the final 5 years was performed to determine whether any significant variations in sex- and age-specific prevalences occurred over time.
 
Statistical analysis
Statistical analyses were conducted using SPSS for Windows (version 20.0; IBM Corp, Armonk [NY], United States). All categorical variables are presented as number and percentage. All continuous variables are presented as median and interquartile range. Comparisons of prevalences among groups and subgroups were carried out using the Chi squared test. The Mann-Whitney U test was used for comparisons of continuous variables. P<0.05 was considered to indicate statistical significance. Comparisons of aneurysm prevalences between participant groups according to an age threshold were conducted using OR and 95% confidence interval (95% CI).
 
Results
Participant characteristics
During the study period between July 1994 and December 2009, 8959 cerebral MRA examinations were conducted; 97.9% of the examined individuals were Chinese. Among them, 2252 repeat MRA examinations and 70 individuals with known history of ruptured/unruptured aneurysm or a family history of cerebral aneurysm were excluded (Fig 1). Finally, first cerebral MRA examinations of 6637 individuals were included for analysis (Table 1).
 

Figure 1. Flowchart of participant inclusion and allocation to groups based on symptoms and history of cerebrovascular disease
 

Table 1. Participant characteristics
 
Prevalences in the General group, stratified according to sex and age
Table 1 shows the prevalences of unruptured intracranial aneurysm among the study groups. In the General group, the overall prevalence was 4.9%; the prevalences in women and men were 5.9% and 3.9%, respectively (P=0.004) [Table 2]. The prevalence was significantly higher in women than in men for almost all age ranges; it generally increased with age (Fig 2). The age threshold with the greatest change in unruptured intracranial aneurysm prevalence was 45 years in the General group overall (OR=3.1; 95% CI, 1.9-4.9), among men in the General group (OR=3.6, 95% CI, 1.6-8.3), and among women in the General group (OR=2.9, 95% CI, 1.6-5.2). In the General group overall, as well among men and women in the General group, the prevalences significantly differed between participants age <45 years and participants age ≥45 years (Table 2).
 

Table 2. Prevalences of unruptured intracranial aneurysm among study groups
 

Figure 2. Sex- and age-specific prevalences of unruptured intracranial aneurysm in the General and Symptom groups
 
Estimation of prevalence in the Hong Kong population
In the General group, the prevalences of unruptured intracranial aneurysm in men age <35, 35 to 44, 45 to 54, 55 to 64, 65 to 74 and >74 years were 1.2%, 1.8%, 2%, 3.4%, 7% and 6.6%, respectively; the corresponding prevalences in women were 1.9%, 1.7%, 4.8%, 7.3%, 7%, and 10.5%, respectively. Census data for Hong Kong from 2019 indicated that the numbers of men in the above age ranges were 1.25 million, 0.4652 million, 0.4896 million, 0.5952 million, 0.3804 million and 0.2514 million, respectively; the numbers of women in those age ranges were 1.3542 million, 0.7141 million, 0.6601 million, 0.6404 million, 0.394 million and 0.3262 million, respectively.19 Thus, we estimated the overall prevalence of unruptured intracranial aneurysm in the Hong Kong population to be 3.6%. There were no statistically significant differences in sex- and age-specific prevalences among participants examined in the final 5 years of the study, compared with participants examined throughout the 15.5-year study period (Table 3).
 

Table 3. Comparison of unruptured intracranial aneurysm prevalences between examination time periods among participants in the General group
 
Comparison of prevalences between the General group and the other groups
The unruptured intracranial aneurysm prevalence was significantly higher in the Symptom group than in the General group (6.3% vs 4.9%, P=0.018) [Table 2]. The prevalence was also significantly higher in the Symptom group than in the General group among all women participants, participants age <45 years, participants age ≥45 years, women age <45 years, and women age ≥45 years. Otherwise, the prevalences of unruptured intracranial aneurysm did not significantly differ between the General group (overall or subgroups) and the other main groups (Table 2).
 
Comparison of prevalence ratios between age-range subgroups and between the General and Symptom groups
Using the prevalence at age 35 to 44 years as the reference value, the prevalences for the subgroups of age 45 to 54, 55 to 64 and 65 to 74 years were 2.8-fold, 4.3-fold and 4.1-fold greater than the reference value, respectively, for women in the General group; these prevalences were 1.1-fold, 1.9-fold and 3.9-fold greater than the reference value, respectively, for men in the General group. For the subgroups of age 35 to 44, 45 to 54, 55 to 64 and 65 to 74 years, the prevalence ratios of women to men were 0.9, 2.4, 2.1 and 1, respectively, in the General group. Additionally, the prevalence ratios of the Symptom group to the General group in the four age subgroups varied from 4.2 to 1.5 for women and from 1.5 to 0.8 for men (Table 4, Fig 2).
 

Table 4. Unruptured intracranial aneurysm prevalence ratios (PRs) between subgroups of the General group and between General and Symptom groups
 
Size and location of unruptured intracranial aneurysms
Among 176 participants with one or more aneurysms in the General group, the largest aneurysm in each participant was selected for size and location analysis. Eleven participants (6.3%) had fusiform aneurysms, while 165 participants (93.8%) had saccular aneurysms. Furthermore, 157 participants (89.2%) had a single aneurysm, 16 participants (9.1%) had two aneurysms, and two participants (1.1%) had three aneurysms. Mirror aneurysm occurred in six participants (3.4%): five men and one woman. Mirror aneurysms were located in the cavernous internal carotid artery in two participants and in the non-cavernous internal carotid artery in four participants. The mirror aneurysms were bilaterally symmetrical; they measured ≤5 mm (four participants), 5-10 mm (one participant), and 10-20 mm (one participant). The size and location distributions of aneurysms in the General and Symptom groups are shown in Table 4. The proportion of posterior cerebral artery aneurysms was significantly greater in the Symptom group than in the General group (10.5% vs 3.4%, P=0.01) [Table 5].
 

Table 5. Locations and sizes of unruptured intracranial aneurysms
 
Discussion
It is resource-intensive to determine the unruptured intracranial aneurysm prevalence in any population because of the need for large-scale studies with prospective and random selection of participants, as well as the utilisation of accurate diagnostic means for aneurysm detection. To achieve this objective within the constraints of a hospital-based retrospective study, our study model used a hospital that served the whole population of Hong Kong; study participants comprised individuals without a family history, past history, or symptoms related to intracranial aneurysms, all of whom were referred to the hospital for body check with MRA. These individuals were assumed to be closely representative of a random sample of the Hong Kong population because there was no identifiable medical reason when they presented themselves to a doctor, therefore the sample was not biased. Because the prevalence of unruptured intracranial aneurysm is sex- and age-dependent, 11 the overall prevalence is dependent on the sex and age composition of participants in the study sample. Sex- and age-specific prevalences are more meaningful than overall prevalences because they allow comparisons among distinct target groups in the same study and in other studies. The analysis of unruptured intracranial aneurysm prevalence in individuals with symptoms and individuals with a known history of CVD provides useful information for physicians who must counsel such patients.
 
Studies of intracranial aneurysm prevalence have multiple limitations. Retrospective studies tend to show lower prevalence rates than do prospective studies.4 13 20 21 22 Prevalences vary according to the modality of aneurysm detection, such that prevalence rates tend to be much lower in autopsy studies than in arteriogram studies or MRA studies. Published prevalences have been 0.4% to 0.5% in retrospective autopsy studies,4 3.1% to 4.1% in prospective autopsy studies,4 0.65% to 4.4% in retrospective arteriogram studies,4 3% to 6.8% in prospective arteriogram studies,4 3.2% to 4.3% in retrospective MRA studies,21 22 and 5% to 7% in prospective MRA studies.13 14 The overall prevalences are also limited by the sex and age compositions of participants in each study. Autopsy and hospital-based retrospective studies usually have biased samples comprising individuals who presented to the hospital with clinical indications for investigation. Furthermore, the identification of an intracranial aneurysm at autopsy is greatly affected by the interest and enthusiasm of the examiner23; intracranial aneurysms are commonly overlooked at autopsy.24 These observations may explain the generally low prevalence rates of 0.2% to 2.2% reported in autopsy studies.6 25 26 27
 
Unruptured intracranial aneurysms are more common in women and relatively older individuals.4 11 14 21 Comparisons of unruptured intracranial aneurysm prevalence between published studies may not be meaningful without considering the sex ratio and age distribution of the study samples; such comparisons are not feasible for studies in which sex ratio and age distribution data are unavailable, and such studies are not uncommon. We compared our results with findings from a prospective study of Chinese individuals in Shanghai,14 in which the sex- and age-specific prevalences had been analysed; both studies shared some common trends. In the previous study, the overall prevalence was 7%; moreover, prevalence increased with age and the female-to-male prevalence ratio decreased with increasing age. These prevalence patterns were similar to patterns observed in the current study. Notably, the age- and sex-specific prevalences were consistently higher in the Shanghai study14 than in the current study, which suggests differences in intracranial aneurysm prevalence between the two populations.
 
There were two main limitations in this study. First, its duration (15 years) was relatively long. Although there were prevalence studies which involved cerebral arteriogram or autopsy lasting for up to 11 years or 30 years respectively,6 20 studies involving MRA typically lasted for 2 to 4 years.14 21 However, the results obtained from the long study period can be regarded as similar to the aggregate results of a series of consecutive short retrospective studies. The overall age- and sex-specific prevalences obtained during the long study period can be regarded as the average value of age- and sex-specific prevalences in the individual shorter studies. A major concern related to a long study period is the potential for variations in population demographics, particularly with respect to age and sex. Because analyses of age- and sex-specific prevalence were conducted in the present study, variations in age and sex composition throughout the population in various time periods were presumed not to affect the analysis outcome. The overall prevalence of a particular disease at any time point can be calculated from the sex and age composition of the population at that particular time point, together with the age- and sex-specific prevalences of that disease. Many published studies report an overall prevalence, which is meaningful only for a specific time period because it is dependent on the age and sex composition of the population during the study period. Age- and sex-specific prevalences are more meaningful than an overall prevalence, they could be regarded as part of the natural process of the disease specific to the population and are expected to exhibit fewer changes over time, therefore, they are more directly applicable to clinical practice. Consistent with that expectation, we found no statistically significant differences in age- and sex-specific prevalences in the final 5 years of the study period, compared with the study period overall.
 
Second, the assumption that the General group is a close representative of the general population in Hong Kong requires validation because certain factors associated with high aneurysm risk may be more common among individuals referred for examination via MRA. Based on the selection criteria for the General group, selection bias may have caused this group to be poorly representative of the general population in Hong Kong. To minimise the potential for such bias, factors associated with a high risk of cerebral aneurysm were addressed by the exclusion of individuals with a family history, past history, or symptoms related to cerebral aneurysm. Additionally, the proportions of individuals with hypertension and a smoking habit in the General group did not significantly differ from those proportions in the wider Hong Kong population. Finally, potential biases involving advanced age and female sex were addressed with age- and sex-specific analyses.
 
In conclusion, the estimated overall prevalence of unruptured intracranial aneurysm in the Hong Kong population was 3.6%. The prevalence was significantly higher in the Symptom group than in the General group. However, the unruptured intracranial aneurysm prevalences did not differ between the General and CVD groups, or between the Symptom and CVD groups.
 
Author contributions
Concept or design: SCH Yu.
Acquisition of data: PW Cheng, GE Antonio, HTG Ma, SCC Chan.
Analysis or interpretation of data: SCH Yu, TWW Lau, SCC Chan.
Drafting of the manuscript: SCH Yu, PW Cheng.
Critical revision of the manuscript for important intellectual content: All authors.
 
All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.
 
Conflicts of interest
The authors declare that they have no conflict of interest.
 
Acknowledgement
The authors thank the following individuals for substantial contributions to data interpretation and manuscript revision: HKM Cheng, BMH Lai, GKC Wong, VKY Pang, ACO Tsang, DPH Wong, KM Leung, R Lee, TKT Chan, and CB Tan.
 
Funding/support
This study was funded by the Vascular and Interventional Radiology Foundation. The funding body had no involvement in the design of the study; in the collection, analysis, and interpretation of data; or in writing the manuscript.
 
Ethics approval
This study was approved by the Chinese University of Hong Kong–New Territories East Cluster Clinical Research Ethics Committee (CRE-2010-381). The requirement for informed consent was waived owing to the retrospective nature of the study.
 
References
1. Brown RD. Unruptured intracranial aneurysms. Semin Neurol 2010;30:537-44. Crossref
2. Graves EJ. Detailed diagnoses and procedures, national hospital discharge survey, 1990. Vital Health Stat 13 1992;113:1-225.
3. Ujiie H, Sato K, Onda H, et al. Clinical analysis of incidentally discovered unruptured aneurysms. Stroke 1993;24:1850-6. Crossref
4. Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998;29:251-6. Crossref
5. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms—risk of rupture and risks of surgical intervention. N Engl J Med 1998;339:1725-33. Crossref
6. Iwamoto H, Kiyohara Y, Fujishima M, et al. Prevalence of intracranial saccular aneurysms in a Japanese community based on a consecutive autopsy series during a 30-year observation period. The Hisayama study. Stroke 1999;30:1390-5. Crossref
7. Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA 1999;282:36-9. Crossref
8. Wardlaw JM, White PM. The detection and management of unruptured intracranial aneurysms. Brain 2000;123:205-21. Crossref
9. Horikoshi T, Akiyama I, Yamagata Z, Nukui H. Retrospective analysis of the prevalence of asymptomatic cerebral aneurysm in 4518 patients undergoing magnetic resonance angiography—when does cerebral aneurysm develop? Neurol Med Chir (Tokyo) 2002;42:105-12. Crossref
10. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1821-88. Crossref
11. Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 2011;10:626-36. Crossref
12. Agarwal N, Gala NB, Choudhry OJ, et al. Prevalence of asymptomatic incidental aneurysms: a review of 2685 computed tomographic angiograms. World Neurosurg 2014;82:1086-90. Crossref
13. Chan DY, Abrigo JM, Cheung TC, et al. Screening for intracranial aneurysms? Prevalence of unruptured intracranial aneurysms in Hong Kong Chinese. J Neurosurg 2016;124:1245-9. Crossref
14. Li MH, Chen SW, Li YD, et al. Prevalence of unruptured cerebral aneurysms in Chinese adults aged 35 to 75 years: a cross-sectional study. Ann Intern Med 2013; 159:514-21. Crossref
15. Igase K, Matsubara I, Igase M, Miyazaki H, Sadamoto K. Initial experience in evaluating the prevalence of unruptured intracranial aneurysms detected on 3-Tesla MRI. Cerebrovasc Dis 2012;33:348-53. Crossref
16. Li MH, Cheng YS, Li YD, et al. Large-cohort comparison between three-dimensional time-of-flight magnetic resonance and rotational digital subtraction angiographies in intracranial aneurysm detection. Stroke 2009;40:3127-9. Crossref
17. Li MH, Li YD, Tan HQ, Gu BX, et al. Contrast-free MRA at 3.0 T for the detection of intracranial aneurysms. Neurology 2011;77:667-76. Crossref
18. T Dill. Contraindications to magnetic resonance imaging. Heart 2008;94:943-8. Crossref
19. Census and Statistics Department, Hong Kong SAR Government. Available from: www.censtatd.gov.hk/en/web_table.html?id=1A. Accessed 18 Sep 2020.
20. Winn HR, Jane JA Sr, Taylor J, Kaiser D, Britz GW. Prevalence of asymptomatic incidental aneurysms: review of 4568 arteriograms. J Neurosurg 2002;96:43-9. Crossref
21. Harada K, Fukuyama K, Shirouzu T, et al. Prevalence of unruptured intracranial aneurysms in healthy asymptomatic Japanese adults: differences in gender and age. Acta Neurochir (Wien) 2013;155:2037-43. Crossref
22. Imaizumi Y, Mizutani T, Shimizu K, Sato Y, Taguchi J. Detection rates and sites of unruptured intracranial aneurysms according to sex and age: an analysis of MR angiography–based brain examinations of 4070 healthy Japanese adults. J Neurosurg 2018;130:573-8. Crossref
23. Chason JL, Hindman WM. Berry aneurysms of the circle of Willis; results of a planned autopsy study. Neurology 1958,8:41-4. Crossref
24. Stehbens WE. Aneurysms and anatomical variation of cerebral arteries. Arch Pathol 1963;75:45-64.
25. Housepian EM, Pool JL. A systematic analysis of intracranial aneurysms from the autopsy file of the Presbyterian Hospital, 1914 to 1956. J Neuropathol Exp Neurol 1958,17:409-23. Crossref
26. McCormick WF, Nofzinger JD. Saccular intracranial aneurysms: an autopsy study. J Neurosurg 1965;22:155-9. Crossref
27. Inagawa T, Hirano A. Autopsy study of unruptured incidental intracranial aneurysms. Surg Neurol 1990;34:361-5. Crossref

Pages